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The laboratory rat is an important experimental model in biomedical research. Rat 
embryonic stem cells (ESCs) are valuable for studying mammalian development 
and for facilitating germ line-modification of rat strains. However, the germline 
contribution of rat ESCs when injected into developing rat embryos can be variable, 
restricting their utility. This investigation addressed two key questions; could rat ESC 
differentiation in vitro be directed towards the germline, and could the proportion of 
cells entering the germ cell lineage be increased by manipulating the gene network 
of epiblast cells? The formation of the unipotent germline precursors known as 
primordial germ cells (PGCs) is induced by BMP4/WNT3-mediated induction of 
essential PGC transcription factors (TFs) BLIMP1, PRDM14 and AP2γ within the 
epiblast. These factors cooperate to direct a small subset of cells at the proximal 
posterior region of the epiblast towards a germ cell fate by re-activating expression 
of naïve pluripotency markers whilst upregulating PGC-specific transcription factors. 
To promote differentiation of rat ESCs into the PGC fate, cells were subjected to a 
differentiation protocol previously developed for mouse ES-to-PGC-like cell 
(PGCLC) differentiation, which was modified for rat ESCs. Using this protocol, a 
small proportion of rat cells expressing the PGC-associated surface marker CD61 
exhibited enhanced expression of PGCLC gene markers, indicating that the 
differentiation protocol had generated a population of rat PGCLCs. 
To increase the efficiency of PGCLC differentiation, three strategies were 
implemented to manipulate the epiblast gene network to improve the proportion of 
rat ESCs entering the germline lineage. The first strategy involved the use of gene-
editing technology (CRISPR/Cas9), to incorporate a PGC gene cassette expressing 
a transgene copy of Blimp1 immediately downstream of the epiblast gene promotor 
of Brachyury. It was hypothesised that insertion of this gene cassette would drive 
expression of the Blimp1 transgene during the epiblast phase of rat ESC fate 
determination and improve the number of rat PGCLCs generated during PGCLC 
differentiation. Indeed, the proportion of cells expressing the PGC-associated 
surface marker CD61 was elevated compared to the parental unmodified cell line. 
Additionally, CD61+ve cells generated from cells containing the Blimp1 transgene 
displayed increased expression of early PGC markers. 
The second strategy involved the conditional expression of the three key PGC 
transcription factors, Blimp1, Prdm14 and Ap2γ from stably integrated doxycycline-
dependant Tet-On transposon vectors.  
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Stably transduced cells cultured in doxycycline during embryoid body and PGCLC 
differentiation protocols had a greater proportion of CD61+ve cells and increased 
PGC marker gene expression compared to the parental cell line. This was most 
noticeable in cells expressing Blimp1 and either of the other two PGC transcription 
factors (Prdm14 or Ap2γ).  
Finally, CRISPR/Cas9 gene editing was also used to inactivate the rat Otx2 
transcription factor gene. Deletion of Otx2 in mouse ESCs has been shown to 
increase the proportion of PGCLCs generated during germline differentiation in vitro. 
Similar to exogenous PGC transcription factor expression, rat Otx2-/- knock-out cells 
generated a greater proportion of CD61+ve cells compared to the parental cell line 
when put through a PGCLC differentiation protocol. CD61+ve Otx2-/- cells also had 
increased PGC transcription factor expression compared to the parental cell line, 
suggesting the loss of Otx2 can help drive the expression Blimp1, Prdm14 and 
Ap2γ.  
In conclusion, rat ESCs subjected to a PGCLC differentiation protocol and 
manipulation of PGC transcription factor expression exhibited increased expression 
of PGC markers. However, this response was more limited than that obtained with 
mouse ESCs, a result which is consistent with reduced germ line transmission of rat 
ESCs in chimaeric rats. This difference could be due to the initial pluripotency state 
of rat ESCs; rat ESCs might be in a more committed primed state compared to 
naïve mouse ESCs, reducing their competence for germ cell lineage differentiation. 
Additionally, rat ESCs may require different combinations of signals or regulatory 
factors to ensure efficient germ cell differentiation in vitro. Further development of 
the cell lines and reagents established during this investigation should provide a 




Embryonic stem cells (ESCs) are a useful tool for introducing mutations into the 
germline, studying embryonic development, and are a source of cell types for cell 
replacement therapies. Using modern gene editing technologies, the genomes of 
ESCs can be altered at specific sequences, facilitating the introduction of mutations 
into the genome. Rat ESCs are isolated from a developing rat embryo, retaining 
their potential to become almost any cell type or tissue within the body while being 
propagated in a laboratory. 
When injected into donor embryos, rat ESCs can incorporate into the tissue of the 
embryo to generate chimaeric animals. Within the chimaera, ESCs can contribute to 
the germline (a population of cells responsible for maintaining the reproductive 
cells), producing gametes and thereby facilitating the transmission of the ESC 
genome into the next generation. However, the contribution of rat ESCs to the 
germline is relatively inefficient compared to mouse ESCs in mouse chimaeras.  
The aim of this investigation was to examine why rat ESCs are inefficiently 
incorporated into the germline and to explore options for improving their contribution 
to that lineage. This knowledge could be used to improve the utility of rat ESCs in 
transgenic research. 
During early embryonic development, a small population of cells are set aside from 
the majority that contribute to tissues required the development of body (somatic) 
tissues and are directed to become the precursor cells of the germline (PGCs). 
These PGCs give rise to the reproductive cells, sperm and eggs. PGC formation can 
be induced by activating the expression of key transcription factor proteins (BLIMP1, 
PRDM14 and AP2γ) within the early embryonic cells; activating the expression of 
genes required for PGC specification whilst also restricting the expression of genes 
required for somatic cell types. Mouse ESCs were efficiently directed into PGCs 
using a specific germ cell differentiation protocol. Rat ESCs were treated with the 
same protocol and a small sub-population of the rat cells had increased expression 
of genes associated with PGCs. To improve the generation of rat PGCs, three gene-
editing strategies were adopted. 
The first strategy utilised gene-editing technology (CRISPR/Cas9) to place a copy of 
the rat Blimp1 gene under the control of the Brachyury gene promoter, a gene 
expressed in the embryo during PGC specification. It was hypothesised that forced 
expression of Blimp1 in rat ESCs during the earliest stages of PGC specification 
would increase the formation of rat PGCs.  
viii 
Expression of Blimp1 via the Brachyury promotor increased the expression of early 
PGC gene markers within a sub-population of cells compared to unmodified rat 
ESCs. This indicated that increased expression of factors involved in PGC 
specification can help direct rat ESCs towards the germline. 
The second strategy involved conditional expression of the three key PGC 
transcription factor proteins (Blimp1, Prdm14 and Ap2γ) from an expression vector 
randomly integrated into the genome of rat ESCs. Expression of these transcription 
factor genes was induced by introducing a drug (doxycycline) into the culture 
medium of the cells. Activation of these genes during the germline differentiation 
protocol increased PGC gene marker expression within a sub-population of cells 
compared to unmodified rat ESCs. This was most noticeable when cells were 
induced to express Blimp1 in combination with either of the other two PGC 
transcription factors proteins (Prdm14 or Ap2γ), showing that expression of multiple 
PGC transcription factors increased expression of PGC markers in rat cells.  
The third strategy used gene editing technology to reduce the number of rat cells 
which became non-germline cells (somatic cells). This was achieved by inactivating 
Otx2, a gene reported to be involved in directing cells away from the germline. In 
mice, loss of Otx2 expression increased the proportion of PGCs. Loss of Otx2 in rat 
ESCs decreased the expression of somatic cell gene markers, suggesting the 
capacity of the Otx2 deficient cells to become somatic cells had been comprised. 
However, expression of PGC markers in three independent Otx2 deficient rat ESC 
clones was inconsistent, making it difficult to conclude whether this strategy was 
useful for directing rat cells towards the germline.  
In summary, although the expression of PGC transcription factors in differentiating 
rat ESCs increased expression of PGC gene markers, this response was more 
limited than that obtained with mouse ESCs. This result was consistent with the less 
effective germline contribution of rat ESCs in chimaeras, leading to the conclusion 
that under the current culture conditions the stem cell status of rat ESCs is 
inherently different to mouse ESC. Future studies should explore what these 
differences are and what factors are critical for efficient germline determination in 
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Chapter 1 Introduction 
1.1 Generation of in vitro cell lines from pluripotent 
rodent cell lines 
1.1.1 The rat as a model organism 
Model organisms such as rodents are used extensively in research to further our 
understanding of the biological processes which occur throughout growth and 
development. Over the last century, the laboratory rat has been used as a model for 
studying many aspects of mammalian biology, including physiology, immunology 
and toxicology (Jacob 1999, Aitman et al. 2008). There are now a large number of 
different inbred rat models available, giving researchers the opportunity to explore a 
range of different biomedical and developmental research questions (Jacob 1999, 
Aitman et al. 2008). A key advantage of the laboratory rat is that it is both 
metabolically and physiologically more similar to humans than the mouse, another 
popular rodent model organism (Gibbs et al. 2004, Blais et al. 2007). In stem cell 
biology, a gold-standard method for interrogating the pluripotency of in vitro cultured 
stem cells is to inject the cells into a blastocyst and determine whether the injected 
cells can contribute to the developing embryo. If these embryos survive the 
procedure, the offspring produced will be chimeras, animals which contain two or 
more genetically distinct cell types derived from more than one zygote. It has been 
proven that in vitro derived rat pluripotent stem cells can contribute to the developing 
germ cell layers and the germline of a host embryo, producing chimaeric rat models 
for future scientific study (Iannaccone et al. 1994, Buehr et al. 2008, Li et al. 2008). 
These characteristics, coupled with other advantages such as a fast generation time 
compared to larger mammalian species, makes the laboratory rat a useful model 
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1.1.2 Early rodent embryogenesis 
The early development of the albino rat (Mus Norvegicus Albinus) was first 
described in 1915, detailing the stages of rat embryogenesis from the establishment 
of the early rat zygote, to the formation of the egg cylinder and its subsequent 
development until ~E9 days post coitum (dpc) (Huber 1915). The developmental 
stages of the rat embryo have since been investigated further (Butcher 1929, 
Nicholas & Hall 1942, Krehbiel 1962, Tarkowski 1962, Schlafke & Enders 1963), 
revealing a similarity in the development of the rat embryo to that of the mouse. As 
the embryonic structures produced during both mouse and rat embryogenesis 
appear consistent, it has become widely accepted that rat embryogenesis follows 
the same developmental pattern to that of the mouse embryo. Comparing the two 
species to the Carnegie staging system developed from the early work of Streeter 
(1942) and O’Rahilly & Müller (1987) (the 23 stages of embryo development used to 
standardise embryogenesis between different vertebrate species), one crucial 
difference between the two is rat embryogenesis is ~1-2 developmental days behind 
that of the mouse. For instance, the mouse embryo reaches the blastocyst stage of 
development at ~E3.5 dpc, compared to the rat which reaches the same stage at 
~E4.5 dpc (Casanova et al. 2012). This section summarises the development of the 
rodent fertilised zygote up until the formation of the early germ cell progenitors. The 
dpc times presented represent the stages during mouse embryogenesis, as this is 
more widely represented in the literature compared to the rat.  
Once fertilised, the rodent zygote undergoes multiple cellular divisions to form a 
cluster of cells (blastomeres) known as the morula (Bedzhov et al. 2014). At this 
stage, blastomeres are totipotent cells, meaning they are capable of differentiating 
into any cell type of the developing embryo including the placenta (Nichols & Smith 
2009). Further cellular division and differentiation of the blastomeres within the 
morula gives rise to the early blastocyst at ~E3.5 dpc in mice, a heterogeneous 
structure composed of trophoblast cells (trophectoderm precursors cells) 
surrounding an inner cell mass (ICM) (Figure 1.1.1) (Bedzhov et al. 2014).  
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Figure 1.1.1. Formation of the mouse blastocyst. The fertilised egg (zygote) undergoes multiple 
rounds of cellular divisions (between E0.5 – E2.5 dpc) to give rise to the Morula, a mass of ~16 cells 
(blastomeres). The cells within the morula will continue to divide and form the early blastocyst (E3.5 
dpc). 
Prior to implantation, the ICM is the naïve compartment of the embryo, harbouring 
the pluripotent cells which will differentiate into the three germ layers, ectoderm, 
endoderm and mesoderm (Nichols & Smith 2009, Nichols & Smith 2011, Bedzhov et 
al. 2014). Cells from the ICM can be isolated and injected into the blastocyst of a 
recipient embryo, contributing to all three germ layers of the host embryo to form a 
chimaeric animal (Nichols & Smith 2009, Nichols & Smith 2011, Bedzhov et al. 
2014). Just before implantation, the ICM segregates into two distinct cell types, the 
epiblast and hypoblast (Nichols & Smith 2009, Nichols & Smith 2011, Bedzhov et al. 
2014, Irie et al. 2014) (Figure 1.1.2). The cells within the epiblast retain the ability to 
differentiate into the germ layers, while the hypoblast cells predominantly 
differentiate into the primitive endoderm (Nichols & Smith 2009, Nichols & Smith 
2011, Bedzhov et al. 2014, Irie et al. 2014).  
 
Figure 1.1.2. Late blastocyst stage of mouse. After blastocyst formation (E3.5 – E4.5 dpc in mice), 
the ICM segregates into the epiblast and the hypoblast. This structure is known as the late blastocyst.  
After implantation (E4.5< dpc in mice), epiblast cells in the developing rodent 
embryos form a cup-shaped epithelium (egg cylinder), a structure different from the 
bilaminar disc seen in other mammalian species such as humans and pigs (Figure 
1.1.3) (Nichols & Smith 2011, Irie et al. 2014, Irie et al. 2015, Wang et al. 
2016).Analysing the gene expression profile of pre- and post-implantation embryos 
has revealed that the expression of naïve stem cell markers such as Nanog is 
reduced after implantation, while the expression of markers of primed cells such as 
Brachyury and Fgf5 increases (Chambers et al. 2003).  
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These results suggest that the cells comprising the post-implantation embryo are 
more “primed” for differentiation than the naïve cells present within the pre-
implantation embryo. Epiblast stem cells (EpiSCs) are pluripotent stem cells 
generated from the successful isolation and in vitro culture of the cells found within 
the ICM of the post implantation epiblast (Tesar et al. 2007, Brons et al. 2007). Cells 
isolated directly from the post-implantation epiblast or cultured in vitro as EpiSCs do 
not form chimeras when injected into a pre-implantation embryo, but they have been 
reported to contribute to all three germ layers ex vivo (Gardner 1985, Tesar et al. 
2007, Brons et al. 2007, Rossant 2008). It has been reported that unlike ESCs, 
EpiSCs derived from either post-implantation embryos or via the differentiation of 
ESCs into EpiSCs can contribute to chimeras when injected into early post-
implantation embryos (Huang Y et al. 2012). Despite the similarity in pluripotency 
gene expression, the cells of the post implantation embryo appear to have a 
different developmental potential compared to the cells of pre-implantation embryo. 
The majority of the cells within the epiblast will then contribute further to the embryo 
proper, reorganising during gastrulation and differentiating into the tissue/cell 
progenitors for all three germ layers (ectoderm, endoderm and mesoderm) (Nichols 
& Smith 2009, Nichols & Smith 2011, Bedzhov et al. 2014).  
 
Figure 1.1.3. Formation of the egg cylinder in mice. After implantation (E4.5 – E5.0 dpc in mice), 
the late blastocyst matures into the egg cylinder. Rapid proliferation of the epiblast and trophectoderm 
occurs, causing the cells to grow and re-order themselves into the blastocyst cavity. Cells generated 
from the trophectoderm make up the extra-embryonic ectoderm (EXE). The differentiating hypoblast 
cells surrounds the epiblast and EXE cells, forming the visceral endoderm (VE).  
However, a small proportion of cells within the post-implantation epiblast do not 
enter the somatic pathway but instead are fated to give rise to primordial germ cells 
(PGCs). PGCs are the unipotent precursor cells of gametes and first emerge in the 
proximal posterior region of the epiblast (Ohinata et al. 2005, Dudley et al. 2007, 
Rao et al. 2010, Welling & Geijsen 2013, Günesdogan et al. 2014, Irie et al. 2014).  
Their formation is stimulated by BMP4 and WNT3 signals generated by the 
extraembryonic ectoderm and visceral endoderm (Winnier et al. 1995, Ohinata et al. 
2005, Rao et al. 2010, Günesdogan et al. 2014). These intercellular signals induce 
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the expression of PGC transcription factors which drive the cells towards the germ 
cell lineage (Ohinata et al. 2005, Dudley et al. 2007, Rao et al. 2010, Günesdogan 
et al. 2014). Once established, PGCs begin to multiply and then migrate through the 
developing hindgut, accumulating at the site of the embryonic gonad by mid-
gestation (~E11.5 dpc in mice) (Ohinata et al. 2005, Richardson & Lehmann 2010, 
Günesdogan et al. 2014) (Figure 1.1.4). After migration, PGCs differentiate into the 
cell types which form the adult reproductive cells (Ohinata et al. 2005, Richardson & 
Lehmann 2010, Günesdogan et al. 2014).  
 
Figure 1.1.4. Generation of mouse primordial germ cells (PGCs). A small proportion of epiblast 
cells in the proximal region of the rodent embryo are stimulated to differentiate into the unipotent germ 
cell precursor cells, primordial germ cells (PGCs) via extracellular signalling from the extra-embryonic 
ectoderm (EXE) and visceral endoderm (VE). These cells migrate through the developing embryo and 
accumulate at the embryonic gonad by ~11.5 dpc in mice.  
1.1.3 Derivation and in vitro culture of rodent pluripotent stem cells 
1.1.3.1 Mouse pluripotent stem cells 
Embryonic stem cells (ESCs) are pluripotent cells derived from the undifferentiated 
ICM of pre-implantation embryos. ESCs can be maintained for prolonged periods in 
tissue culture conditions and be induced to differentiate into the three primary germ 
layers, ectoderm, endoderm and mesoderm. The method for deriving and culturing 
mouse ESC lines in vitro was established by two research groups independently in 
1981 (Evans & Kaufman 1981, Martin 1981). Since then, the derivation protocol has 
been further optimised to generate one of the most widely used mammalian ESC 
models in scientific research. Naïve cells contained within the mouse epiblast can 
be isolated from the ICM (~E3.5 dpc) and captured in a self-renewing ESC state in 
vitro by culturing them either on mouse embryonic fibroblast (MEF) feeder layers or 
feeder-free (e.g. on gelatin-coated plates) (Ward et al. 2002, Czechanski et al. 2014) 
(Figure 1.1.5). The established cell culture mediums for mouse are a basal medium 
supplemented with FCS (foetal calf serum) and LIF (leukaemia inhibitory factor) 
(Williams et al. 1988) or 2i+LIF conditions, a culture medium containing a MEK 
(mitogen activated protein kinase) and GSK3 (glycogen synthase kinase) inhibitor in 
addition to LIF (Silva et al. 2008, Ying et al. 2008).  
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These culture mediums have been optimised to retain the self-renewal capability 
associated with cells of the pre-implantation epiblast. ESCs cultured in 2i+LIF 
medium are characterised by the expression of the core pluripotency factors (e.g. 
Nanog) (Chambers et al. 2003), as well as widespread hypomethylation of the 
genome (Leitch et al. 2013, Habibi et al. 2013, Bagci et al. 2013). Cultured mouse 
ESCs can be injected into a blastocyst and contribute to the developing embryo to 
form chimeras. However, certain strains of mouse ESCs develop chimeras which 
have poor viability or abnormalities during development, such as the inbred strain 
C57BL/6 (Eggan et al. 2001). There is also reported to be variability in the germline 
competency of mouse ESC strains (the ability of ESCs to contribute to the germline 
of the embryo). For instance, the germline competency of the mouse ESC strains 
DBA/1Ola, BALB/c, and FVB/N are all thought to be lower than that of ESCs derived 
from the 129 strain of mouse strains (129/Sv, 129/SvEv, and 129/Ola) (Auerbach et 
a. 2000, Ware et al. 2003). This has been suggested to be due to inherent issues 
acquired during the derivation of these inbred strains impacting their ability to enter 
the germ cell lineage.  
 
 
Figure 1.1.5. ESC derivation. Cells harvested from the ICM of a pre-implantation embryo can be 
cultured in vitro in culture medium such as 2i+LIF.  
Primed pluripotent stem cells, referred to as epiblast-derived stem cells (EpiSCs), 
are derived by explanting cells from the epiblast of post-implantation embryos and 
culturing them in culture medium often supplemented with either FCS or knock-out 
serum replacement (KSR), Activin A and FGF2 (bFGF) (Tesar et al. 2007, Brons et 
al. 2007) (Figure 1.1.6). It is also possible to irreversibly differentiate ESCs into 
EpiSCs by culturing them in N2B27 culture medium supplemented with Activin A and 
bFGF (Guo et al. 2009). EpiSCs express the core pluripotency factors found in 
ESCs (e.g. Nanog, Oct4, Sox2) and can form teratomas when injected into 
immunodeficient mice (Tesar et al. 2007, Brons et al. 2007).  
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However, EpiSCs have a distinct “primed” gene expression profile compared to 
ESCs, increased DNA methylation of gene promotors, and are not incorporated 
efficiently into the germline of chimaeric animals if injected into a blastocyst (Brons 
et al. 2007, Guo et al. 2009, Veillard et al. 2014).  
 
Figure 1.1.6. EpiSC derivation. Cells isolated from the epiblast cells of a post-implantation embryo 
can be cultured in vitro in a chemically defined culture medium (Knock-out DMEM + Fetal Calf Serum 
(FCS) or Knock-out serum replacement (KSR)) supplemented with Activin A and bFGF.  
It is also possible to derive pluripotent cell lines by isolating and maintaining PGCs 
in vitro from the developing embryo (Matsui et al. 1992, Resnick et al. 1992). PGCs 
can be retained and will proliferate in vitro when the cells are cultured in DMEM with 
FCS supplemented with LIF and bFGF (Matsui et al. 1992, Resnick et al. 1992, 
Durcova-Hills et al. 2006). The explanted PGCs transition into embryonic germ cells 
(EGCs), cells which share similar characteristics to ESCs derived from the pre-
implantation embryo, such as the ability to form chimeras when injected into an 
embryo (Matsui et al. 1992, Resnick et al. 1992, Labosky et al. 1994, Stewart et al. 
1994) and the expression of pluripotency factors (Buhr et al. 2008, Hochedlinger 
2011). 
 
Figure 1.1.7. EGC derivation. Primordial germ cells (PGCs) isolated from the developing embryo can 
be cultured in vitro in either serum culture medium or in 2i+LIF. These cells transition into embryonic 
germ cells (EGCs), cells with similar properties to ESCs.  
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1.1.3.2 Rat pluripotent stem cells 
Early attempts to derive rat ESCs from blastocysts using similar techniques as those 
used to generate mouse ESC lines proved unreliable, generating cell lines with high 
variability in their potential to form chimaeras and to contribute to the tissue of a host 
blastocyst (Ouhibi et al. 1995, Stranzinger 1996, Vassilieva et al. 2000, Buehr et al. 
2003). These cell lines also suffered from cell heterogeneity and spontaneous 
differentiation during in vitro cell culture (Ouhibi et al. 1995, Stranzinger 1996, 
Vassilieva et al. 2000, Buehr et al. 2003).  
Direct genetic modification of germ cells and zygotes has been demonstrated to be 
capable of generating genetically modified rats without the need for deriving rat 
ESCs (Smits et al. 2006, Geurts et al. 2009, Izsvảk et al. 2010). Although these 
approaches proved a useful alternative to avoid the apparent issues with in vitro rat 
ESC derivation, extensive screening methods to identify suitable candidates were 
required and the generated cells were far more limited in their usefulness to 
generate reporter cell lines (Smits et al. 2006, Geurts et al. 2009, Izsvảk et al. 2010). 
Similar to the mouse, rat PGCs could be isolated and cultured in 2i+LIF medium in 
vitro to derive EG cell lines (Leitch et al. 2010). These EG cell lines share similar 
characteristics to other in vitro-derived pluripotent cells, such as the expression of 
the core pluripotency network (Leitch et al. 2010).  
In 2008, the derivation and culture of genuine ESCs from the rat blastocyst was 
accomplished (Buehr et al. 2008, Li et al. 2008), providing another alternative 
source of ESCs from a model which is metabolically close to humans (Gibbs et al. 
2004, Blais et al. 2007). Rat ESC derivation was performed by isolating cells from 
the ICM of rat blastocysts and maintaining them in serum-free 2i culture medium 
(culture medium containing a MEK and GSK3 inhibitor) whilst attached to a MEF 
feeder layer (Figure 1.1.8) (Buehr et al. 2008, Li et al. 2008).  
 
Figure 1.1.8. Rat ESC derivation. Rat cells explanted from the ICM of a pre-implantation embryo can 
be cultured in vitro in 2i+LIF medium on mouse embryonic fibroblast (MEF) layers.  
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These rat ESC lines have been shown to exhibit all the properties of naïve 
pluripotent cells such as being responsive to LIF (improving the stability of the cells 
in culture), a capacity for clonal expansion and have the ability to contribute to the 
germline of chimaeras. The addition of LIF alongside the 2i inhibitors (2i+LIF cell 
medium) has proven useful in retaining ESCs in a self-renewing pluripotent state by 
blocking MEK/ERK activity and preventing the degradation of β-catenin, a factor 
involved in restricting the repressive action of TCF3 (Figure 1.1.9) (Buehr et al. 
2008, Li et al. 2008, Ying et al. 2008, Meek et al. 2013). 
 
Figure 1.1.9. Model of CHIR99021, PD0325901 and LIF mediated ESC self-renewal during 2i+LIF 
cell culture. TCF3 and LEF1 are involved in driving ESC differentiation.TCF3 represses the 
expression of pluripotent genes, while LEF1 induces differentiation through induction of differentiation 
genes and suppressing pluripotency genes. Both transcription factors are downregulated by the 
presence of CHIR99021 and PD0325901 in the culture medium, assisting in maintaining ESC self-
renewal. CHIR99021 increases β-catenin (β-Cat) stability by reducing wnt signalling inhibition, 
inhibiting TCF3 mediated suppression of pluripotency genes. LIF/STAT3 signalling assists in the 
suppression of Lef1 expression, while also maintaining the expression of pluripotency genes. 
Despite the relative success in the derivation and maintenance of rat ESC lines, 
there are still multiple issues to be resolved to better improve their usefulness as an 
ESC model. Although rat ESCs express the core pluripotency factors, increased 
expression of lineage specific genes suggests that rat ESCs may be more ‘primed’ 
for differentiation than mouse ESCs (Blair et al. 2011, Hong et al. 2013). 2i+LIF 
culture conditions can maintain rat ESCs in a pluripotent and self-renewal state in 
vitro, but spontaneous differentiation can still occur during standard cell culture 
(Buehr et al. 2008, Li et al. 2008, Meek et al. 2013). It has also been noted in our 
laboratory and by colleagues that there is a problem with karyotypic instability of rat 
ESCs, as well as greater variability in the germline competency of rat ESCs 
compared to mouse ESCs (data not published).  
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To generate transgenic animals, it is important that ESCs are incorporated into the 
germline of a developing embryo to facilitate the transmission of the ESC genome 
into the next generation. However, reports have shown variable success rates in the 
generation of chimaeric animals, with some strains of rat being more efficient at 
germline transmission than others (Buehr et al. 2008, Li et al. 2008, Ueda et al. 
2008, Li et al. 2008, Zhao et al. 2010). This variability in germline transmission can 
restrict the utility of rat ESCs as a tool for scientific research. Therefore, a better 
understanding of the ESC genetic background and the conditions required for rat 
germline determination both in vitro and in vivo is required. 
 
1.2 Derivation of the germline 
1.2.1 Primordial germ cells (PGCs) 
Mammalian germ cell specification begins after blastocyst implantation, where a 
small proportion of post-implantation cells found in the proximal posterior region of 
the embryo are diverted from differentiating into somatic precursor cells and instead 
differentiate into the unipotent germline precursor cells, referred to as PGCs 
(Ohinata et al. 2005, Dudley et al. 2007, Rao et al. 2010, Welling & Geijsen 2013, 
Günesdogan et al. 2014, Irie et al. 2014).  
An investigation performed in mouse embryos by Saitou et al (2003) found that once 
established, the developing PGCs can be separated into two separate categories, 
Fragilis+ve/Stella–ve or Fragilis+ve/Stella+ve. Cells positive for both genes (found in the 
centre of PGC clusters) are thought to be the cells destined for the germ cell 
lineage, as the presence of Stella is a hallmark of PGCs (Saitou et al 2003).  
Once formed, the PGC progenitors will multiply and then migrate through the 
developing hindgut and accumulate at the site of the embryonic gonad by mid-
gestation, ~E11.5 dpc in mice (Ohinata et al. 2005, Richardson & Lehmann 2010, 
Günesdogan et al. 2014) and ~E13 dpc in rats (Kemper & Peters 1987). Migrating 
germ cells in mice retain Stella expression (Yeom et al. 1996), but also have a 
strong repression of homeobox genes (e.g. Hoxa1, Hoxb1) (Saitou et al. 2003), 
despite the opposite being true in neighbouring somatic cells. The expression of the 
pluripotency factor Oct4 has also been detected in migratory PGCs of both mice and 
rats (Yeom et al. 1996, Encinas et al. 2012). This retention of pluripotency gene 
expression alongside the repression of differentiation markers is what gives the 
PGCs the pluripotency potential necessary to generate the germline during 
embryogenesis. 
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1.2.2 Driving forces in PGC specification 
To direct the differentiation of epiblast cells towards the germ cell lineage, the BMP 
and WNT signalling cascades induce the expression of three transcription factors 
required for PGC specification, BLIMP1 (PRDM1), PRDM14 and AP2γ (TFAP2C) 
(Figure 1.2.1) (Ohinata et al. 2005, Dudley et al. 2007, Rao et al. 2010, Welling & 
Geijsen 2013, Günesdogan et al. 2014).   
 
Figure 1.2.1. Rodent PGC specification. At ~E6.25 in the mouse post-implantation embryo, signalling 
molecules (e.g. BMP4) are secreted from the extraembryonic ectoderm (EXE) and visceral endoderm 
(VE), activating signal pathways which drives the differentiation of epiblast cells in the proximal region 
of the egg cylinder towards the embryonic mesoderm (EM) or PGC precursor cells  
1.2.2.1 BLIMP1: The transcriptional repressor 
BLIMP1 (B-lymphocyte-induced maturation protein 1 or PR domain-containing 
protein 1 (PRDM1)) belongs to the PRDM SET domain family of proteins and is 
induced by the BMP4-SMAD1/5 signalling pathway (Ohinata et al. 2005, Dudley et 
al. 2007, Fog et al. 2012, Günesdogan et al. 2014) (Figure 1.2.2). BLIMP1 has been 
reported to be important in mature adult cells; decreased Blimp1 expression in 
human testicular germ cell tumours (Eckert et al. 2008) and in B Cell Lymphoma 
restores the ability of mature adult cells to enter a pluripotent state (Mandelbaum et 
al. 2010). Blimp1 expression is undetectable at the pre-implantation stage of 
embryogenesis (Chu et al. 2011), but is detected within the developing PGC 
progenitor cells and the visceral endoderm (VE) in the mouse post-implantation 
embryo (Ohinata et al. 2005, Vincent et al. 2005). 
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Figure 1.2.2. BMP4 signalling activates Blimp1 expression. BMP4 binds to a BMP receptor, 
inducing the phosphorylation of members of the SMAD family (SMAD1 & SMAD5). This 
phosphorylation activity induces the formation of the SMAD complex (SMAD4 associated with 
phosphorylated SMAD1 and SMAD5) at the promotor region of the Blimp1 gene, inducing the 
expression of the Blimp1 transcription factor.  
 
The BLIMP1 transcription factor is involved in the silencing of the somatic pathway 
during embryogenesis, driving cells at the proximal posterior region of the epiblast to 
differentiate into the germ cell lineage (Ohinata et al. 2005, Bikoff et al. 2009, John & 
Garrett-Sinha 2009, Schäfer et al. 2011). BLIMP1 lacks histone methyl-transferase 
activity in their conserved PR/SET domain (Fog et al. 2012), suggesting it does not 
directly influence histone methylation. Instead, it is reported that BLIMP1 acts as a 
platform, recruiting histone modifying factors such as PRMT5 and histone 
deacetylases (HDACs) to promoter regions, inducing the silencing of target genes 
(Bikoff et al. 2009, Nagamatsu et al. 2011). This role assists in the repression of 
factors which promote the formation of the somatic lineages, such as the homeobox 
genes (e.g. Hoxa1/Hoxb1) and de novo methyltransferases (e.g. Dnmt3a/Dnmt3b) 
(Ohinata et al. 2005, Bikoff et al. 2009, John & Garrett-Sinha 2009, Schäfer et al. 
2011).  
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Inhibiting these factors prevents differentiation of the epiblast cells into somatic cells 
and assists the re-activation of pluripotent factors necessary for PGC development 
(Figure 1.2.3).  
  
Figure 1.2.3. BLIMP1 inhibits somatic differentiation. The BLIMP1 transcription factor acts as a 
scaffold, recruiting histone modifying enzymes and their co-factors to promotor regions of genes which 
drive somatic cell differentiation. Recruitment of these factors induces epigenetic repression of these 
genes, restricting somatic cell differentiation of these cells.  
It is reported BLIMP1 is key to early specification and generation of PGCs, as it is 
the first of three PGC transcription factors to be active during PGC specification in 
the post-implantation embryo (~E6.25 dpc in the mouse) (Ohinata et al. 2005). Loss 
or downregulation of Blimp1 due either to mutation or impaired BMP or WNT 
signalling, can reduce the proportion of epiblast cells transitioning into the PGC 
lineage, as well as inhibiting the proliferation of already established PGCs (Ohinata 
et al. 2005, 2009). Loss of Blimp1 expression has no influence on the derivation or 
growth of in vitro mouse ESCs from Blimp1-/- knock-out embryos (Bao et al. 2012).  
However, overexpression of Blimp1 within mouse ESCs can adversely affect ESC 
colony growth (Nagamatsu et al. 2011), suggesting there is a threshold of Blimp1 
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1.2.2.2 PRDM14: The critical regulator 
PRDM14 (PR domain-containing protein 14) is also a member of the PRDM family 
of proteins and is induced by the BMP4-SMAD1/5 signalling pathway (Ohinata et al. 
2005, Dudley et al. 2007, Fog et al. 2012, Günesdogan et al. 2014). Prdm14 is a key 
component of the pluripotency transcription network and is expressed exclusively 
within PGCs and pluripotent cells (Yamaji et al. 2008, Chia et al. 2010). Similar to 
BLIMP1, PRDM14 lacks histone methyl-transferase activity in the conserved 
PR/SET domain (Fog et al. 2012). After embryo implantation, Prdm14 expression is 
detected in cells contained within the proximal region of the epiblast and is induced 
at ~E6.75 dpc, shortly after the initiation of Blimp1 expression at ~E6.25 dpc 
(Ohinata et al. 2005,Yamaji et al. 2008). Both BLIMP1 and PRDM14 are required to 
drive the differentiation of ESCs towards the PGC lineage (Bikoff et al. 2009, Yamaji 
et al. 2013, Nakaki et al. 2014). PRDM14 is involved in silencing de novo 
methyltransferases (e.g. Dnmt3a/Dnmt3b) and FGF receptors via the recruitment of 
polycomb repressor complexes (such as PRC2) (Yamaji et al. 2013, Nakaki et al. 
2014). This prevents hypermethylation of genes encoding transcription factors 
required for PGC development and genes required to maintain stem cell self-
renewal (Figure 1.2.4) (Nakaki et al. 2014).  
 
Figure 1.2.4. PRDM14 inhibits expression of pluripotency gene repressors. The association of 
PRDM14 with the polycomb repressor complexes (e.g. PRC2) induces epigenetic silencing of de novo 
methyltransferases (e.g. Dnmt3a/Dnmt3b) and FGF receptors. This silencing reduces DNA methylation 
and allows for the re-activation of pluripotency factors required for self-renewal and PGC specification.  
However, PRDM14 is also involved in the re-activation of pluripotent factors during 
PGC differentiation by co-operating with the transcription factors NANOG and 
Estrogen-Related Receptor Beta (ESRRβ) at enhancer elements of target genes 
(Yamaji et al. 2013, Nakaki et al. 2014).  
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This dual repressive and active function of PRDM14 assists the establishment of 
self-renewing PGCs (Yamaji et al. 2013, Nakaki et al. 2014). Mice lacking functional 
expression of Prdm14 are viable but they are infertile due to the lack of germ cells 
(Nakaki et al. 2014). In the absence of functional BMP4 and WNT3 signalling 
cascades, differentiated mouse cells have reduced Prdm14 and Blimp1 expression, 
resulting in little to no germ cell formation (Bagci & Fisher 2013). It is hypothesised 
that epiblast cells destined for the PGC lineage were able to repress the somatic 
mesodermal program due to the presence of functional BLIMP1 activation, but PGC 
progenitors lacking Prdm14 expression are lost due to their inability to re-acquire 
self-renewal capability (Ohinata et al. 2009, Nakaki et al. 2014). 
 
1.2.2.3 AP2γ: The mediator 
AP2γ (or TFAP2C) is a member of the family of AP2 transcription factors and is a 
downstream target of the BLIMP1 transcription factor (Eckert et al 2005, Kurimoto et 
al. 2008, Schäfer et al. 2011). It is expressed in several locations throughout the 
developing embryo, including PGCs and the trophectoderm (Auman et al. 2002, 
Kurimoto et al. 2008, Schäfer et al. 2011). Ap2γ is expressed at ~E7.25 dpc in 
mouse PGCs, after the induction of both Blimp1 and Prdm14 gene expression 
(Kurimoto et al. 2008, Schäfer et al. 2011). Ap2γ is reported to be involved in the 
suppression of genes which induce terminal differentiation, apoptosis and factors 
which slow cellular growth (Schäfer et al. 2011, Günesdogan et al. 2014). The AP2γ 
transcription factor is enriched at promotor/enhancer binding sites of both BLIMP1 
and PRDM14 (Günesdogan et al. 2014). A complete loss of Ap2γ expression is 
embryonic lethal, resulting in the loss of the developing embryo at ~E6.5 due to 
defects in the development of the placenta (Auman et al. 2002, Werling & Schorle. 
2002). However, inducing the loss of Ap2γ transcription factor expression in the 
mouse via a floxed Ap2y gene results in the loss of PGCs at ~E8.5 dpc, producing 
infertile offspring (Weber et al. 2010). The loss of Ap2γ can also result in de-
repression of mesoderm markers such as Hoxa1 and Hoxb1, and a failure to 
upregulate genes associated with PGC specification, such as Stella and Nanos3 
(Figure 1.2.5) (Auman et al. 2002).  
The AP2γ transcription factor is considered to be an important mediator of PGC 
specification, either by ensuring self-renewal and the continued proliferation of 
PGCs by either acting as a co-factor for both BLIMP1 and PRDM14, or by directly 
assisting the upregulation of pro-PGC and/or downregulation of pro-somatic genes.  
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Figure 1.2.5. AP2γ supports BLIMP1 and PRDM14 activity. AP2γ associates with BLIMP1 and 
PRDM14 at their sites of activity, supporting the suppressive/active function in PGCs to repress 
somatic cell differentiation and retain cell pluripotency.  
 
1.2.2.4 The role of the Wnt signalling cascade 
Both the BMP4 and WNT3 signalling pathways are required for successful PGC 
specification (Ohinata et al. 2005, Dudley et al. 2007, Günesdogan et al. 2014). 
While BMP4 is required for the activation of Blimp1 and Prdm14 expression during 
the early stages of PGC specification (Ohinata et al. 2005, Dudley et al. 2007, 
Günesdogan et al. 2014), the WNT3 signalling cascade is reported to sustain the 
expression of the PGC transcription factors via the mesodermal factor Brachyury 
(Rivera-Pérez & Magnuson 2005, Rao et al. 2010, Aramaki et al 2013). WNT3-/- 
mice have impaired WNT3/β-catenin signalling in EpiLCs (Armaki et al. 2013). 
Brachyury is a downstream target of the WNT3/β-catenin signalling cascade, 
primarily expressed in the post-implantation epiblast and within the primitive streak 
during gastrulation (Rivera-Pérez & Magnuson 2005). BRACHYURY is also involved 
in the formation of the mesoderm during embryogenesis and the differentiation of 
epiblast cells into the somatic lineage (Winnier et al. 1995, Rivera-Pérez & 
Magnuson 2005).  
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It is reported that the BRACHYURY transcription factor can interact with the 
regulatory factors driving Blimp1 and Prdm14 expression, positively influencing the 
expression of both PGC transcription factors (Aramaki et al 2013) (Figure 1.2.6).  
 
Figure 1.2.6. WNT3 signalling sustains Blimp1 and Prdm14 expression during PGC 
specification. Wnt3 binds to a frizzled receptor, inhibiting GSK3 activity. Reduced GSK3 stabilises β-
catenin (β-cat) expression, which associates with TCF to induce the expression of Brachyury. The 
BRACHYURY transcription factor (T) then binds to the enhancer elements upstream of the Blimp1 and 
Prdm14 genes, maintaining their expression as PGCs migrate through the embryo to the site of the 
embryonic gonad.  
Loss of functional BRACHYURY protein has a negative effect on the expression of 
all three PGC transcription factors (BLIMP1, PRDM14, AP2γ) during the late streak 
stages of mouse embryogenesis (~E7.0) (Aramaki et al 2013). It is therefore 
suggested that although BMP4 signalling alone is sufficient to initiate Blimp1 and 
Prdm14 expression in the early stages of PGC specification (Ohinata et al. 2005, 
Dudley et al. 2007, Günesdogan et al. 2014), BRACHYURY is required to ensure 
the successful maturation of the developing PGCs and to retain PGC transcription 
factor expression during their migration towards the genital ridges (Aramaki et al 
2013). However, it has been proposed that Brachyury is not required for the 
generation of human in vitro derived-PGC like cells (PGCLCs) and it is instead the 
WNT-driven expression of EOMEs which helps drive human germ cell fate 
determination (Kojima et al. 2017, Chen et al. 2017).  
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Perhaps these results suggest that it is not the specific action of Brachyury that 
helps to drive the expression PGC factors, but the generation of a PGC-progenitor 
niche environment via functional WNT signalling and the activation of its 
downstream targets.  
 
1.2.3 Generation of in vitro-derived PGCLCs 
Mouse ESCs can be induced to differentiate into the germ cell lineage by a two-step 
protocol developed by Hayashi et al (Hayashi et al. 2011, Hayashi & Saitou 2013). 
ESCs are differentiated into primed epiblast-like cells (EpiLCs) and then induced to 
form primordial germ cell-like cells (PGCLCs) (Figure 1.2.7) (Hayashi et al. 2011, 
Hayashi & Saitou 2013).  
 
Figure 1.2.7. The “Hayashi” PGCLC differentiation protocol. ESCs represent the cells found in the 
ICM of a pre-implantation blastocyst. EpiLCs have similar characteristics and differentiation potential to 
the epiblast cells of a post-implantation embryo. Cells cultured in suspension in PGCLC medium, 
referred to as PGC-like cells (PGCLCs), share similar characteristics to the migratory PGCs found in 




(N2B27 + KSR + Activin A + bFGF)  
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EpiLC differentiation medium, a basal medium containing bFGF and Activin A, is 
used to direct the differentiation of ESCs into a primed epiblast-like state (Hayashi et 
al. 2011, Hayashi & Saitou 2013). Although they share similar characteristics to the 
post-implantation embryo, the transcriptome of EpiLCs is considered to be distinct 
from EpiSCs (Ohinata et al. 2009). The EpiLC state is considered to be a necessary 
transitionary phase of mouse PGCLC differentiation, making the cells more 
responsive to the germ cell inducers present during the second stage of the protocol 
(Hayashi et al. 2011, Hayashi & Saitou 2013). EpiLCs are then transferred into 
PGCLC medium in suspension culture to form multiple small aggregates (Hayashi et 
al. 2011, Hayashi & Saitou 2013). The PGCLC differentiation medium contains a 
cocktail of cytokines (BMP4, BMP8a, SCF, EGF, LIF) which are reported to assist 
cellular differentiation into the germ cell lineage (Hayashi et al. 2011, Hayashi & 
Saitou 2013). Mouse PGCLCs can be isolated from the resulting cell pools by 
fluorescent activated cell sorting (FACs), based on co-expression of the surface 
markers SSEA-1 and CD61 (Hayashi et al. 2011, Hayashi & Saitou 2013). Isolation 
of PGCLCs is confirmed by qRT-PCR analysis, checking for the expression of the 
key PGC transcription factors (Blimp1, Prdm14, Ap2γ) and PGC associated marker 
genes (Nanos3, Dazl, etc) (Hayashi et al. 2011, Hayashi & Saitou 2013).  
The PGCLC differentiation protocol described above has also been successfully 
adapted for other model systems, including porcine (Wang et al. 2016) and human 
(Meyenn et al. 2016) induced pluripotent stem cells (IPSCs). Despite being a well-
established scientific model, there currently is no published report showing 
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1.3 Aims 
Mouse cells can be differentiated in vitro into the germ cell lineage and can 
successfully contribute to the germline in chimeras (Hayashi et al. 2011, Hayashi & 
Saitou 2013). Although EGCs lines can be derived from rat embryos by dissociating 
cells from genital ridges and culturing them in 2i+LIF culture conditions (Leitch et al. 
2010), there is currently no published data showing successful generation of rat 
PGCLCs from in vitro cultured rat ESCs. Therefore, could similar differentiation cues 
be used to direct the differentiation of rat ESCs towards the germline? This 
investigation has two aims; 1) to direct the differentiation of rat ESCs to the germline 
using a PGCLC differentiation protocol, and 2) to improve the number of cells 
directed towards the PGC lineage by manipulating the gene network of epiblast 
cells. To accomplish the first of these aims, the PGCLC differentiation protocol 
developed by Hayashi et al (2011, 2013) was tested and adapted for rat ESC 
culture. To achieve the second aim, the epiblast gene network of rat ESCs was 
manipulated by using gene editing technology to ‘hijack’ or ‘rewire’ epiblast gene 
expression to direct cells towards the germ cell lineage and to direct cell 
differentiation away from the somatic lineage.  
In addition, expression of key PGC transcription factors via a dox-inducible Tet-On 
piggyBac transposon vector was used to drive PGCLC differentiation. Both 
approaches built upon the current model of in vitro PGC specification, and 
attempted to improve understanding of mechanisms regulating rat ESC 
differentiation potential.  
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Chapter 2 Materials and Methods 
2.1 General solutions 
LB agar 
1% w/v Bacto-trytone (Difco, 211705), 0.5% w/v Bacto-yeast extract (Difco, 




1% w/v Bacto-trytone, 0.5% w/v Bacto-yeast extract, 1% w/v NaCl, Made to pH 7 
and autoclaved 
 
Cell lysis buffer 
100mM Tris-HCL (pH 8.5), 5mM EDTA (pH 8.0), 0.2% w/v SDS, 200mM NaCl. 
Solution made up to 500mls, filter sterilised using a 0.22µM filter and stored at room 
temperature for up to one year. 
 
PBS 
137mM NaCl, 2.7mM KCl, 4.3mM Na2HPO4, 1.47mM KH2PO4, made to pH7.4 
 
PBS-T 
PBS, 0.1% v/v Tween-20 
 
PFA (4%) 
4% w/v in PBS, dissolved at 70oC for 2 hours 
 
TAE (50x) 
2M Tris, 50mM EDTA, made to pH 7.7 
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2.2 Cell culture solutions & culture mediums 
2.2.1 Cell culture reagents 
Table 2.2.1. List of reagents used during cell culture. 
Reagent Company Reference code 
Activin A Peprotech 120-14 
B27 supplement Gibco™ 12587-010 
β-mercaptoethanol InvitrogenTM 21985-023 
bFGF InvitrogenTM 13256-029 
BMP4 R&D Systems 314-BP-010 
BMP8b R&D Systems 1073-BP-010 
Chicken serum GibcoTM 16110082 
CHIR99021* Axon Medchem 1386 
DMEM/F12 (1:1) Gibco™ 21331-020 
DMSO Sigma-Aldrich™ D2650 
Epidermal growth factor (EGF) R&D Systems 2028-EG-010 
ESGRO® LIF Millipore ESG1106 
Fetal Calf Serum (FCS) GibcoTM 10270-106 
GMEM InvitrogenTM 11710-035 
Knockout Serum Replacement (KSR) InvitrogenTM 10828-028 
L-glutamine (L-Glut) Gibco™ 25030-024 
N2 supplement Gibco™ 17502-048 
Neurobasal Gibco™ 21103-049 
Non-essential amino acids (NEAA) Gibco™ 11140035 
Optimem GibcoTM 11058021 
PD0325901** Axon Medchem 1408 
Stem cell factor (SCF) R&D Systems 455-MC-010 
Sodium pyruvate Gibco™ 11360039 
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2.2.2 Culture mediums 
N2B27 Medium 
DMEM/F12 (1:1), Neurobasal, 0.5% N2 supplement, 1% B27 supplement, 2mM L-
Glut, 0.1mM β-mercaptoethanol. Filter sterilised (0.22µM filter) and stored at 4oC for 
up to four weeks. 
 
Rat ESC growth medium - 1i medium 
N2B27 medium, 1µM PD0325901. Filter sterilised (0.22µM filter) and stored at 4oC for 
up to two weeks. 
 
Rat ESC growth medium - 2i+Lif medium 
N2B27 medium, 1µM PD0325901, 2µM CHIR99021, 1000U/ml ESGRO® LIF. Filter 
sterilised (0.22µM filter) and stored at 4oC for up to two weeks. 
 
Epi-like cell differentiation medium (EpiLC medium) 
N2B27 medium, 20ng/ml Activin A, 12ng/ml bFGF, and 1% KSR. Filter sterilised 
(0.22µM filter) and made fresh before each use.  
 
Serum-free GK15 medium (GK15 medium) 
GMEM, 15% KSR, 0.1mM NEAA, 1mM sodium pyruvate , 0.1mM β-
mercaptoethanol, 2 mM L-glut. Filter sterilised (0.22µM filter) and stored at 4oC for 
up to two weeks. 
 
Primordial germ cell differentiation medium (PGCLC medium) 
GK15 medium, 50ng/ml BMP4, 1000U/ml ESGRO® LIF, 10 ng/ml SCF, 50 ng/ml 
BMP8a, and 10 ng/ml EGF. Filter sterilised (0.22µM filter) and made fresh before 
each use. 
 
Feeder medium  
GMEM, 10% FCS, 1x NEAA, 1mM sodium pyruvate, 2mM L-glutamine, 0.1nM β-
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Phosphate buffered saline (PBS) (Tissue culture grade) 
Prepared from commercially available PBS tablets dissolved in tissue grade water 
and autoclave sterilised. 
 
TVP (trypsin)  
0.025% trypsin, 1mM EDTA, 1% chicken serum in PBS. Filter sterilised (0.22µM 
filter) and stored at -20oC for up to one year. Aliquots thawed and stored at 4oC for 
up to two weeks. 
 
Cell freezing mix (2x stock) 
20% FCS and 20% DMSO added to N2B27. Filter sterilised (0.22µM filter) and stored 
at 4oC for up to two weeks. 
 
2.3 Cell culture 
2.3.1 Cell attachment substrates 
Gelatin from porcine skin (Sigma-Aldrich™, G1890-100G)  
Gelatin from porcine skin (0.1% w/v) was introduced to tissue grade water and 
autoclave sterilised.  
 
Laminin (Sigma-Aldrich™, L1010) 
Laminin was pipetted into 100µl aliquots from Engelbreth-Holm-Swarm murine 
sarcoma basement membrane and stored at -20oC.  
 
Fibronectin (Millipore, FC010) 
Human plasma fibronectin was diluted to 16µg/ml in 1xPBS, separated into 50µl 
aliquots and stored at 4oC.  
 
2.3.2 Mouse embryonic fibroblasts (MEFs) feeder layers 
CF1 (GibcoTM, A34181) 
MEFs derived from Carworth CF-1 colony mice. Primarily used for routine 
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DR4 (GibcoTM, A34966) 
MEFs derived from mice generated from an intercross of multiple strains, 
129/SvJae + OlaHsd + BALB/c + C57BL/6. Used when required to culture 
cells in the presence of puromycin. 
 
2.3.3 Gelatin coating 
Wells were coated in 0.1% gelatin for five minutes at room temperature in a tissue 
culture hood. Gelatin was aspirated and the wells allowed to dry for approximately 
five minutes.  
 
2.3.4 Laminin coating 
Wells were coated with 10µg/ml Laminin for at least one hour prior to use at 37oC. 
Laminin solution was aspirated and the well washed three times with 1x PBS. The 
final 1x PBS wash was left and removed immediately prior to plating cells. 
 
2.3.5 Fibronectin coating 
Wells were coated with 16.6µl/ml fibronectin for at least two hours prior to use at 
37oC. Fibronectin solution was aspirated immediately prior to plating cells.  
 
2.3.6 Passaging in vitro cultured ESCs 
The culture medium was aspirated and a minimal volume of TVP added to cover the 
cells (typically 200μl per well of a 24-well plate). Cells were incubated at 37oC, 5% 
CO2 for three minutes and then dispersed to a single cell suspension using a pipette 
(confirm by observing under a light microscope). Cell suspensions were transferred 
to a sterile tube containing 10-20x volume of N2B27 medium and the cells pelleted by 
centrifugation at 1200rpm for 4 minutes. The supernatant was aspirated and the 
cells resuspend in their standard culture medium to an appropriate density, as 
recommended by the chosen cytometric method (typically 1 x 106 / ml using a 
haemocytometer). Cells plated at a density of 1 - 1.5 x 105/cm2 onto a monolayer of 
γ-irradiated MEFs in the appropriate medium. After 24 hours, half of the culture 
medium was removed and replaced with fresh culture medium. Cells were passaged 
every 48 hours or before ~90% well confluency had been reached. 
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2.3.7 Freezing and thawing in vitro cultured cells 
2.3.7.1 Freezing cells 
Single cell suspensions were prepared as described during passaging of in vitro 
cultured ESCs. Cells were pelleted and resuspended in appropriate culture medium, 
transferring at least 5x105 cells to a cryovial (NuncTM Cryotube, Thermo Scientific™, 
375418) in 500μl culture medium. Added an equal volume of 2x freezing mix, gently 
pipetting to ensure uniform distribution of cells. Cryovials were stored at -80oC 
overnight or up to one month. For long term storage, vials were transferred to -
150oC within one week of -80oC storage.  
 
2.3.7.2 Thawing cells 
Frozen cyrovials were collected from -150oC storage on dry-ice and thawed in a 
37oC water bath. The cell stock was transferred into 10mls of pre-warmed (37oC) 
N2B27 in a 15ml sterile falcon tube and pelleted by centrifugation at 1200rpm for 4 
minutes. Supernatant was aspirated and the pellet gently resuspended in 
appropriate cell culture medium. The cell suspension was transferred onto a 
monolayer of γ-irradiated MEFs containing cell culture medium (typically 2-4 x 105 
frozen cell stock/cm2). Any left-over cells were recovered by rinsing the 15ml falcon 
tube with cell culture medium and transferred to the same well. Cells were incubated 
at 37oC, 5% CO2 overnight and the medium replaced with fresh culture medium the 
following morning. 
 
2.3.8 Lipofectamine transfection of ESCs 
ESC transfections were performed using Lipofectamine™ LTX with PLUS™ reagent 
(InvitrogenTM, 15338100), using a protocol adapted from the manufacturer’s 
instructions. Donor DNA mixes were prepared for each individual transfection event 
containing up to 500ng/µl donor DNA (1:1 Hybase (250ng) to donor vector (250ng)) 
and 1µl of plus™ reagent. The mixture made up to 50µl with Optimem. Transfection 
reagent was prepared by mixing 2µl Lipofectamine™ LTX with 48µl Opti-MEM™ for 
each individual transfection reaction. 50µl of transfection reagent was added to 50µl 
Donor DNA mix and incubated for 30 minutes at room temperature. 1 x 105 ESCs 
were introduced into a 24 well containing a monolayer of γ-irradiated MEFs in with 
500µl of 2i+LIF medium. Before the cells had a chance to attach to the feeder layer, 
100µl DNA:LTX mix was added and mixed gently to ensure equal distribution. Cells 
were incubated in the transfection medium overnight at 37oC, 5% CO2.  
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The transfection medium was exchanged for fresh culture medium the following 
morning and the cells allowed to recover over 3-4 days. Half of the culture medium 
was removed and replaced with fresh medium every 24 hours. 
 
2.3.9 Embryoid body (EB) differentiation protocol (rat ESCs) 
2.3.9.1 Generating aggregates  
Single cell suspensions were prepared as described during passaging of in vitro 
cultured ESCs ~2.4 x 106 cells were introduced into a well of a 400 AggreWell™ 
plate (StemCell Technologies, 34415) in 2mls 2i+LIF medium, pelleted into 
microwells by centrifugation for 1 minute at 100xg and incubated for 48 hours. This 
cell density ensured each microwell contained ~2,000 cells. After 24 hours, 1.5mls 
culture medium was aspirated and fresh 2i+LIF medium added. After 48 hours, 
cellular aggregates formed within each microwell were collected in 15ml falcon 
tubes and allowed to pellet by gravity. The culture medium was aspirated and 
replaced with 5mls of feeder medium. Aggregates were gently pipetted up and down 
to prevent clumping while not breaking up the aggregates into single cells. The 
resulting cell suspensions were transferred to 6-well ultra-Low attachment plates 
and cultured for an extended period of time. Care was taken to ensure the 
aggregates were spread evenly across the well to reduce clumping.  
 
2.3.9.2 Plating down aggregates onto gelatin coated plates  
After 4 days culture in 6-well ultra-Low attachment plates, suspended aggregates 
were collected in 15ml falcon tubes and allowed to pellet by gravity. The culture 
medium was aspirated and the aggregates resuspended in 1ml of feeder medium. 
Aggregates were transferred to 6-well tissue culture grade plates coated and 
supplemented with 4mls fresh Feeder medium. Care was taken to ensure 
aggregates were distributed evenly across the plate to reduce clumping. Aggregates 
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2.3.10 Epiblast-like cell (EpiLC) differentiation protocol 
During the course of this investigation, variations of this method were tested. The 
following is a general protocol used to induce EpiLC differentiation of ESCs adapted 
from that used by Hayashi et al (2013).  
12-well culture plates were coated with the designated attachment substrate (e.g. 
Fibronectin, MEFs) up to 24 hours prior to starting the EpiLC differentiation protocol. 
1 - 2 × 105 ESCs were transferred into the coated 12-well culture plates and cultured 
for 48-72 hours in 1ml of EpiLC differentiation medium at 37oC, 5% CO2. The culture 
medium was aspirated and exchanged for fresh EpiLC medium after 24 hours.  
 
2.3.11 Primordial germ cell-like cell (PGCLC) differentiation 
During the course of this investigation, variations of this method were tested. The 
following is a general protocol used to induce PGCLC differentiation of cells which 
have been subjected to the EpiLC differentiation protocol, adapted from that used by 
Hayashi et al (2013).  
Cells were first put through the EpiLC medium differentiation protocol as described 
above (2.3.10). Tissue culture grade 15cm dishes were filled with 10-15mls of 1x 
PBS and stored at 37oC, 5% CO2 1 hour prior to PGCLC differentiation. The EpiLC 
differentiation medium was aspirated and the cells washed three times with 1x PBS 
solution to ensure its complete removal. Cells were trypsinised using 200μl of TVP 
and the detached cellular supernatant transferred to a 15-ml falcon tube with 10-20x 
GK15 medium. The falcon tube was centrifuged at 500xg for 3 min at room 
temperature, and the supernatant removed. The cell concentration was adjusted to 
6.7 × 104 cells per ml with PGCLC differentiation medium. 40-50 hanging drops 
consisting of 30μl of the cell suspension (~2 x 103 cells per drop) were pipetted onto 
the lids of the prepared tissue culture grade 15cm dishes. The hanging drop plates 
were incubated at 37oC, 5% CO2 for 48 hours. The cells within each hanging drop 
are noted to form small aggregates during the 48 hour incubation. After 48 hours, 
hanging drops were washed from the lids of the 15cm dishes with GK15 medium 
and collected in 15ml falcon tubes. Aggregates were allowed to pellet by gravity at 
room temperature and the supernatant aspirated. Aggregates were re-suspended in 
PGCLC differentiation medium and divided between multiple 3cm plates. ~20 
aggregates were added to each 3cm plate to reduce risk of clumping while 
maintaining enough aggregates to promote cell survival.  
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Plates were incubated at 37oC, 5% CO2 for ~96 hours and shook at random 
intervals to reduce clumping of aggregates and attachment to the bottom of the 
plate. Fresh PGCLC medium was introduced to each plate after 48 hours.  
 
2.3.12 Karyotyping cells 
2.3.12.1 Preparation  
Fixative solution (3:1, Methanol : Acetic acid) was prepared and cooled to -20oC 2 
hours prior to karyotyping. Any remaining solution could be stored up to 1 week at -
20oC for future use. 0.56% KCl solution (1.12g KCl in 200mls dH2O) was prepared 
and incubated at 37oC, 5% CO2 for 1 hour prior to karyotyping. Any remaining 
solution was stored at room temperature for future use. 
 
2.3.12.2 Incubation 
KaryoMAX™ Colcemid™ solution (10ug/ml) (GibcoTM, 15212-012) was added at a 
ratio of 1:100 to the fresh culture medium (0.1mg/ml final concentration). The culture 
medium was aspirated from the wells to be karyotyped and was replaced with 
enough Colcemid/media mixture to cover the bottom of the well. The plates were 
incubated 37oC, 5% CO2 for 2 – 3 hours. 
 
2.3.12.3 Collection 
The Colcemid/media mixture was aspirated from each well and the cells trypsinized 
with TVP. Single cell suspensions were generated by triturating in N2B27 medium. 
The resulting cell suspensions were centrifuged at 1200rpm for 4 minutes in a 15ml 
falcon tube and the resulting supernatant aspirated. 
 
2.3.12.4 Swell 
The cells pellets were resuspended in 5mls 0.56% KCl (37oC) and incubated for 10-
15 minutes at room temperature. 100µl of cold fixative was added drop-wise to the 
falcon tubes and the tube inverted several times to ensure proper mixture. The 
resulting cell suspension was centrifuged at 1200rpm for 4 minutes and supernatant 
aspirated.  
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2.3.12.5 Fix 
1ml cold fixative solution was added slowly along the side of the 15ml falcon tube 
and incubated for 30 minutes on ice. The resulting suspension was centrifuged at 
1200rpm for 4 minutes and the supernatant aspirated. 
 
2.3.12.6 Preparation of slides and Imaging  
Small drops (~10µl) of cell suspension were dropped onto the surface of clear glass 
slides. Drops were allowed to spread and dry without disturbance. Glass coverslips 
were mounted onto the slides using VECTASHIELD® Mounting Medium with DAPI 
(Vector labortoies, H-1200). 20-50 images of burst cells taken for each slide/cell line 
at 630x under oil. Chromosomes were counted using the image processing 
programme ‘ImageJ’. Counts were used to estimate the percentage of karyotypically 
normal and abnormal cells within the population.  
 
2.4 Cloning 
DNA fragments were generated either via PCR amplifications, restriction enzyme 
digests or were built by an external company. Generated DNA fragments were 
resolved on TAE agarose gels to determine if its size met expectations. If a single 
fragment was generated, samples were purified using ExoSAP-IT™ PCR clean-up 
(Applied Biosystems, 78200.200.UL) following manufactures instructions. 
Otherwise, the desired fragment was excised from the agarose gel and purified 
using Wizard® SV Gel and PCR Clean-Up System (Promega, A9281). 
 
2.4.1 TOPO cloning 
Purified DNA fragments were added to a PCR reaction mix with a non-proofreading 
Taq Polymerase (NEB, M0273S) and incubated in a thermocycler for 15 minutes at 
72oC. 4µl of PCR reaction mix cloned into the pCR™8/GW/TOPO® vector following 
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2.4.2 Gibson cloning 
Table 2.4.1. Gibson cloning master mix 
Reagent Volume (µl) Final Concentration 
1M Tris-HCL 40 100mM 
1M MgCl2 4 10mM 
dNTPs (100mM) 3.2 0.2mM (each) 
NEB Taq Polymerase (2U/µl) 5 25U/mL 
T5 Exonuclease (10 U/µl) 0.32 8U/mL 
dH2O 147.8  
 
Gibson cloning method: 
10µl aliquot of Gibson cloning master mix was thawed on ice for each vector to be 
ligated. The linearised vector and DNA fragments were added together at a ratio of 
1:3 and 1:5 p/mols. Concentration of vector ranged between 50ng-150ng and the 
total volume was made up to 20ul with dH2O. The Gibson cloning reactions were 
incubated at 50oC for 60 minutes. Samples were then either transferred to ice for 
immediate transformation or stored at -20oC for transformation at a later date.  
 
2.4.3 Bacterial transformations 
2.4.3.1 Standard transformation 
Previously derived/verified vectors were typically transformed at 50ng/µl into 100µl 
of competent DH5α cells (Invitrogen™, 18265017). Aliquots of bacterial culture were 
thawed on ice ~5 minutes prior to transformation. The DNA vectors to be transfected 
were pipetted into the DH5α aliquots and incubated on ice for a further 30 minutes. 
Vector/bacterial mixes were heatshocked at 42oC for 1 minute and then placed back 
on ice for 2 minutes. 900µl of LB medium was added and the vector/bacterial mixes 
incubated on a 37oC shaker for 1 hour. 100, 250 and 500µl of vector/bacterial mixes 
were plated onto 9cm LB agar dishes containing the appropriate antibiotic 
necessary for selection of successful transformants. Even spreading of the bacteria 
was accomplished using disposal plastic bacterial spreaders. Dishes were incubated 
overnight at 37oC to allow colony growth. Colonies were picked in LB medium 
containing the appropriate antibiotic necessary for selection of successful 
transformants.  
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2.4.3.2 High competency transformation 
Vectors generated by Gibson cloning were transformed into NEB® 5-alpha 
Competent E. coli (NEB, C2987H) as this is recommended in the protocols followed 
for Gibson cloning. The method used is very similar to that described in 2.4.3.1, with 
the following changes: 
• 3µl of Gibson master mix was added to a 50µl aliquot of high competency 
bacteria 
• 950µl of SOC medium is added to the vector/bacteria mix after heatshock.  
• 50µl and 250µl of vector/bacterial mixes were plated onto 9cm LB agar 
dishes containing the appropriate antibiotic necessary for selection of 
successful transformants.  
 
2.5 Sample preparation 
2.5.1 Plasmid vector isolations 
2.5.1.1 Minipreps 
Colonies from LB agar dishes were picked and cultured overnight at 37oC in 3mls of 
LB medium containing the appropriate antibiotic necessary for selection of 
successful transformants. The next day, pellets of bacteria were made and re-
suspended in 600µl nuclease-free H2O. The transformed vector was then isolated 
using the PureYield™ Plasmid Miniprep System (Promega, A122), following 
manufacturer’s instructions.  
 
2.5.1.2 Midipreps 
Colonies from LB agar dishes were picked and cultured overnight at 37oC in 50mls 
of LB medium containing the appropriate antibiotic necessary for selection of 
successful transformants. The transformed vector was then isolated using the 
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2.5.2 Genomic DNA isolation 
Genomic DNA was isolated from cells either in suspension or attached to a basal 
membrane using the following method. Cells in suspension were spun at 1200rpm 
for 4 minutes to pellet cells. The supernatant was aspirated and an appropriate 
volume of ESC lysis buffer and 100µg/ml proteinase K (Invitrogen™, AM2548) 
added. Cells were left at 37oC overnight or 50oC for between 1-6 hours to promote 
cell lysis. The lysate was transferred to an Eppendorf with an equal volume of 
isopropanol and centrifuged at 8,000xg for 10 minutes at room temperature. The 
supernatant was removed and the pellet washed twice with 500µl 70% ethanol, 
followed by centrifugation at 8,000xg for 2 minutes at room temperature. After the 
second ethanol wash, the supernatant was removed and the pellet allowed to air-dry 
for 5-10 minutes. The pellet was resuspended in dH2O overnight at 4oC to assist 
resuspension. 
 
2.5.3 RNA isolation 
2.5.3.1 Extraction from tissue 
Small sections of tissue were mixed with 700µl of RLT buffer (Qiagen, 79216) with 
β-mercaptoethanol. Mixes were subjected to multiple rounds of syringe-and-needle 
homogenization until the majority of the tissue had dissolved into the RLT buffer. A 
QIAshredder was used to ensure further homogenisation following manufacturer’s 
instructions (Qiagen, 79654). RNA was isolated from tissue using the RNeasy™ 
Mini Kit (Qiagen, 74104) following the manufacturer’s instructions. The optional 
DNase treatment step was performed, following manufacturer’s instructions 
(Qiagen, 79254).  
 
2.5.3.2 Extraction from cells 
Previously isolated cells were pelleted at 150xg for 5 minutes. The supernatant was 
removed and the cell pellet re-suspended in 1x PBS. The cells were pelleted a 
second time at 300xg for 3 minutes and the supernatant removed. Cell pellets were 
then either transferred to ice for RNA extraction or were stored at -20oC for future 
extraction. RNA was isolated from tissue using the RNeasy™ Mini Kit (Qiagen, 
74104) following the manufacturer’s instructions. The optional DNase treatment step 
was performed, following manufacturer’s instructions (Qiagen, 79254).  
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2.5.4 cDNA synthesis 
cDNA synthesis from RNA samples was performed using SuperscriptTM First Strand 
Synthesis system for RT-PCR (InvitrogenTM, 11904-018) following manufacturer’s 
instructions.  
 
2.5.5 Protein isolation 
2.5.5.1 Attached Cells  
The culture medium was aspirated and the cells washed three times with 1x PBS. 
1ml cold RIPA buffer (Thermo Scientific™, 89900) with Halt Protease Inhibitor 
Cocktail Kit (Thermo Scientific™, 78410) was added to each well and the plate 
incubated on ice for 15 minutes. The lysate was collected and transferred to a 
microcentrifuge tube, centrifuging at ~14,000xg for 15 minutes at 4oC to pellet the 
cell debris. The supernatant was then transferred to a new microcentrifuge tube for 
analysis.  
 
2.5.5.2 Cells in suspension 
Cells were pelleted by centrifugation at 2500xg for 5 minutes at room temperature in 
15ml Falcon tube. The supernatant was aspirated and the cells washed three times 
with sterile 1x PBS, followed by centrifugation at 2500xg at room temperature for 5 
minutes. 1ml cold RIPA buffer (Thermo Scientific™, 89900) with Halt Protease 
Inhibitor Cocktail Kit (Thermo Scientific™, 78410) was added and the falcon tube 
placed on a rotatory shaker for 15 minutes at 4oC. The resulting cell solution was 
centrifuged at ~14,000xg for 15 minutes at 4oC to pellet the cell debris. The 
supernatant containing the isolated protein was transferred to a microcentrifuge tube 
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2.6 Detection and quantitative methods 
2.6.1 Routine PCR 
Routine PCR was performed using Q5® High-Fidelity DNA Polymerase (NEB, 
M0491) following the manufacturer’s protocol. All reaction components were kept on 
ice during set up and quickly transferred to a thermocycler. 
  
Table 2.6.1. Components of routine PCR master mix 
Component Volume Final concentration 
5X Q5 Reaction Buffer 10 µl 1X 
10 mM dNTPs 1 µl 200 µM 
10 µM Forward Primer 2.5 µl 0.5 µM 
10 µM Reverse Primer 2.5 µl 0.5 µM 
Template DNA variable <1,000 ng 
Q5 High-Fidelity DNA Polymerase 0.5 µl 0.02 U/µl 
Nuclease-Free Water to 50 µl N/A 
 
The volume of template DNA used varied depending on the concentration required. 
Used either 1ng – 1ug of Genomic DNA or 1ng – 10ng of Plasmid DNA. 
 
Table 2.6.2. Thermocycling conditions for routine PCR 
Step Temperature Time (secs) 







30 per kb 
Final Extension 72°C 120 
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2.6.2 Quantitative RT-PCR (qRT-PCR) 
cDNA samples were typically diluted 1:50, with 8µl per replicate used for qRT-PCR 
analysis. Analysis was performed using Brilliant III Ultra-Fast SYBR® Green qRT-
PCR Master Mix (Aligent Technologies, 600882), following manufacturer’s 
instructions. qRT-PCR reactions performed using a MX-3000 thermocycler (Aligent 
Technologies).  
 
Table 2.6.3. Thermocycling conditions for qRT-PCR 
Step Temperature Time (secs) 
Initial Denaturation 95°C 120 












2.6.2.1 qRT-PCR Primers (Specificity to both mouse and rat) 














































































2.6.3 Statistical tests 
Unless otherwise stated, the statistical test used on quantifiable data was the 
Student’s T-Test.  
 
2.6.4 DNA sequencing 
500-750ng of purified DNA was mixed with 6.4pmoles of sequencing primer, made 
up to a total volume of 6µl with dH2O. Sequencing was carried out by Edinburgh 
Genomics using BigDye v3.1 Terminator Cycle Sequencing Kit (Thermofisher P/N 
AB0384/240; BS034042) and analysed on a 3730xl DNA Analyzer (Applied 
Biosystems™, 3730xl).  
 
2.6.5 Alkaline Phosphatase staining (Sigma-Aldrich™) 
Alkaline Phosphatase staining was performed using an alkaline phosphatase 
staining kit (Sigma-Aldrich™, 86R-1kT), following the manufacturer’s instructions 
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with minor changes. Solutions for Alkaline Phosphatase staining were made up as 
follows: 
2.6.5.1 Fixative 
5ml citrate solution, 13ml acetone, 1.6ml formaldehyde (37%). Prepare fresh. 
 
2.6.5.2 Stain 
200µl sodium nitrite solution + 200µl FRV-alkaline solution. Incubated for two 
minutes at room temperature then added 9ml MQ water. Added 200µl naphthol AS-
BI alkaline solution, mixed and was used immediately. 
 
2.6.5.3 Protocol 
Extracted tissue was washed with 1x PBS and fixed with fixative solution for five 
minutes to ensure fixative had had time to permeate throughout the tissue. The 
tissue was washed with 5ml MQ H2O 3 times to ensure the fixative had been 
removed. The staining solution was added for 15-30 minutes at room temperature in 
the dark. After staining, the tissue was washed with MQ H2O 3 times to ensure the 
staining solution had been removed. The last MQ H2O was left to ensure the sample 





Dissolved paraformaldehyde (4% w/v) in PBS at 70oC for two hours. Aliquoted and 
stored solution at -20oC for up to four weeks 
 
PBST 
Triton X100 (0.3% v/v) in PBS. 
 
Blocking solution 
Dissolved bovine serum albumin (1% w/v) and serum (10% v/v) (from the same 
species as the secondary Ab was raised in) in PBST. 
2.6.6.2 Fixation of cells 
The cell culture medium was aspirated and each well washed twice with 1x PBS. 
The fixative solution was added to each well and incubated for 15-20 minutes at 
room temperature. Fixative solution was aspirated, and the wells washed three 
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times for 1-2 minutes each in 1x PBS. If the plates were to be stored at this stage, 
the last 1x PBS wash was left, the plate sealed with parafilm and then stored at 4oC. 
2.6.6.3 Permeabilisation/Blocking 
Cells were permeabilised by adding enough ice-cold Methanol to cover the bottom 
of the well and incubating the plate at -20oC for 10 minutes. The methanol was 
aspirated and the cells washed three times for 1-2 minutes each in 1x PBS. Blocking 
solution was added to each well and left for 1 hour at room temperature. 
 
2.6.6.4 Primary antibody staining  
The primary antibody was diluted in the blocking solution at the recommended ratio. 
The blocking solution was removed from the cells and the primary antibody dilution 
added at the manufacturers recommended ratio. Primary antibody staining took 
place overnight at 4oC, with the plate sealed with parafilm to reduce condensation. 
 
2.6.6.5 Secondary antibody staining 
The plate was removed from 4oC and each well washed four times for 5 minutes 
with PBST. Secondary antibody was diluted in blocking solution to the 
manufacturers recommended ratio. Diluted secondary antibody was added to each 
well and incubated for 1 hour at room temperature in the dark as fluorescent 
antibodies are light sensitive. After incubation, each well washed four times for 5 
minutes with PBST. 
 
2.6.6.6 DAPI staining and imaging 
DAPI was diluted 1:10,000 in PBST and added as part of the final wash noted 
above. After final PBST wash, the wells were washed twice with 1x PBS. 
Fluorescent images were taken of each well, the plates sealed in parafilm, and 
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2.6.7 Flow Cytometry and Fluorescent activated cell sorting (FACs) 
If fluorescent antibody staining was not required (e.g. Looking for expression of 
fluorescent marker from incorporated vector), single cell suspensions were made 
and resuspended in 2% FACs buffer (2% FCS in 1x PBS). If fluorescent antibody 
staining was required, single cell suspensions were blocked with 10% FACs buffer 
for 30 minutes to avoid nonspecific antibody binding. 1 – 5 x 105 cells were stained 
with a fluorescent antibody for 1 hour in 10% FACs buffer. Cells were washed 3 
times with 2% FACs buffer and re-suspended in 2% FACs buffer.  
Flow cytometry was performed on a BD LSR Fortessa (16 colour Analyser) with 
High Throughput Sampler. FACs was performed on a BD FACS Aria IIIu 4-laser/11 
detector Cell Sorter, operated by Roslin Bioimaging and Flow Cytometry 
department. The gating strategy used was consistent throughout this investigation 
and so has been summarised here. First, forward (FSC-A) versus side scatter (SSC-
A) was plotted to identify the cells of interest with the expected size and granularity 
of the cells. To remove doublets, forward scatter height (FSC-H) was plotted against 
forward scatter area (FSC-A) and a gate drawn so that only single cells were 
analysed further. Finally, the live cells were then sorted from the dead by staining 
the cells with DAPI. Only the cells which stained negative for DAPI (450/50) were 
analysed further. Further gating, alterations or deviations from this gating strategy 
are detailed in the relevant chapters. 
 
2.6.8 Antibodies and Dyes 
Table 2.6.5. List of antibodies used for Flow, FACs or Immunostaining cells 
Antigen Concentration Species Specificity Marker Ref 













OTX2 1:100 Goat (IgG) Human N/A 
RD 
system, AF1979 


















Dead cell stain: DAPI fluorescent dye (1:10, 000) - Invitrogen™, D1306 
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Chapter 3 Cytokine-mediated induction of 
germline differentiation in 
embryonic stem cells 
3.1 Introduction 
Primordial germ cells (PGCs), the unipotent precursor cells to germ cells can not 
only be isolated from the genital ridges of developing embryos of mouse and rats 
(Matsui et al. 1992, Resnick et al. 1992, Durcova-Hills et al. 2006, Leitch et al. 
2010), but can also be derived in vitro by directing mouse pluripotent embryonic 
stem cells (ESCs) towards the germline by activating the same signalling pathways 
involved in guiding in vivo epiblast cells towards PGCs, e.g. the BMP pathway 
(Ohinata et al. 2005, Ohinata et al. 2009, Hayashi et al. 2011, Hayashi & Saitou 
2013). Mouse ESCs can be induced to differentiate into an epiblast-like cell (EpiLC) 
fate in a basal medium containing basic fibroblast growth factor (bFGF) and activin 
A (Hayashi et al. 2011, Hayashi & Saitou 2013). These cytokine factors drive the 
differentiation of ESCs and generate flat monolayers of epithelium-like cells, thought 
to be similar to the epiblast of the early post-implantation embryo (Hayashi et al. 
2011, Hayashi & Saitou 2013). Induction of ESCs into an EpiLC ‘differentiation 
primed’ state is essential for the cells to respond appropriately to germ cell inducers 
(Hayashi et al. 2011). In contrast, more immature pluripotent cells exposed to 
cytokines associated with inducing germline competency (e.g. BMP4) do not 
differentiate, remaining in the naïve state and retaining their self-renewal capabilities 
(Ying et al 2003, Hayashi et al. 2011). EpiLCs are then placed into a suspension 
culture to form multiple small aggregates in medium containing a cocktail of 
cytokines that direct differentiation towards a germ cell fate (BMP4, BMP8a, SCF, 
EGF, LIF) (Hayashi et al. 2011, Hayashi & Saitou 2013). These differentiated cells 
share many characteristics of their in vivo counterparts, and so are referred to as 
primordial germ cell-like cells (PGCLCs) (Hayashi et al. 2011, Hayashi & Saitou 
2013). PGCLCs can then be isolated from aggregates by staining for co-expression 
of the surface markers SSEA-1 and CD61 and performing fluorescent-activated cell 
sorting (FACs) (Hayashi et al. 2011, Hayashi & Saitou 2013). The identity of the 
purified cells can then be confirmed by qRT-PCR analysis of key PGC transcription 
factors (Blimp1, Prdm14 and Ap2γ), as well as by the presence of PGC associated 
marker genes (e.g. Nanos3, Dazl, etc) (Hayashi et al. 2011, Hayashi & Saitou 
2013). This PGCLC differentiation protocol has been successfully adapted for both 
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porcine (Wang et al. 2016) and human induced pluripotent stem cells (IPSCs) 
(Meyenn et al. 2016), showing that IPSCs generated from these species can be 
directed towards the germline using similar cocktails of cytokines as the mouse 
ESCs.  
Embryonic germ cell lines (EGCs) can be derived from rat embryos by dissociating 
the cells of harvested genital ridges, pre-culturing them for 2-3 days in serum based 
medium (DMEM-F12 medium. 15% FCS, 0.1% NEAA, 4 mM glutamate, 2 mM sodium 
pyruvate, 0.1 mM 2-mecaptanethanol and LIF) and then expanding the cultures in 
2i+LIF conditions (N2B27 medium, 1 μM PD0325901, 3 μM CHIR99021 and LIF) 
(Leitch et al. 2010). However, currently there is no published data showing 
successful generation of rat PGCLCs from rat ESCs. This chapter details the 
experiential approaches taken to induce the formation of rat PGCLCs using a similar 
differentiation protocol to that used for mouse ESCs.  
 
3.2 Rat PGC marker expression 
3.2.1 Expression of PGC markers in rat genital ridges 
To track the transition of rat cells entering a PGC-like fate, it was important to 
confirm that the markers commonly used to identify PGCs were also expressed in 
the germ cells of the developing rat embryo. Embryos were collected from the uteri 
of female pregnant rats between E11.5 – 16.5 dpc in order to sample rat PGCs at 
different stages of their maturation. Embryos dissected at E11.5 - E13.5 dpc were 
too small to confidently identify the genital ridges (data not shown). However, genital 
ridges dissected from E14.5, E15.5 and E16.5 dpc rat embryos were readily 
harvested under a dissection microscope (Figure 3.2.1). Alkaline phosphatase (AP) 
staining has been used previously to determine the presence of PGCs (Hayashi et 
al 2011). AP staining of the extracted genital ridges showed a positive speckled 
stain throughout the genital ridge tissue, suggesting these genital ridges did contain 
PGCs.  
 
Chapter 3          43 
 
Figure 3.2.1. Dissection of rat genital ridges from an E14.5 dpc embryo. Embryos were gathered 
from the uterine of pregnant rats and dissected to collect the genital ridges. Harvested genital ridges 
(outlined by white arrows) were stained for alkaline phosphatase to identify the presence of the 
pluripotent PGCs.  
The genital ridges extracted from embryos of a pregnant rat were pooled and 
processed for RNA extraction. qRT-PCR analysis was performed on the samples 
gathered from genital ridges of  E14.5, E15.5 and E16.5 dpc embryos and the adult 
ovary and testis tissues, as controls (Figure 3.2.2).  
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Figure 3.2.2. qRT-PCR analysis of rat genital ridges. Samples were collected from the genital ridges 
of E14.5, E15.5 and E16.5 dpc embryos and compared to samples taken from adult rat ovary and 
testis tissue. Data shown is the average of two experimental replicates (6 litters in total). All data was 
normalised to the house keeping gene GAPDH (dCT) and fold change was calculated by normalising 
gene expression to that detected in rat ovary tissue (2-DDCT). Bars represent mean of the two 
experimental replicates ± SD. 
Elevated levels of the PGC transcription factors (Blimp1, Prdm14, Ap2y), PGC gene 
markers (Nanos3, Dazl) and stem cell markers (Stella, Oct4) were detected in 
genital ridge samples compared to those from adult rat tissue. Expression of Dazl in 
rat testis has been reported previously (Rocchietti et al. 2000), and therefore 
elevated expression of this gene in the testis compared to the rat ovary was not 
unexpected. These results confirmed that rat PGCs do express the standard PGC 
gene markers commonly found in mouse. The surface markers C-KIT and ITGβ3 
(CD61) have been used previously to identify and separate PGCs from the genital 
ridges of mice, and isolate PGC-like cells from differentiated in vitro human cells 
(Hayashi & Saitou 2013, Meyenn et al. 2016). CD61 has been noted to be 
expressed in the ovaries of mice (Burns et al. 2002), so it was not surprising to see 
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C-KIT has been identified on the surface of both human and mouse PGCs (Keshet 
et al. 1991, Høyer et al. 2005, Hayashi et al 2011). Therefore, the expression of both 
of these factors in the genital ridge samples are consistent with rat PGC expressing 
these surface markers.  
 
3.2.2 Basal expression of PGC transcription factors in rat ESCs 
To establish the base line expression of PGC related factors (e.g. Blimp1, Prdm14, 
and Ap2γ) in rat ESCs, RNA transcript levels were analysed in self-renewing rat 
ESC cultures maintained in 2i+LIF by qRT-PCR (Figure 3.2.3). Basal expression of 
the PGC transcription factors and marker genes from rat genital ridges was 
compared to the expression in both mouse and rat ESCs. The qRT-PCR data was 
generated from the average transcript expression of three independent replicates of 
dark agouti rat ESCs (DA) and 129/OLA mouse ESCs (Figure 3.2.4). 
Oligonucleotide primer pairs for each gene were selected so they exactly matched 
both the rat and mouse target sequences, thus ensuring that qRT-PCR analysis 
could be performed using the same primer set, and allow direct quantitative 
comparison of gene expression between the species.  
 
Figure 3.2.3. Bright field photographs of rat and mouse ESCs. Photographs taken show 1x105 cells 
seeded onto MEF layers and cultured in 2i+LIF medium for 24 hours.  
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Figure 3.2.4. qRT-PCR analysis of mouse and rat ESCs compared to rat E14.5 dpc genital 
ridges. Samples were taken from the genital ridges of E14.5 rat embryos dpc (E14.5 Rat GR) and 
were compared to rat (Rat ESCs) and mouse (Mouse ESCs) ESCs. All data was normalised to the 
house keeping gene GAPDH (dCT) and fold change was calculated by normalising gene expression to 
that seen in the rat ESCs (2-DDCT). Bars represent the average transcript expression of three 
independent replicates generated from one rat (DAK31) and one mouse (129/OLA) cell line ± SD. 
*P<0.05, **P<0.01. 
Rat and mouse ESC populations showed a significantly lower expression of two 
PGC transcription factors (Blimp1, Ap2y) and two PGC marker genes (Nanos3, 
Dazl) compared to rat genital ridges. Prdm14 expression was significantly higher in 
mouse ESCs, whereas rat ESCs had a significantly higher expression of Stella 
compared to both rat genital ridges and mouse ESCs.  
A notable difference between mouse and rat ESCs was that rat ESCs had 5-fold 
decrease in Blimp1 expression compared to mouse ESCs. BLIMP1 is thought to be 
the key transcription factor necessary for initiating PGC specification in a specific 
population of epiblast cells (Ohinata et al. 2005), and therefore its low level of 
expression might affect the ability of rat ESCs to transition into a PGCLC fate.  
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3.3 Primordial germ cell-like (PGCLC) differentiation 
of mouse ESCs 
129/OLA mouse ESCs cultured in the same standard 2i+LIF conditions as rat ESCs 
were subjected to a PGCLC differentiation protocol adapted from the method used 
by Hayashi et al (2011, 2013) (Figure 3.3.1). Although mouse ESC culture is often 
performed in feeder-free conditions (cultured in the absence of an irradiated feeder 
cell layer), colonies which have been derived and cultured on MEF layers in 2i+LIF 
medium were used for this experiment in order to closely match the initial starting 
conditions of the rat ESCs. Performing the differentiation protocol on mouse cells 
cultured in the rat ESC culture conditions would eliminate differences in culture 
condition as a variable in the formation of rat PGCLCs.   
 
Figure 3.3.1 Schematic of the mouse PGCLC differentiation protocol. Mouse ESCs cultured in 
2i+Lif conditions on a MEF layer were transferred onto a fibronectin layer with EpiLC differentiation 
medium for 2 days. These cells were pipetted into hanging drops containing ~2,000 cells in PGCLC 
culture medium. After 2 days of culture, aggregates were collected and transferred into fresh PGCLC 
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3.3.1 EpiLC differentiation of mouse ESCs 
129/OLA mouse ESCs cultured in 2i+LIF medium on MEF layers were transferred to 
12-well plates coated with fibronectin at a cell density of 1 x 105 cells per ml. The 
cells were then cultured in EpiLC culture medium (N2B27 + bFGF + Activin A) for 2 
days, with the medium being replaced with fresh EpiLC medium after 24 hours to 
replenish bFGF and Activin A. Cells were photographed after 2 days of EpiLC 
differentiation to record the morphology of the differentiating cells, and compared 
with those described by Hayashi et al (2011, 2013). Mouse ESCs cultured in EpiLC 
medium for 2 days formed a flat monolayer, quite different to the domed individual 
colonies seen in wells of mouse ESCs cultured in 2i+LIF medium on MEF layers 
(Figure 3.3.2). 
 
Figure 3.3.2. Bright field images of mouse cells after the 2 day EpiLC differentiation protocol. 
Images were taken prior to (Day 0 – left panel) and 2 days (Day 2 – right panel) after cells had been 
cultured on laminin in EpiLC differentiation medium. 
Mouse cells were harvested after 24 and 48 hours of EpiLC differentiation and RNA 
processed for qRT-PCR analysis. The expression of gene markers associated with 
EpiLC differentiation were analysed to assess the progression of the cultures to the 
EpiLC fate. qRT-PCR analysis identified a significant drop in pluripotency and naïve 
markers (Nanog, Klf4 and Prdm14) when cultured in EpiLC medium compared to 
the mouse ESCs prior to differentiation (Figure 3.3.3).  
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Gene markers characteristic of EpiLCs (Otx2, Tcf15 and Fgf5) were significantly 
higher in cells cultured in EpiLC medium compared to mouse ESCs (Figure 3.3.3). 
This data suggested that these mouse cells were responding in a similar manner to 
what has been reported previously (Hayashi et al. 2011, Hayashi & Saitou 2013) 
and were being driven out of the naïve state towards an EpiLC fate. 
 
Figure 3.3.3 qRT-PCR of mouse cells undergoing the EpiLC differentiation protocol. 129/OLA 
mouse cells were harvested after 0, 1 and 2 days culture on fibronectin in EpiLC differentiation 
medium. All data was normalised to the house keeping gene β-actin (dCT) and fold change was 
calculated by normalising gene expression to that seen in mouse ESCs (ESC D0) cultured in 2i+LIF 
medium (2-DDCT). Bars represent the mean of three independent experiments performed with 
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3.3.2 PGCLC differentiation of mouse cells 
Mouse cells cultured in EpiLC medium for 2 days were collected and suspended in 
hanging drops of PGCLC medium (GMEM +KSR(15%) +L-Glut +BMP4 +BMP8a 
+SCF +EGF +LIF) on the lids of 15cm dishes. Each hanging drop consisted of 
~2,000 EpiLCs contained within a 30µl drop of PGCLC medium. Dishes containing 
the suspended hanging drops were incubated for 2 days to promote aggregation of 
the EpiLCs. After 2 days, aggregates were transferred into 6-well low adhesion 
plates with fresh PGCLC medium to retain the aggregates in suspension and 
incubated for a further 4 days. Bright field photographs of these cellular aggregates 
were taken after 2 and 6 days of culture in PGCLC medium (Figure 3.3.4). 
Aggregation of EpiLCs occurred within 24 hours in hanging drop suspension and the 
cells formed large spheroid structures by the time they had completed the PGCLC 
differentiation protocol at day 8 (Figure 3.3.4). 
 
Figure 3.3.4. Bright field photographs of mouse aggregates undergoing the PGCLC 
differentiation protocol. Images were taken 2 days after hanging drop set up (left panel) and 4 days 
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To identify the presence of PGCLCs within the aggregates, aggregates were 
carefully dispersed by trituration and the cell suspensions stained with fluorescent 
antibodies for the surface markers SSEA-1 (CD15) and CD61. The gating strategy 
detailed in section 2.6.7 was used. The remaining cells were gated to isolate 
populations of double negative, single stained and double stained populations by 
plotting CD61 (586/15A) versus SSEA-1 (670/14A) using fluorescent activated cell-
sorting (FACs). The gates were set against unstained mouse ESCs. Mouse ESCs 
cultured in 2i+LIF medium alongside the PGCLC differentiation protocol were used 
as a SSEA-1+ve/CD61-ve control. Mouse ESCs are positive for the SSEA-1 marker, 
so it was expected that during PGCLC differentiation there would be a global loss of 
this marker. Any PGCLCs present within the aggregates would be positive for both 
SSEA-1 and CD61, as described in the literature (Hayashi et al. 2011, Hayashi & 
Saitou 2013). Flow cytometry plots generated during cell sorting are displayed in 
Figure 3.3.5. 
 
Figure 3.3.5. Flow cytometry plots of 129/OLA mouse cells after undergoing a PGCLC 
differentiation protocol. Mouse ESCs cultured in 2i+LIF and cells which had been stimulated to 
differentiate using the PGCLC differentiation protocol were stained for SSEA-1 and CD61. Percentages 
represent total proportion of the population which were either positive or negative for SSEA-1 and 
CD61 surface markers. 
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Interestingly, 129/OLA mouse ESCs cultured in 2i+LIF medium on MEFs showed a 
50:50 split of SSEA-1+ve and SSEA-1-ve cells. A similar profile has been observed in 
both rat and mouse cell lines cultured on MEF layers within our lab, suggesting this 
may be a consequence of the MEF / 2i+LIF culture condition. Another potential 
factor was the presence of MEFs in the same culture well as the mouse ESCs, 
contributing to the SSEA-ve population and thereby generating the 50:50 split of 
SSEA-1+ve and SSEA-1-ve.  
Cells which had undergone the PGCLC differentiation protocol had a reduced 
population of SSEA-1+ve / CD61-ve cells compared to the ESC control and a general 
shift towards the CD61+ve state. A distinct population of SSEA1+ve / CD61+ve cells 
was identified after PGCLC differentiation.  
Cells which had been separated into these four quadrants were harvested and their 
RNA processed for qRT-PCR analysis in order to determine the distribution of PGC 
marker genes within the different populations. The quality of the RNA gathered from 
the SSEA-1+ve / CD61-ve population of cells which had undergone the PGCLC 
differentiation protocol was too poor for qRT-PCR and so was not analysed.  
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Figure 3.3.6. qRT-PCR of stained populations after undergoing a PGCLC differentiation 
protocol. Mouse cells stained for SSEA-1 and CD61 were sorted by FACs into double negative, single 
and double positive populations. All data was normalised to the house keeping gene β-actin (dCT) and 
fold change was calculated by normalising gene expression to that seen in the mouse ESCs (mESCs) 
cultured in 2i+LIF medium (2-DDCT). S- = SSEA-1-ve, C- = CD61-ve, S+ = SSEA-1+ve, C+ = CD61+ve. 
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The SSEA-1+ve / CD61+ve population showed the greatest expression of the PGC 
transcription factors Blimp1 and Prdm14 compared to the other sorted populations. 
This population also showed the highest transcript expression of the PGC marker 
Nanos3 and pluripotency markers Nanog and Stella compared to all other sorted 
populations. Additionally, there was no detectable expression of either the definitive 
endoderm marker Gata6 or trophectoderm marker Gata3 in SSEA-1+ve / CD61+ve 
cells when compared to the other sorted populations. These results therefore 
confirmed that the PGCLC differentiation protocol applied to mouse cells cultured in 
2i+LIF on MEFs did produce cells with a PGCLC-like profile similar to that described 
in the literature (Hayashi et al. 2011, Hayashi & Saitou 2013).  
 
3.4 Epiblast-like (EpiLC) differentiation of rat ESCs 
3.4.1 Attachment of rat ESCs to a basement membrane 
Before mouse ESCs are induced to differentiate into PGCLCs, they are transitioned 
into an EpiLC fate, ensuring they are sensitised to the differentiation cues activated 
by the cocktail of cytokines present in the PGCLC culture medium (Hayashi et al. 
2011, Hayashi & Saitou 2013). The EpiLC differentiation protocol employs a 
fibronectin substratum to enable attachment and differentiation of cells towards the 
EpiLC fate. Rat DAK31 cells (dark agouti) were plated into tissue culture plates 
coated with different basement membranes; MEFs (1.5x104 cells/cm2), fibronectin 
(16.7 μg/ml) or laminin (10 µg/ml). Rat ESCs were also cultured as suspended 
aggregates in aggrewells® to determine their survival in a non-adherent 
environment. In all conditions rat ESCs were seeded at a density of 1x105 cells and 
cultured for 48 hours in 2i+LIF medium (Figure 3.4.1).  
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Figure 3.4.1. Bright field microscopy photographs of rat ESCs cultured on different basement 
membranes. Cells were seeded at a density of 1x105 per well and were cultured for 2 days in 2i+LIF 
medium within tissue culture wells. For aggregate suspension, cells were passaged into the 
aggrewells® so that each microwell depression contained 1x105 cells. 
After 48 hours, there was no evidence of attachment of the rat ESCs to the 
fibronectin layer. The cells floated in the culture medium, aggregating together to 
form spheroids. Several different concentrations of fibronectin were tested in both 
2i+LIF and EpiLC medium to try to improve attachment. However, no condition 
promoted attachment of rat ESCs to the fibronectin layer. Rat ESCs were capable of 
attaching to both the MEF and laminin substratum layers, however. Cells cultured on 
MEFs formed tight, domed colonies while those cultured on laminin formed a flat 
monolayer. Rat ESCs readily formed spheroid aggregates in suspension culture in 
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3.4.2 Inducing rat cell differentiation (EpiLC differentiation) 
As rat ESCs did not attach to fibronectin, they were plated instead into 12-well 
plates coated with laminin or containing MEFs. 1x105 cells/well were cultured in 
EpiLC medium for up to 3 days. Rat ESCs were also cultured in aggrewell plates at 
a density representing ~1x105 cells per microwell depression. This density of 
starting cells was chosen to replicate the mouse EpiLC differentiation protocol. Cells 
were photographed every 24 hours to record their response to the EpiLC medium 
and ascertain whether there was any noticeable differences in cell morphology or 
growth between the different populations. Rat ESCs cultured in laminin coated 
plates attached to the basement membrane as a flat monolayer rather than domed 
colonies (Figure 3.4.2). Cellular debris was apparent after 24 hours in EpiLC 
medium, but those remaining cells showed a flattened morphology (Figure 3.4.2).  
Rat ESCs grown in suspension quickly formed small aggregates which did not grow 
in size during the 3-day culture (Figure 3.4.2). Cell debris indicative of cell death was 
present at the bottom of all microwells and attached to the outer surface of each 
aggregate (Figure 3.4.2).  
ESCs cultured on MEF layers in the presence of EpiLC medium formed domed 
colonies during the first 48 hours of EpiLC differentiation (Figure 3.4.2). However, by 
day 3, there were patches of morphologically flat cells reminiscent of mouse EpiLC 
differentiation (Figure 3.4.2). Cells cultured on MEFs with EpiLC medium also 
showed greater evidence of cellular debris compared with all other basement 
substrates tested (Figure 3.4.2). 
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Figure 3.4.2. Bright field microscopy photographs of rat ESCs undergoing an EpiLC 
differentiation protocol. 1x105 rat ESCs were cultured for 3 days in EpiLC medium in tissue culture 
wells coated with Laminin (10µg/ml), MEFs (1.5x104 cells/cm2) or cultured in suspended aggregates. 
Rat cells cultured in EpiLC medium were harvested at 24 hour time points over 3 
days. qRT-PCR analysis was performed to quantify the expression of markers 
commonly associated with EpiLC differentiation.  
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Figure 3.4.3. q-RT PCR of rat ESCs undergoing an EpiLC differentiation protocol. 1x105 rat ESCs 
were cultured for 3 days in EpiLC medium in wells coated with Laminin (10µg/ml), MEFs (1.5x104 
cells/cm2) or cultured in suspended aggregates. Cells were harvested at 24 hour time points. The data 
shown is the average of two experimental replicates of rat DAK31 ESCs cultured in EpiLC medium for 
3 days. All data was normalised to the house keeping gene β-actin (dCT) and fold change was 
calculated by normalising gene expression to that seen in rat ESCs cultured in 2i+LIF medium on 
MEFs (2-DDCT). Bars represent mean of two independent experiments performed with DAK31 ESCs ± 
SD. 
During the 3-day EpiLC differentiation protocol, all cell treatments displayed a 
substantial reduction in Nanog transcript expression and by day 3, there was little or 
no detectable Nanog expression from any of the cell treatments (Figure 3.4.3).   
It is reported that expression of Tcf15 during EpiLC differentiation of mouse ESCs 
increases within the first 24 hours of culture, and then falls as the cells transition out 
of the naïve state (Hayashi et al. 2011). In the rat cells, no rise in Tcf15 expression 
was detected, only a gradually reduction in all conditions during the EpiLC 
differentiation protocol (Figure 3.4.3). Otx2 gene expression increased within the 
first 24 hours of being cultured in EpiLC medium within suspended aggregates and 
then gradually declined over the next 48 hours (Figure 3.4.3). The expression of 
Otx2 in cells cultured on laminin decreased gradually over the 3 days, becoming 
almost undetectable after 3 days culture in EpiLC medium (Figure 3.4.3). ESCs 
cultured on MEF layers in EpiLC medium displayed increased levels of Otx2, which 
was maintained throughout the 3-day protocol (Figure 3.4.3). Expression of the 
growth factor Fgf5 did not change in any culture condition during the first 48 hours of 
EpiLC differentiation (Figure 3.4.3).  
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However, between 48-72 hours, cells cultured on MEF layers showed a sharp 
increase in Fgf5 (Figure 3.4.3), suggesting there was a proportion of cells entering 
an epiblast-like fate. Based on the induction of EpiLC markers, it seemed that the 
protocol originally optimised for the mouse system to induce EpiLC differentiation 
(Hayashi et al. 2011, Hayashi & Saitou 2013) could not be simply translated to rat 
ESCs without modification. The best differentiation response came from rat cells 
cultured on MEFs during a 3-day protocol of EpiLC differentiation. This condition not 
only produced cells with the characteristic flattened monolayer morphology typical of 
mouse EpiLCs (Figure 3.4.2), but also displayed increased expression of Otx2 and 
Fgf5 compared to the rat ESCs (Figure 3.4.3).  
 
3.4.3 Inducing rat cell differentiation after pre-treatment (EpiLC 
differentiation) 
Induction of both Otx2 and Fgf5 within rat ESCs grown on MEFs in EpiLC medium 
suggested that this condition might support EpiLC differentiation of rat ESCs. 
However, the induction of both of these genes was far lower than that compared to 
mouse ESCs (Figure 3.4.4).  
 
Figure 3.4.4. qRT-PCR of mouse and rat ESCs undergoing an EpiLC differentiation protocol. The 
mouse (129/OLA) data shown is the average of three experimental replicates mouse cells, whereas the 
rat (DAK31) is the average of two experimental replicates. All data was normalised to the house 
keeping gene β-actin (dCT) and fold change was calculated by normalising gene expression to that 
seen in mouse ESCs cultured in 2i+LIF medium on MEFs (2-DDCT). Bars represent mean of 
independent experiments ± SD. 
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The OTX2 transcription factor is thought to be a critical determinant for EpiLC 
differentiation of mouse ESCs (Acampora et al 2013, Yang et al. 2014). The basal 
expression of Otx2 within rat ESCs was interrogated to identify whether rat and 
mouse ESCs both expressed Otx2 at a similar level prior to being cultured in EpiLC 
medium. Three independent rat ESC lines (2x dark agouti, 1x Sprague-dawley) 
were cultured on MEF layers in 2i+LIF medium for 2 days alongside 3 independent 
mouse ESC lines (2x 129/OLA, 1x E14). qRT-PCR analysis showed that the basal 
expression of Otx2 in rat ESCs was far lower than that in the mouse ESC lines 
(Figure 3.4.5).  
 
Figure 3.4.5. qRT-PCR displaying basal Otx2 expression within mouse and rat ESCs. 1.5x105 
mouse and rat ESCs were cultured for 2 days in 2i+LIF on MEF layers. Cells were harvested after 48 
hours. All data was normalised to the house keeping gene β-actin (dCT) and fold change was 
calculated by normalising gene expression to that seen in mouse ESCs cultured in 2i+LIF medium on 
MEFs (2-DDCT). Bars represent mean of three independent mouse and rat cell lines ± SD. **p<0.01 to 
Mouse ESCs. 
During the establishment of the rat ESC culture conditions in our laboratory, Otx2 
transcript expression was found to increase when ESCs were cultured in 1i medium, 
a culture medium containing only PD0325901 without CHIR99021 or LIF. 3 
independent rat ESC lines (2x DA, 1x SD) were cultured on MEF layers in 2i+LIF 
and 1i medium for 3 days. These cells were then harvested and their RNA 
processed for qRT-PCR analysis. After 3 days culture in 1i medium, there was a 
substantial rise in Otx2 transcript expression compared to cells cultured in 2i+LIF 
medium (Figure 3.4.6).  
** 
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Figure 3.4.6. qRT-PCR displaying Otx2 expression within rat ESCs cultured in 2i+LIF and 1i 
culture medium. 1.5x105 rat ESCs were cultured for 3 days in 2i+LIF and 1i medium on MEF layers. 
Cells were harvested after 3 days and the transcript expression (2-DDCt) normalised to the population 
of rat ESCs prior to the 3 day culture (Day 0 ESCs) hours. Bars represent mean of three independent 
rat cell lines ± SD. **P<0.01 to Day 0 Rat ESCs. 
To determine if increased Otx2 expression assisted transition into the EpiLC fate, rat 
ESCs were pre-cultured in 1i medium for 3 days prior to the 3-day EpiLC 
differentiation protocol. Cells were cultured on either a laminin layer, MEF layer or in 
suspended aggregates to identify if any of these conditions showed greater 
expression of EpiLC markers after 1i pre-culture. Cells were photographed every 24 
hours to observe their response to being cultured in EpiLC medium. ESCs cultured 
on laminin coated plates formed flat monolayers, similar to the cells cultured in 
2i+LIF medium prior to EpiLC medium (Figure 3.4.7). However, cells pre-cultured in 
1i medium had a flatter morphology (Figure 3.4.7) compared to their 2i+LIF 
counterparts (Figure 3.4.2). Cellular aggregates formed from cells pre-cultured in 1i 
medium (Figure 3.4.7) appeared smaller and had greater cellular debris within each 
microwell compared to those cells pre-cultured in 2i+Lif medium prior to EpiLC 
medium (Figure 3.4.2). 
After 3 days of being cultured in EpiLC medium on MEFs, cells pre-cultured in 1i 
medium displayed a flat monolayer morphology with very little cellular debris (Figure 
3.4.7) when compared to the cells pre-cultured in 2i+LIF medium (Figure 3.4.2). Rat 
cells which had been pre-cultured in 1i medium and then cultured for 3 days in 
EpiLC medium on different basement substrates were harvested at 24 hour time 
points after being photographed (Figure 3.4.7). 
** 
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Figure 3.4.7. Bright field microscopy photographs of rat ESCs undergoing an EpiLC 
differentiation protocol after 3 days of 1i medium pre-culture. 1x105 rat ESCs were pre-cultured for 
3 days in 1i medium on MEFs. 1x105 were then transferred into EpiLC medium in wells coated with 
Laminin (10µg/ml), MEFs (1.5 x 104 cells/cm2) or cultured in suspended aggregates. 
qRT-PCR analysis was performed for cells which had either been pre-cultured in the 
presence (2i+LIF) or absence (1i) of CHIR99021 and LIF. No substantial difference 
in Nanog, Tcf15 and Otx2 transcript expression from cells pre-cultured in 1i medium 
compared to those pre-cultured in 2i+LIF (Figure 3.4.8).  
However, 1i pre-cultured cells in all conditions had double the expression of Fgf5 
after being cultured in EpiLC medium for 3 days compared to cells pre-cultured in 
2i+LIF medium (Figure 3.4.8). This increased Fgf5 expression was most noticeable 
in cells which had been cultured on MEF layers (Figure 3.4.8). 
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Figure 3.4.8. q-RT PCR of rat ESCs undergoing an EpiLC differentiation protocol with or without 
1i medium pre-culture. Cells undergoing EpiLC differentiation for 3 days were harvested at 24 hour 
time points. The data shown is the average of two experimental replicates performed on the same 
DAK31 ESC line. All data was normalised to the house keeping gene β-actin (dCT) and fold change 
was calculated by normalising gene expression to that seen in rat ESCs cultured in 2i+LIF medium on 
MEFs (2-DDCT). Bars represent the mean of two independent experiments performed in rat DAK31 ± 
SD. 
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3.4.4 Summary of rat EpiLC differentiation 
The loss of Nanog expression and the changes in morphology of rat cells subjected 
to the EpiLC differentiation protocol indicated that they were being directed out of 
the naïve ESC state under these conditions. However, it was difficult to conclude 
whether these cells were actually entering an EpiLC fate. The expression of Fgf5 
indicated that at least a small portion of these cells were adopting an epiblast fate. 
The greatest induction of this gene occurred when cells were pre-cultured in 1i 
medium and then co-cultured with MEFs during the EpiLC differentiation protocol. 
Based on these results, it was decided that prior to PGCLC differentiation, rat ESCs 
would be cultured with either 2i+LIF or 1i medium on MEF layers prior to undergoing 
the EpiLC differentiation protocol (Figure 3.4.9). These conditions were chosen as a 
3 day culture in EpiLC medium on MEFs appeared to show the greatest induction of 
Fgf5 expression in the experiments performed. Because it was still unclear at this 
point whether the 1i medium pre-culture might impair further differentiation, it was 
considered prudent to test both treatments when attempting to differentiate these 
cells towards a PGCLC fate.  
 
Figure 3.4.9. Revised EpiLC differentiation protocol for rat ESCs. Rat ESCs cultured in 24-well 
plates with 2i+Lif conditions on a MEF layer are transferred into 24-well plates with fresh MEF layers 
and pre-cultured in either 2i+LIF or 1i medium for 3 days. These pre-cultured cells are then moved onto 
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3.5 Primordial germ cell-like (PGCLC) differentiation 
of rat ESCs 
3.5.1 Rat PGCLC differentiation protocol 
The PGCLC differentiation protocol shown in Figure 3.5.1 was tested in rat DAK31 
ESCs. This was to determine if rat ESCs could efficiently differentiate towards a 
PGC-like fate. The DAK31 cell line was chosen as it has been previously shown to 
be germline competent when injected into rat embryos (Blair et al. 2012) and does 
not express any fluorescent marker which could complicate immunostaining and 
analysis by flow cytometry. This protocol was adapted from the PGCLC 
differentiation protocol reported in the literature to drive mouse cells towards 
PGCLCs (Hayashi et al. 2011, Hayashi & Saitou 2013), and a method used for 
differentiating 129/OLA mouse ESCs in our laboratory.  
 
Figure 3.5.1. PGCLC differentiation protocol applied to rat ESCs. Cells were first induced to 
differentiate using the revised EpiLC differentiation protocol described in section 3.4.4. The cells were 
then pipetted into hanging drops containing ~2,000 cells in PGCLC culture medium. After 2 days of 
culture, aggregates were collected and transferred into fresh PGCLC culture medium in 6-well low 
adhesion plates for 4 days. 
DAK31 ESCs were transferred to fresh MEF layers and pre-cultured for 3 days in 
either 2i+LIF or 1i medium. After 3 days, 1x105 cells were passaged 12-well plates 
coated with fresh MEF layers in EpiLC medium. Cells were incubated for 3 days, 
with the EpiLC medium being replaced with fresh medium every 24 hours to 
replenish the bFGF and activin A. Cells were photographed after 3 days in EpiLC 
culture medium. Both 2i+LIF and 1i medium pre-cultured cells showed a flattened 
morphology compared to the domed rat ESC colonies under standard rat ESC 
culture conditions (Figure 3.5.2). 
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Wells of pre-cultured cells showed evidence of differentiation in the form of small, 
cobblestone patches (Figure 3.5.2 - white arrows). Although the cells pre-cultured in 
1i medium appeared to grow slower, there was less cellular debris present in this 
treatment compared to cells pre-cultured in 2i+LIF medium (Figure 3.5.2). 
 
Figure 3.5.2. Bright field microscopy photographs of rat ESCs after 3 days culture in EpiLC 
differentiation medium. DAK31 cells pre-cultured in either 2i+LIF (Pre-2i+LIF) or 1i medium (Pre-1i) 
for 3 days were seeded at a density of 1x105 on MEF layers in EpiLC medium and incubated for 3 
days. White arrows highlight patches of ‘cobblestone’ differentiation after being cultured in EpiLC 
medium. Images taken are cells cultured in standard rat ESCs culture conditions (D0) and cells which 
had been cultured in EpiLC medium (D6). 
Cells which had undergone the EpiLC differentiation protocol were transferred into 
hanging drops of PGCLC culture medium. Each hanging drop consisted of ~2,000 
cells contained within 30µl PGCLC culture medium. Dishes containing the 
suspended hanging drops were incubated for 2 days to promote aggregation of the 
cells. Cells which had been pre-cultured in 2i+LIF medium and 1i medium but had 
not been cultured in EpiLC differentiation medium were also transferred to hanging 
drops to observe whether the efficiency of aggregate formation was affected by 
culturing the cells in EpiLC differentiation medium. Cell aggregates were 
photographed after 2 days using bright field microscopy. Cells which had not been 
through the EpiLC differentiation protocol produced either multiple tiny aggregates 
or a single small aggregate surrounded by cellular debris (Figure 3.5.3). Cells 
exposed to EpiLC differentiation medium however produced on average one single 
aggregate within each hanging drop (Figure 3.5.3). Aggregates formed from cells 
pre-cultured in 1i medium were on average larger compared to those in 2i+LIF 
medium after the cells had been cultured in EpiLC culture medium (Figure 3.5.3).  
Rat ESCs D0 
(2i+LIF) 
Rat EpiLC D6 
(Pre-2i+LIF) 
Rat EpiLC D6 
(Pre-1i) 
100µM 100µM 100µM 
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Hanging drop cultures from cells pre-cultured in 2i+LIF medium contained 
noticeable levels of cellular debris surrounding the main aggregates (Figure 3.5.3). 
This debris was less evident in the hanging drops formed from the 1i pre-cultured 
cells (Figure 3.5.3). Finally, it was interesting to note that the size of the aggregates 
formed from differentiating rat cells were far smaller than those generated from 
mouse cells (Figure 3.3.4), suggesting that the rat cells were either not growing 
under these conditions or that cell death restricted the growth of these aggregates, 
maintaining them at a similar size.   
 
Figure 3.5.3. Bright field microscopy photographs of hanging drops containing rat cell 
aggregates after 2 days culture. Photographs were obtained 2 days after hanging drops were set up. 
Each drop of PGCLC medium (30μl) contained ~2,000 cells. The top panels show rat cells which have 
been taken from pre-cultured wells and placed immediately into PGCLC hanging drops. The bottom 
panels show rat cells which have been pre-cultured in 2i+LIF or 1i medium, induced to differentiate by 
culturing in EpiLC medium for 3 days and then transferred to hanging drops containing PGCLC 
medium.  
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After 2 days in hanging drops, the aggregates were transferred into 6-well low 
adhesion plates and remained in suspension for a further 4 days. During this period 
the aggregates were monitored daily and bright field photographs were taken on the 
final day of PGCLC culture. There appeared to be little noticeable difference in the 
growth or survival of either of the pre-cultured populations after the 4-day culture 
(Figure 3.5.4). Both pre-cultured populations exhibited significant signs of cell death 
(Figure 3.5.4), and did not appear to increase in size during the PGCLC 
differentiation protocol, unlike the mouse aggregates (Figure 3.3.4). 
 
Figure 3.5.4. Bright field photographs of rat aggregates after 6 days culture in PGCLC 
differentiation medium. Aggregates cultured in hanging drops of PGCLC medium for 2 days were 
transferred to 6-well low adhesion plates in fresh PGCLC medium and cultured for a further 4 days. 
  
100µM 
Rat D12 PGCLC medium 
(Pre-2i+LIF) 
100µM 
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3.5.2 Analysis of PGC markers from rat cells 
Aggregates formed by the end of the 12 day protocol were carefully broken apart by 
gentle pipetting (trituration) and the cell suspensions stained with fluorescent 
antibodies for SSEA-1 and CD61. These surface markers were used to monitor the 
differentiation status of the cells and sort the pools by FACs into populations of cells 
which were either unstained, single stained, or double stained for both surface 
markers. A population of cells which are both SSEA-1+ve / CD61+ve is reported to be 
generated after mouse ESCs are induced to differentiate via the PGCLC 
differentiation protocol (Hayashi et al. 2011, Hayashi & Saitou 2013). It was hoped 
that by isolating these separate populations in the rat cells, rat PGCLCs could be 
identified by increased expression of pluripotency markers and expression of PGC 
marker genes. Co-expression of the markers SSEA-1 (CD15) and germ cell nuclear 
antigen 1 (GCNA1) have been noted to identify mouse PGCs (Hayashi et al. 2011, 
Encinas et al. 2012). However, it has been reported that these markers, were not 
detectable in rat PGCs within the genital ridges (Encinas et al. 2012). Nonetheless, 
it was still of interest to see if this applied to rat cells subjected to the PGCLC 
differentiation protocol, with the differentiation of rat ESCs being monitored by the 
loss of the SSEA-1 surface marker. Similar to their mouse counterparts, rat ESCs 
are known to be positive for SSEA-1, and during the differentiation protocol, it was 
expected that the majority of these cells would lose SSEA-1 expression. The gating 
strategy detailed in section 2.6.7 was used. The remaining cells were gated to 
isolate populations of double negative, single stained and double stained 
populations by plotting CD61 (586/15A) versus SSEA-1 (670/14A) using fluorescent 
activated cell-sorting (FACs). The FACs plots generated during the analysis of rat 
cells are shown in Figure 3.5.5. Rat DAK31 ESCs cultured in standard 2i+LIF 
culture conditions were used as a rat ESC control, representing the surface marker 
expression of rat cells prior to PGCLC differentiation. The gates were set against 
unstained DAK31 ESCs. 
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Figure 3.5.5. Flow cytometry plot of DAK31 rat cells after PGCLC differentiation. Rat ESCs 
cultured in 2i+LIF and pools of rat cells induced to differentiate using the PGCLC differentiation 
protocol were stained for SSEA-1 and CD61 surface markers. Percentages represent total proportion 
of the population which were either positive or negative for SSEA-1 and CD61 surface markers. 
Similar to the 129/OLA mouse ESCs shown previously (Figure 3.3.5), rat ESC 
cultures maintained in 2i+LIF on MEFs possessed both SSEA-1+ve and SSEA-1-ve 
cells (Figure 3.5.5). This profile is consistent with other ESC lines cultured within the 
laboratory, suggesting that this might be a consequence of culturing rodent ESCs on 
MEF layers with 2i+LIF medium instead of a feeder-free environment. This 
difference could also be compounded by staining mixed cell populations containing 
both ESCs and MEFs, where ESCs are SSEA-1+ve while the MEFs are SSEA-1-ve. 
Cells which had been induced to differentiate by being subjected to the PGCLC 
differentiation protocol showed a general loss of SSEA-1+ve cells within the whole 
population (Figure 3.5.5). There was a population of SSEA-1+ve / CD61+ve cells 
present in rat cell pools after PGCLC differentiation (Figure 3.5.5). However unlike 
the mouse cells, rat ESC pre-cultured in either condition did not show a distinct 
population of SSEA-1+ve / CD61+ve cells when compared to the stained ESCs; 
showing instead a general shift of the whole population towards increased CD61+ve 
presence (Figure 3.5.5).  
0% 
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Although the proportion of SSEA-1+ve / CD61+ve cells in pools pre-cultured in either 
2i+LIF or 1i medium was not substantially different, there was a greater proportion of 
SSEA-1+ve cells in pools pre-cultured in 1i medium (Figure 3.5.5). There was little 
variation in the percentages of each population between the 3 experimental repeats 
performed in the rat DAK31 cell line.  
These individual populations were analysed for expression of PGC related 
transcripts. The qRT-PCR data represents the average of three experimental 
replicates performed in the rat DAK31 cell line. All stained populations of cells after 
PGCLC differentiation had significantly greater Blimp1 expression compared to rat 
ESCs (Figure 3.5.6). The most marked increase in Blimp1 expression was observed 
in the SSEA-1-ve / CD61+ve population of cells pre-cultured in 2i+LIF medium (Figure 
3.5.6). However, this population also had the greatest variation in Blimp1 expression 
between the three experimental replicates (Figure 3.5.6). 
In all but one of the sorted cell populations, there was a significant drop in Prdm14 
expression compared to ESCs (Figure 3.5.6). The SSEA-1-ve / CD61+ve population of 
cells pre-cultured in 2i+LIF medium retained a similar expression of Prdm14 
compared to ESCs (Figure 3.5.6). 
Ap2y expression remained fairly consistent between the different populations, with 
only the population of SSEA-1-ve / CD61+ve cells pre-cultured in 2i+LIF showing a 
significant rise in expression after PGCLC differentiation compared to rat ESCs 
(Figure 3.5.6). 
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Figure 3.5.6. qRT-PCR analysis of the expression of PGC TFs in SSEA1/CD61 stained 
populations of rat cells subjected to a PGCLC differentiation protocol. Rat cells which had 
undergone PGCLC differentiation and had been stained for SSEA-1 and CD61 were sorted by FACs 
into double negative, single and double positive populations. All data was normalised to the house 
keeping gene β-actin (dCT) and fold change was calculated by normalising gene expression to that 
seen in the rat ESCs (ESCs (D0)) cultured in 2i+LIF medium (2-DDCT).The y-axis for BLIMP1 
expression is presented as a log scale. SS- = SSEA-1-ve, CC- = CD61-ve, SS+ = SSEA-1+ve, CC+ = 
CD61+ve. Bars represent mean of three independent experiments performed with DAK31 cells ± SD. 
*P<0.05, **P<0.01 to ESCs (D0). 
Expression of the pluripotency markers, Oct4, Nanog and Stella was on average 
significantly reduced in sorted cells derived after the PGCLC differentiation protocol 
when compared to rat ESCs (Figure 3.5.7). Nanog expression in the population of 
SSEA-1-ve / CD61+ve cells pre-cultured in 2i+LIF medium was slightly elevated 
compared to rat ESCs (Figure 3.5.7). However, this population also displayed a 
significant variation in Nanog expression between the three independent 
experiments (Figure 3.5.7). Expression of Oct4 within the SSEA-1+ve / CD61-ve cells 
pre-cultured in 1i medium was equivalent to the expression within rat ESCs (Figure 
3.5.7). 
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Figure 3.5.7. qRT-PCR analysis of expression of pluripotency genes in SSEA1/CD61 stained 
populations of rat cells subjected to a PGCLC differentiation protocol. Rat cells which had 
undergone PGCLC differentiation and had been stained for SSEA-1 and CD61 were sorted by FACs 
into double negative, single and double positive populations. All data was normalised to the house 
keeping gene β-actin (dCT) and fold change was calculated by normalising gene expression to that 
seen in the rat ESCs (ESCs (D0)) cultured in 2i+LIF medium (2-DDCT).  SS- = SSEA-1-ve, CC- = 
CD61-ve, SS+ = SSEA-1+ve, CC+ = CD61+ve. Bars represent mean of three independent experiments 
performed with DAK31 cells ± SD.*P<0.05, **P<0.01 to ESCs (D0). 
qRT-PCR data generated showed no evidence of significantly increased expression 
of any of the PGC markers compared to the rat ESCs (Figure 3.5.8). Nanos3 
transcript level was significantly reduced in both the SSEA-1-ve / CD61-ve and SSEA-
1+ve / CD61+ve populations compared to rat ESCs (Figure 3.5.8). There was also no 
detectable Nanos3 expression in SSEA-1-ve / CD61+ve cells pre-cultured in 2i+LIF 
medium (Figure 3.5.8). The remaining populations expressed lower levels of 
Nanos3 transcript compared to rat ESCs (Figure 3.5.8). Dazl expression from 
SSEA-1-ve / CD61+ve cells pre-cultured in 2i+LIF medium was higher than that in rat 
ESCs (Figure 3.5.8).  
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Dazl transcript expression was not detected in either SSEA-1+ve / CD61+ve 
populations and was reduced in all other populations when compared to rat ESCs 
(Figure 3.5.8). In almost all cases, Vasa transcript was significantly lower than that 
in rat ESCs; only the population of SSEA-1-ve / CD61+ve cells pre-cultured in 2i+LIF 
medium retained a similar expression of Vasa to the rat ESCs (Figure 3.5.8) 
 
Figure 3.5.8. qRT-PCR analysis of PGC marker gene expression in SSEA1/CD61 stained 
populations of rat cells subjected to a PGCLC differentiation protocol. Rat cells which had 
undergone PGCLC differentiation and had been stained for SSEA-1 and CD61 were sorted by FACs 
into double negative, single and double positive populations. All data was normalised to the house 
keeping gene β-actin (dCT) and fold change was calculated by normalising gene expression to that 
seen in the rat ESCs (ESCs (D0)) cultured in 2i+LIF medium (2-DDCT).  SS- = SSEA-1-ve, CC- = 
CD61-ve, SS+ = SSEA-1+ve, CC+ = CD61+ve. Bars represent mean of three independent experiments 
performed with DAK31 cells ± SD. *P<0.05, **P<0.01 to ESCs (D0). 
Transcript expression of markers of endoderm (Gata4, Gata6) and trophectoderm 
(Gata3) were also analysed to determine whether a proportion of the differentiating 
cells were directed towards these lineages during the PGCLC differentiation 
protocol. Expression of both Gata4 and Gata6 was upregulated in all stained 
populations compared to the expression seen in rat ESCs (Figure 3.5.9).  
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However, there appeared to be no noticeable differences in the expression of these 
markers between the 2i+LIF and 1i medium pre-cultured cell pools (Figure 3.5.9). 
Gata3 expression was higher in all stained populations compared to rat ESCs 
(Figure 3.5.9). The population of SSEA-1-ve / CD61+ve cells generated from pools 
pre-cultured in 1i medium was greater than those pre-cultured in 2i+LIF medium 
(Figure 3.5.9). This expression data suggested that subjecting these cells to a 
PGCLC differentiation protocol was directing a proportion of the cells towards 
endoderm and trophectoderm lineage rather than the PGCLC lineage.  
 
Figure 3.5.9. qRT-PCR analysis of expression of endoderm and trophectoderm markers in 
SSEA1/CD61 stained populations of rat cells subjected to a PGCLC differentiation protocol. Rat 
cells which had undergone PGCLC differentiation and had been stained for SSEA-1 and CD61 were 
sorted by FACs into double negative, single and double positive populations. All data was normalised 
to the house keeping gene β-actin (dCT) and fold change was calculated by normalising gene 
expression to that seen in the rat ESCs (ESCs (D0)) cultured in 2i+LIF medium (2-DDCT). SS- = 
SSEA-1-ve, CC- = CD61-ve, SS+ = SSEA-1+ve, CC+ = CD61+ve. Bars represent mean of three 




















76  Chapter 3 
The data generated from rat cell pools subjected to the PGCLC differentiation 
protocol highlighted that in its current state, the protocol does not seem to reliably 
drive rat cells towards the germ cell lineage. Although mouse PGCLCs are 
characterised being both SSEA-1+ve / CD61+ve cells, this population of rat ESCs did 
not appear to show the upregulation of PGC transcription factors or PGC marker 
genes. Interestingly, the SSEA-1-ve / CD61+ve population of cells pre-cultured in 
2i+LIF medium consistently expressed the highest levels of PGC transcription 
factors and gene markers, suggesting that this population of cells might harbour rat 
PGCLCs.  
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3.6 Chapter 3 discussion 
Rat ESCs are demonstrably pluripotent and have been shown to have the capability 
of contributing to the germline in chimaeric animals (Buehr et al. 2008, Li et al. 
2008). Mouse ESCs can be differentiated in vitro into PGCLCs, cells similar to the 
unipotent germ line precursor cells present within the developing epiblast embryo 
(Hayashi et al. 2011, Hayashi & Saitou 2013). Although variations of this 
differentiation protocol have been used to produce PGCLCs from other mammalian 
species (Wang et al. 2016, Meyenn et al. 2016), there is no published evidence of 
rat ESCs being successfully differentiated into PGCLCs. The aim in this chapter was 
to determine whether the PGCLC differentiation protocol described by Hayashi et al 
(2011, 2013) could direct rat ESC differentiation into the PGC lineage.  
 
3.6.1 Mouse ESCs cultured in identical conditions as rat ESCs can be 
differentiated into PGCLCs using the PGCLC differentiation 
protocol developed by Hayashi et al 
To establish the Hayashi protocol in our laboratory, we first applied it to mouse 
ESCs established and grown in the same conditions as our rat ESCs. Mouse 
PGCLCs are identified by co-expression of the surface markers SSEA-1 and CD61 
(Hayashi et al. 2011, Hayashi & Saitou 2013). A distinct population of SSEA-
1+ve/CD61+ve PGCLCs was purified from our mouse cells by FACs and shown to 
have upregulated PGC transcription factor (Blimp1, Prdm14, Ap2γ) and PGC 
specific marker (e.g. Nanos3) gene expression. These results match the previously 
reported characteristics of mouse PGCLCs (Hayashi et al. 2011, Hayashi & Saitou 
2013). The percentage of SSEA-1+ve/CD61+ve PGCLCs generated from our mouse 
ESCs (~15%) was within the range shown by Hayashi et al (8-15%) (Hayashi et al. 
2011, Hayashi & Saitou 2013).  
These mouse cells were used as a positive control for the rat PGCLC differentiation 
experiments, showing that any differences between the responses of the rat and 
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3.6.2 Rat cells subjected to the EpiLC differentiation protocol had low 
expression of epiblast markers compared to mouse ESCs 
Direct application of the Hayashi protocol to rat ESCs was not successful, 
suggesting that the protocol could not be simply translated from mouse to rat ESCs 
without additional modification. During the EpiLC stage of the differentiation 
protocol, two key differences between the responses of the mouse and rat ESCs 
were observed. Firstly, rat ESCs were unable to attach to fibronectin layers. 
Fibronectin is the substratum used to induce EpiLC differentiation of mouse cells 
prior to PGCLC differentiation (Hayashi et al. 2011, Hayashi & Saitou 2013). 
Attachment to fibronectin requires the integrin receptor α5β1 on the cell surface (Wu 
et al. 1993, Zhang et al. 1993). However, both α5 and β1 integrins are expressed at 
low levels in rat ESCs (Li et al. 2008, Yaoyao et al. 2017), providing an explanation 
why rat cells would not attach to fibronectin coated wells. Laminin and MEF layers 
were used as alternative basement substratum to facilitate attachment of rat cells, 
as both have been shown previously to support rat ESC growth (Buehr et al. 2008, 
Li et al. 2008). Rat cells cultured on MEF layers in EpiLC medium showed the 
greatest transcript expression of the Epiblast marker Fgf5 compared to cells cultured 
on laminin or in suspended aggregates. This result suggested that not only was 
attachment of the cells important for driving Epiblast marker expression, attachment 
of rat ESCs to MEFs was the most suitable condition of the three to assist directed 
differentiation towards the Epiblast-like state.  
The second difference between mouse and rat cells was that the expression of 
markers associated with EpiLC differentiation (e.g. Tcf15 and Otx2) were not 
induced in rat cells after being cultured in EpiLC medium. TCF15 is important for 
early epiblast differentiation in mice, inhibiting Nanog and driving Otx2 expression as 
cells transition out of the naïve state (Davies et al. 2013). It is also reported that 
active Tcf15 expression assists in the repression of endoderm markers during cell 
differentiation (Davies et al. 2013). Therefore, the lack of Tcf15 expression in rat 
ESCs could have allowed a greater proportion of cells to differentiate towards the 
endoderm lineage rather than becoming EpiLCs. The role of the OTX2 transcription 
factor during EpiLC differentiation is to redirect OCT4 binding to genomic regulatory 
elements of Epiblast-related genes and driving the cells out of the naïve state (Yang 
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Further analysis of the basal expression of Otx2 in our rat ESCs showed there was 
a substantially reduced expression of Otx2 in rat ESCs compared to the mouse 
cells. This low initial expression of Otx2 in rat ESCs could have negatively impacted 
the capacity of rat cells to differentiate into EpiLCs or indicate that the rat ESCs 
were not in the same initial pluripotency state as the mouse ESCs. Previous studies 
have shown that increasing Wnt-signalling in mouse cells by the addition of high 
concentrations of CHIR99021 to the culture medium can reduce the expression of 
Otx2 transcript (Zhang et al. 2018). Increased β-catenin activity has been identified 
in rat ESCs compared to the mouse during standard 2i+LIF culture conditions (Meek 
et al. 2013), therefore, the low basal expression of Otx2 in rat ESCs may have been 
due to increased Wnt-signalling within rat ESCs compared to the mouse. Rat ESCs 
cultured in medium lacking the Wnt-signalling inhibitor CHIR99021 and LIF (1i 
medium) had increased Otx2 gene expression compared to cells cultured in 2i+LIF 
medium. When subjected to EpiLC differentiation medium, cells pre-cultured in 1i 
medium had no substantial difference in Tcf15 expression compared to 2i+LIF pre-
cultured cells. However, elevated Fgf5 expression was detected in cells which had 
been pre-cultured in 1i medium compared to 2i+LIF medium. This result suggested 
that this pre-culture condition may have improved the differentiation of rat ESCs 
towards the epiblast fate.  
Overall, the low expression of Tcf15 and Otx2 during the EpiLC differentiation 
protocol made it difficult to confirm if rat ESC differentiation was being directed 
towards the EpiLC fate. Exploring the expression of other factors used in the 
identification of EpiLCs in other mammalian species (e.g. Rab15 in porcine IPSCs 
(Wang et al. 2016)) or the markers present in the in vivo rat epiblast during 
embryogenesis may help identify the presence of rat EpiLCs in future investigations. 
Additionally, female mouse EpiLCs lack H3K27me3 enrichment (Hayashi et al. 
2012) and are reported to have a similar epigenetic status to mouse ESCs 
(Takahashi et al. 2018), suggesting that epigenetic profiling could potentially be 
used in future investigations to distinguish the presence of rat EpiLCs from a pool of 
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3.6.3 CD61+ve rat cells have increased PGC marker expression after 
being subjected to the PGCLC differentiation protocol 
The surface markers SSEA-1 and CD61 have been used to identify mouse PGCLCs 
from differentiated ESC cultures (Hayashi et al. 2011, Hayashi & Saitou 2013). 
However, immunohistochemistry staining of the genital ridges of rat embryos (E13 - 
E19 dpc) showed that rat PGCs do not express SSEA-1 on their surface, unlike the 
PGCs within the genital ridges of mice (Encinas et al. 2012). Therefore SSEA-1 was 
used in this investigation to monitor the loss of undifferentiated stem cells during the 
differentiation protocol rather than as a marker of rat PGCLCs. As expression of 
Cd61 was present in tissue harvested from the genital ridge of rat embryos, it was 
assumed that the population of cells expressing CD61 on their cell surface could 
also harbour PGCLCs generated during the differentiation protocol. PGC markers 
were detected in CD61+ve rat cells, although the level of expression was lower than 
that generated from mouse cells.  
Rat cells subjected to the PGCLC differentiation protocol had increased expression 
of the endoderm marker Gata6 and trophectoderm marker Gata3. In mice, 
expression of these markers was elevated in all cells except the distinct 
SSEA1+ve/CD61+ve population of PGCLCs. This suggests that rat PGCLCs 
generated during the differentiation protocol were not isolated from the 
heterogeneous differentiated population of cells and remained a small sub-
population within the CD61+ve population. This would explain why PGC marker 
expression was lower than that generated by the mouse. However, this result could 
also be due to inefficient PGCLC differentiation of the rat cells. Tcf15 expression is 
reported to represses endoderm marker expression (Davies et al. 2013), while the 
primitive endoderm of the developing mouse embryo has been shown to lack OTX2 
protein (Boroviak et al. 2018). Additionally, rat cells harvested from the epiblast and 
cultured in vitro have been shown to have more evidence of endoderm 
differentiation than their mouse counterparts (Nichols et al. 1998), suggesting rat 
cells may be more primed for differentiation into certain lineages than mouse cells. 
Therefore, the absence of Otx2 and Tcf15 induction in cells already pre-primed for 
differentiation may have driven rat cell differentiation towards other lineages such as 
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Rat cells pre-cultured in 2i+LIF medium had increased PGC marker expression 
compared to cells pre-cultured in 1i medium, showing that culturing rats cells in 1i 
medium prior to the differentiation protocol did not improve the proportion of cells 
which differentiated into the germ cell lineage.  
A recent study in mouse ESCs showed that the loss of Otx2 expression prior to 
differentiation produced a greater number of PGCLCs (Zhang et al. 2018).  
As the expression of Otx2 was raised in rat ESCs pre-cultured in 1i medium, could 
the loss of Otx2 expression have a similar impact on PGCLC determination in rat 
cells? The data generated suggests that the in vitro differentiation protocol 
described by Hayashi et al (2011, 2013) is not suitable for driving rat PGCLC 
differentiation. As it is possible for rat ESCs to be engrafted into chimeras with 
variable success (Buehr et al. 2008, Li et al. 2008), the inefficiency of generating rat 
PGCLCs is likely due to the culture conditions not being appropriate for driving germ 
cell differentiation of rat ESCs. Therefore, could PGCLC differentiation of rat ESCs 
be improved by manipulating the epiblast gene network of rat ESCs during the 
differentiation protocol? As the expression of the Blimp1 transcription factor within 
rat ESCs is low, it was of interest to explore whether increasing its expression could 
direct a greater proportion of rat ESCs towards the germ cell lineage during 
differentiation.  
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Chapter 4 Directing differentiation by 
‘rewiring’ the expression of Blimp1 
via the Brachyury promotor 
4.1 Introduction 
The PGCLC differentiation protocol described by Hayashi et al did not efficiently 
induce PGCLC formation in rat ESCs. However, overexpression of PGC 
transcription factors within mouse epiblast-like cells can promote adoption of the 
PGCLC fate (Nakaki et al. 2013). This chapter details an alternative experimental 
approach to ‘hijack’ or ‘rewire’ the epiblast transcriptional programme to place an 
exogenous copy of a PGC transcription factor (TF) under the control of an epiblast 
promoter. It is hypothesised that activation of the epiblast promotor during cellular 
differentiation will drive the expression of the PGC TF, increasing the efficiency of 
epiblast cells entering the germ cell lineage when subjected to the PGCLC 
differentiation protocol. 
The BRACHYURY (T) transcription factor is primarily expressed in the late epiblast 
stage, within the proximal region of the embryo and within the primitive streak, the 
regions with the highest expression of WNT3 (Rivera-Pérez & Magnuson 2005). The 
Brachyury gene is a downstream target of the WNT signalling cascade, and is 
activated as ESCs transition out of the naïve state and differentiate towards the 
more primed epiblast fate (Aramaki et al. 2013, Günesdogan et al. 2014). It is 
involved in the formation of the mesoderm during embryogenesis and the 
differentiation of epiblast cells into the somatic lineage (Rivera-Pérez & Magnuson 
2005). BRACHYURY has also been reported to interact with the regulatory regions 
of Blimp1 and Prdm14 genes (Aramaki et al. 2013). The association of 
BRACHYURY with these regulatory regions is thought to enhance the expression of 
PGC transcription factors as PGC precursor cells migrate towards the embryonic 
genital ridges (Aramaki et al. 2013). As BRACHYURY is linked with both the 
differentiation of epiblast cells (Rivera-Pérez & Magnuson 2005) and PGC 
specification (Aramaki et al. 2013), the Brachyury promotor was deemed a suitable 
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BLIMP1 is the first of the three PGC TFs to be active during PGC specification in the 
post implantation embryo (~E6.25 in the mouse) and is essential for early PGC 
specification, ensuring that the default somatic pathway is silenced so that the 
epiblast cells within the proximal region of the embryo are directed towards the germ 
cell lineage (Ohinata et al. 2005, Dudley et al. 2007, Fog et al. 2012, Günesdogan et 
al. 2014).  
The aim was to use homologous recombination to insert a cDNA copy of the 
BLIMP1 transcription factor downstream of the Brachyury promotor. To accomplish 
this targeted insertion, a CRISPR/Cas9 gene editing strategy would be implemented 
to improve the recombination frequency and promote efficient recovery of correctly 
targeted clones. The intended outcome was to generate rat ESC clones containing a 
heterozygous insertion of exogenous Blimp1 cDNA within the Brachyury locus so as 
not to completely disrupt the expression of Brachyury.  
 
4.2 Gene-editing strategy for editing the Brachyury 
locus 
4.2.1 CRISPR/Cas9 gene editing overview 
Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/CAS9 gene 
editing is a gene targeting technique with two primary components, a CRISPR-
associated endonuclease (Cas nuclease) and guide RNA (gRNA or sgRNA) (Cong 
et al. 2013, Mali et al. 2013). The gRNA acts as a scaffold for the Cas nuclease, 
guiding it to the specified region of the genome (Cong et al. 2013, Mali et al. 2013). 
If this targeted region is directly followed by a protospacer-adjacent motif (PAM), the 
Cas nuclease cleaves the DNA by inducing a double strand break (DSB) (Cong et 
al. 2013, Mali et al. 2013). DNA repair mechanisms such as non-homologous end 
joining (NHEJ) or homology directed repair (HDR) can then promote the re-joining of 
the cut strands (Cong et al. 2013, Mali et al. 2013, Hsu et al. 2014). A template 
sequence/vector with homology to either side of the DSB is co-transfected with Cas 
nuclease and gRNA, acting as a template for HDR repair and introducing genetic 
modifications into the targeted region of the genome (Cong et al. 2013, Mali et al. 
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4.2.2 CRISPR/Cas9 strategy to be implemented 
To place a rat Blimp1 transgene under the control of the Brachyury promotor, a 
CRISPR/Cas9 nuclease strategy was designed to target the ATG start codon of the 
Brachyury gene. Targeted cleavage at the ATG site would assist homologous 
recombination of the Blimp1 cDNA into the region downstream of the Brachyury 
promotor (Figure 4.2.1). 
 
Figure 4.2.1. Strategy for ‘hijacking’ the Brachyury promotor. CRISPR gRNA was designed so 
Cas9 nuclease was recruited downstream of the Brachyury promotor. A HDR template containing a rat 
Blimp1 transgene with homology arms spanning either side of the cut region was co-transfected with 
the Cas9 nuclease and gRNA to assist incorporation of the Blimp1 transgene via HDR repair. 
Heterozygous clones containing a WT allele, and an edited Brachyury allele containing the BLIMP1 
cDNA (red box) would be identified and used for further investigation.  
Using the CRISPR Design tool produced by the Zhang Lab (crispr.mit.edu), two 
gRNA sequences with PAM sites within 30 base pairs of the Brachyury ATG start 
codon were identified and chosen to target the Cas9 nuclease to the ATG site of 






(-PAM, 20bp + G) 
PAM DSB location 
(After ATG site, bp) 
AT1 (G)TGGCGGGAGGATGAGCTCCC CGG 10 
AT2 (G)CCCTGCGCTCTCTGTGCCCG GGG 27 
 
Figure 4.2.2.  gRNA sequences designed to target ATG initiation codon within exon 1 of the 
Brachyury locus. Both AT1 and AT2 gRNAs targeted regions within 30bps of the ATG site and inside 
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exon 1 of Brachyury. Each gRNA sequence was 21 base pairs long, with 20 base pairs of homology 
before the PAM sequence. A ‘G’ was added to the 5’ end of each gRNA sequence to ensure efficient 
expression of the gRNA from the U6 promotor of the PX458 vector. 
4.3 Generation of Cas9 nuclease vectors designed to 
target the Brachyury locus 
4.3.1 Insertion of gRNA sequences into PX458 Cas9 nuclease 
The Cas9 nuclease used during this investigation was a human codon optimised S. 
pyogenes Cas9 (SpCas9) nuclease expressed from the PX458 Cas9 mCherry 
vector (Figure 4.3.1), provided by the Hohenstein group (Roslin Institute).  
 
Figure 4.3.1. Px458 mCherry CRISPR vector. A CAG enhancer/promoter (CAG) drove the 
expression of a CRISPR/Cas9 nuclease (CAS9 Nuclease), which was coupled to a 2A peptide (T2A) 
and mCherry fluorescent protein (mCherry). Upstream of this cassette was a Human U6 promotor (U6) 
which drove the expression of the chimaeric gRNA scaffold. gRNA sequences were introduced into the 
plasmid by linearization of the vector via BbsI digestion (BbsI) and ligation of an oligonucleotide 
containing the gRNA sequence. The vector co-expressed both the Cas9 nuclease and gRNAs required 
to target Cas9 nuclease DSBs. 
The PX458 vector was designed to co-express Cas9 nuclease and mCherry 
fluorescent protein. A gRNA sequence was inserted into the same vector 
downstream of a human U6 promotor via restriction digest and ligation. Once 
inserted the PX458 vector was capable of driving the expression of the gRNA 
sequence in addition to the nuclease and mCherry protein. Insertion of the gRNA 
sequences was performed as presented in Figure 4.3.2. Two complementary 
strands of oligonucleotides matching the sense and anti-sense sequences of each 
gRNA were synthesised. The sense strand was designed to have a 5’-CACC 
overhang, while the anti-sense strand a 5’-CAAA overhang. Sense and anti-sense 
sequences were annealed together overnight to form double-stranded gRNA 
sequences. Insertion of these gRNA sequences was performed by linearization of 
the PX458 vector by BbsI restriction digest, followed by incubation of linearised 
vector and gRNA with T4 ligase.  
 
Chapter 4          87 
 
Figure 4.3.2. Strategy for insertion of gRNA into PX458 vector. The PX458 mCherry CRISPR 
vector was linearized with BbsI, producing overhangs or “sticky ends” which would not ligate back 
together. The oligonucleotides strands (encoding for the gRNA)  with matching 5’ overhangs were 
introduced and ligated to form a circular vector (PX458 vector) containing Cas9 nuclease, mCherry and 
gRNA.  
4.3.2 CRISPR/Cas9 nuclease induced cutting of the Brachyury locus 
Due to the variability in NHEJ and the formation of indels during CRISPR/Cas9 gene 
editing, it can be difficult to visualise and assess the efficiency of the Cas9 nuclease 
induced DSB at the target region. Sanger sequencing can be used to determine 
whether indels have occurred at the target region after CRISPR/Cas9 gene editing. 
However, it would be time consuming and expensive to use this to report on the 
efficiency of Cas9 nuclease induced cutting at the target region. To monitor the 
generation of CRISPR/Cas9 induced DSB at the ATG site of Brachyury, another set 
of Cas9 nuclease vectors were designed to induce DSBs in the intronic sequence 
downstream of the exon 1 of Brachyury.  
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When the gRNA sequences successfully target Cas9 nuclease to the correct 
regions, co-transfection of AT1 or AT2 with any of the intron targeting PX458 vectors 
(IN1, IN2, IN3) should generate a deletion. This deletion can be detected by PCR 
amplification of the genomic DNA of transfected cells. A small band represented 
cells which had been cleaved at both genomic target sites (Figure 4.3.3). Efficiency 
of Cas9 nuclease cutting was estimated by the relative intensity of the PCR bands 





(-PAM, 20bp + G) 
PAM DSB location  
(After ATG site, 
bp) 
IN1 (G)CGTGCGGCAAGCCGGCAGTC TGG 233 
IN2 (G)AAACTTTCCCTGACGAAACC TGG 272 
IN3 (G)CTCTGAGTTAACAGCCCCCA GGG 326 
 
Figure 4.3.3. gRNAs designed to target genomic regions downstream of exon 1 of the rat 
Brachyury sequence. Three gRNAs were designed to target varying regions downstream of exon 1 of 
Brachyury. Each gRNA sequence was 21 base pairs long, with 20 base pairs of homology before the 
PAM sequence. A ‘G’ was added to the 5’ end of each gRNA sequence to ensure efficient expression 
of the gRNA from the U6 promotor of the PX458 vector. 
The parental rat DAK31 ESC line was co-transfected with different combinations of 
AT PX458 vector and IN PX458 vector. DAK31 ESCs were chosen as they 
contained no fluorescent marker which could interfere with mCherry 
immunofluorescence screening of the transfected cell pools. Successful transfection 
was determined by the presence of mCherry expression from the PX458 vectors 24 
hours post transfection (Figure 4.3.4).  
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Figure 4.3.4. PX458 vector transfection of rat DAK31 cell pools. Rat DAK31 ESCs were 
transfected with either a vector containing CAG-EGFP or the PX458-mCherry Cas9 nuclease vector. 
After 24 hours, mCherry expression was observed from PX458 vector transfected cells, but not from 
CAG-EGFP transfected cells. 
Genomic DNA (gDNA) was isolated 48 hours post transfection and used as a 
template for PCR amplification of the Brachyury locus. Oligonucleotides were 
designed to bind to regions ~300bp upstream and ~500bp downstream of the 
Brachyury ATG site, producing a wild type PCR band of ~800bp (Figure 4.3.5A). Gel 
electrophoresis was performed to confirm the presence of Cas9 nuclease induced 
cutting within the locus (Figure 4.3.5B). Every combination of AT-PX458 and IN-
PX458 vector showed evidence of a faint band matching the size of a DSB-
mediated deletion within the Brachyury gene (~445-590bp) and an intense wild type 
band (~800bp). DAK31 cells transfected with AT1-PX458 had more intense edited 
(MUT) PCR bands compared to those pools transfected with the AT2-PX458 vector 
(Figure 4.3.5B). Therefore, it was decided that the AT1-PX458 vector would be used 
for the insertion of exogenous Blimp1 cDNA downstream of the Brachyury gene.  
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Figure 4.3.5. Screening for successful deletion within genomic DNA from the Brachyury locus 
of rat ESCs transfected with CRISPR/Cas9 PX458 vectors. (A) Schematic showing target sites of 
gRNA and the binding locations of the PCR oligonucleotides on the Brachyury locus. (B) Agarose 
electrophoresis gel showing amplified PCR bands from CRISPR/Cas9 transfected cells. PCR 
fragments from un-transfected DAK31 ESCs and cells transfected with PX458 vector containing no 
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4.4 Generation of rat ESC clones expressing BLIMP1 
from the endogenous Brachyury promotor  
4.4.1 Generating the HDR template for CRISPR Cas9-mediated 
insertion of Blimp1 cDNA 
To enable precise insertion of the Blimp1 cDNA downstream of the rat Brachyury 
promoter, a vector was constructed with homology arms spanning either side of the 
DSB induced by the AT1-PX458 vector within the Brachyury locus. A 2.1kb region of 
the rat Brachyury gene spanning ~1kb either side of the Brachyury start codon was 
PCR amplified from genomic DNA isolated from rat ESCs (Figure 4.4.1A). The 
amplified region was cloned into a TA cloning vector (Figure 4.4.1A) and sequence 
verified. Inverse PCR amplification of the resulting TA vector was performed to 
produce a linearised vector which did not have the Brachyury ATG start site or the 
AT1-PX458 Cas9 nuclease cut site (Figure 4.4.1B). This ensured that the Cas9 
nuclease was not targeted to the HDR template vector when co-transfected into the 
rat ESCs, which would have disrupted the vector by inducing a DSB and reduced 
the efficiency of Blimp1 cDNA insertion. The linearised vector was purified using a 
gel electrophoresis purification kit to remove any residue TA vector. 
A BLIMP1-2a-mCherry cassette was generated by PCR amplification from a Tet-On 
piggyBac transposon vector containing a Blimp1 cDNA and mCherry fluorescent 
protein expression cassette (see Chapter 5 for further details). Inclusion of the 
mCherry fluorescent marker was considered beneficial as activation of exogenous 
gene expression from the Brachyury locus could then be monitored and analysed by 
immunofluorescence imaging and flow cytometry. The exogenous rat Blimp1 cDNA 
was previously synthesised to match the sequence displayed on the Ensembl 
database (ENSRNOT00000076541.1). Homology to the linearised 2.1kb TA-
Brachyury vector was introduced during PCR amplification of the BLIMP1-2a-
mCherry cassette (Figure 4.4.1B). Gibson cloning was performed to incorporate the 
BLIMP1-2a-mCherry sequence into the linearised TA vector containing the 
Brachyury homology arms. The resulting vector, referred to as the HDR template 
vector, was sequenced to verify that the BLIMP1-2a-mCherry had been inserted 
correctly into the HDR template vector. 
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Figure 4.4.1 Generation of BRACHYURY-BLIMP1 HDR template vector. (A) Genomic DNA from rat 
DAK31 ESCs was PCR amplified to produce a 2100bp fragment spanning Brachyury exon 1. This 
fragment was inserted into a TA cloning vector following the manufacturers cloning protocol. (B) 
Inverse PCR was used to amplify TA-vector containing the Brachyury homology arms. 
Oligonucleotides were designed so the reverse primer would bind upstream of the ATG start codon, 
while the forward primer bound approximately 40bp downstream of ATG start codon. PCR amplification 
of BLIMP1-2a-mCherry cassette was performed to introduce 15bp homology arms to both the 5’ and 3’ 
ends of cassette. Homology arms were designed to match linearised ends of previously generated TA 
Brachyury homology arm vector. Gibson cloning annealed the two fragments together to generate a 
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4.4.2 CRISPR-Cas9 nuclease-induced gene editing of rat ESCs 
The aim was to generate rat ESC clones which were heterozygous for BLIMP1-2a-
mCherry insertion into the Brachyury locus, and also retained a functional Brachyury 
WT allele (Figure 4.4.2).  
 
Figure 4.4.2. Schematic showing the insertion of BLIMP1-2a-mCherry sequence into the 
BRACHYURY locus via Homology directed repair. The AT1 PX458 vector was designed to express 
both the Cas9 nuclease enzyme and the gRNA which targeted the Cas9 nuclease to the ATG region of 
the Brachyury locus. When co-transfected with the HDR template vector (Figure 4.4.1), the BLIMP1-
2a-mCherry cassette was incorporated into the cut region by homology-directed repair.  
DAK31 ESCs were co-transfected with the AT1-PX458 Cas9 nuclease vector ( 
Figure 4.2.2) and the BLIMP1-2a-mCherry HDR template vector (Figure 4.4.1). 48 
hours post transfection, ~300 mCherry positive ESCs from the transfected cell pool 
were single cell sorted into the wells of four 96 well plates. The gating strategy 
detailed in section 2.6.7 was used. The remaining cells were gated to isolate 
populations of mCherry+ve cells by plotting mCherry (610/20A) versus side scatter 
area (SSC-A). The gates were set against untransfected rat ESCs. The flow 
cytometry plots generated during the FACs of these mCherry positive populations 
are shown in Figure 4.4.3. These single cells were cultured in 2i+LIF medium and 
allowed to recover for 7 days.  




Figure 4.4.3. Flow cytometry plots of PX458 transfected cells. Cells transfected with the PX458 
vector were separated into mCherry positive and negative populations. The percentages shown 
indicate the proportion of mCherry positive cells within the transfected cell pools.  
Of these sorted mCherry positive cells, 100 single cell clones survived the single cell 
plating procedure and generated large enough colonies to propagate further. After a 
further 2 weeks, 20 clones were passaged further from 24-well plates. Aliquots of 
the 20 clones were frozen and screened for insertion of the BLIMP1-2a-mCherry 
sequence by PCR amplification using purified genomic DNA. The PCR 
oligonucleotides were designed so they would bind outside of the homology arms 
contained in the HDR template to ensure the amplified regions were from the rat 
genome and not derived from HDR template vector. If insertion of the BLIMP1-2a-
mCherry cassette was successful, a PCR band of ~7.2kb would be generated. A 
visual representation of the PCR screen and the resulting PCR amplified bands from 
3 of the analysed clones is shown in Figure 4.4.4.  
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Figure 4.4.4. PCR screen for the insertion of the Blimp1-2a-mCherry cassette. (A) Schematic 
showing the binding sites of the screening oligonucleotides on both the WT and edited Brachyury 
alleles. (B) Gel electrophoresis of PCR amplified regions from 3 transfected cell line clones (Brach-B1-
1, 2 & 3). Insertion of BLIMP1-2a-mCherry increased the size of the PCR band by ~4070bps. Pools of 
the parental cell line (Parental (DAK31)) and cells transfected with a PX458 vector without a gRNA 
sequence (Emp Cas9 Nuclease) were used as PCR controls. 
Of the 20 clones screened by PCR, 8 generated an amplified band which matched 
the expected size if the BLIMP1-2a-mCherry cassette had been successfully 
inserted downstream of the Brachyury promotor. Of these 8 clones, 5 retained a 
wildtype sized amplicon as well as and the edited Brachyury allele.  
A secondary PCR screen was used to confirm insertion of the BLIMP1-2a-mCherry 
cassette in the Brachyury locus. The 8 clones were screened with oligonucleotides 
designed to bind outside of the Brachyury homology arm and within the BLIMP1-2a-
mCherry cassette. PCR bands are only amplifiable if the BLIMP1-2a-mCherry 
cassette was present within the Brachyury locus. All remaining clones had an 
amplified band with both PCR oligonucleotide sets, while the parental and cells 
transfected with an empty Cas9 vector did not generate an amplified band. A visual 
representation of the PCR screen and the resulting PCR amplified bands from 3 of 
the analysed clones is shown in Figure 4.4.5. 3 clones (renamed BRACH-B1-1, 2 
and 3) were determined to be karyotypically normal (between 75%-80% of cells of 
each clone).  
 
7182bp – BLIMP1 – BRACHYURY 
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Figure 4.4.5. Internal PCR screen to confirm insertion of Blimp1-2a-mCherry cassette into the 
Brachyury locus. (A) Schematic showing the regions amplified if the BLIMP1-2a-mCherry cassette 
has been successfully inserted into the Brachyury locus (B) Gel electrophoresis of the PCR amplified 
regions. Insertion of BLIMP1-2a-mCherry was identified by the presence of a PCR band with both sets 
of oligonucleotides. The parental and cells transfected with PX458 without a gRNA sequence were 
used as negative controls. 
 
BRACH-B1-1 did not display any substantial differences in growth or morphology 
compared to the parental DAK31 cell line when cultured in standard 2i+LIF medium. 
BRACH-B1-2 and BRACH-B1-3 however grew noticeably slower and the colonies 
were smaller and rounder than the parental line (Figure 4.4.6).  
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Figure 4.4.6. Bright field microscopy images of BRACH-B1 clones. Photographs were taken of the 
karyotypically normal clones containing at least one allele of Brachyury containing the BLIMP1-2a-
mCherry sequence. The top panel shows the parental WT cell line. All cells were seeded at 1.5 x 105 
cells and cultured for 2 days in 2i+LIF culture medium. 
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4.4.3 Sequencing of the edited Brachyury alleles from the BRACH-B1 
clones 
PCR amplification of the BRACHYURY locus had shown that within these isolated 
clones, all three had one allele which contained the BLIMP-2a-mCherry cassette. 
Sanger sequencing was performed on the amplified bands from the second PCR 
screen (Figure 4.4.5) with oligonucleotides designed to sequence the joining regions 
between the Brachyury locus and the BLIMP1-2a-mCherry cassette. Sequence 
traces generated from the 5’ insertion site of the BLIMP1-2a-mCherry gene 
sequence matched the expected reference sequence (Figure 4.4.7).  
 
Figure 4.4.7. Sanger Sequencing report generated at the 5’ insertion site of the BRACH-B1 
clones. Sequencing report generated in the 3’ – 5’ direction. Blue box = Blimp1 transgene of Blimp1-
2a-mCherry cassette, Grey box = Kozak sequence of Blimp1-2a-mCherry cassette, Black box = Exon 1 
of endogenous Brachyury (UTR region upstream of ATG start codon). 
Sequence traces generated from the 3’ insertion site of the BLIMP1-2a-mCherry 
showed seamless insertion of the BLIMP1-2a-mCherry cassette into the Brachyury 
locus (Figure 4.4.8) in all three clones.  
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Figure 4.4.8. Sanger Sequencing report generated at the 5’ insertion site of the BRACH-B1 
clones. Sequencing report generated in the 5’ – 3’ direction. Purple box = PolyA tail of Blimp1-2a-
mCherry cassette, Black box = Exon 1 of endogenous Brachyury (downstream of ATG start codon). 
 
4.4.4 Sequencing of the non-HDR Brachyury allele within the BRACH-
B1 clones 
PCR amplification of the targeted region in the BRACH-B1-2 clone suggested there 
was no wild type Brachyury allele within the clonal population, implying that either 
the BLIMP1-2a-mCherry cassette had been inserted into both alleles of Brachyury 
or that NHEJ had removed one or both PCR oligonucleotide binding regions, 
preventing the amplification of the region with the screening oligonucleotides (Figure 
4.4.4). BRACH-B1-1 and BRACH-B1-3 were sequenced to identify whether either of 
these clones had a wild type copy of the Brachyury gene. Sanger sequencing was 
performed on the smaller amplified bands (~3112 bps) generated from the first PCR 
screen (Figure 4.4.4) with oligonucleotides designed to span the CRISPR cut site at 
the Brachyury locus.  
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Figure 4.4.9. Sanger Sequencing report of the 5’ ATG site allele Brachyury of the ‘wildtype’ in 
the BRACH-B1 clones. Sequencing report generated in the 5’ – 3’ direction. Red box = ATG start 
codon, Black box = Exon 1 of endogenous Brachyury. Black arrow/red dotted line represents 
CRISPR/Cas9 cut site at position ‘+10’ downstream of the Brachyury ATG site, highlighted regions (red 
outline) indicates indels present in the sequence after CRISPR gene editing. Evidence of multiple 
traces within each sample suggests that not all clones within the population had the same mutation, 
hence why the trace was more difficult to read. (A) BRACH-B1-1. A ‘T’ has been inserted at position +7 
(B) BRACH-B1-3. 2 deletions were present at positions +2 and +6, and 2 further changes identified at 
position +4 and +5. 
The sequence trace for both BRACH-B1-1 and BRACH-B1-3 had modifications near 
the ATG start site of Brachyury (Figure 4.4.9). BRACH-B1-1 had a deletion of a ‘T’ 
nucleotide 7 bases downstream of the ATG codon (+7) (Figure 4.4.9A). While 
BRACH-B1-3 had evidence of four base changes; two deletions at positions 2 bases 
(+2) and 6 bases (+6) downstream of ATG and either two substitutions, ‘A’ to ‘C’ and 
‘G’ to ‘T’ or an insertion of a ‘CT’ at 4 bases downstream of the ATG (+4 and +5) 
(Figure 4.4.9B). These modifications within both clones produced a frameshift 
mutation, indicating that all three generated BRACH-B1 clones were likely to be 
Brachyury knock-outs. Additionally, both clones had evidence of multiple traces, 
suggesting that these populations might be comprised of more than one single 
clone. Despite all three BRACH-B1 clones being effectively Brachyury nulls, they 
were analysed further to identify if the inserted Blimp1 and mCherry cDNA could be 
expressed from the Brachyury locus. 
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4.5 Expression of the BLIMP-2a-mCherry cassette  
4.5.1 Inducing the BLIMP1-2a-mCherry cassette by CHIR99021 titration 
It has been previously shown that rat ESCs cultured in high concentrations of 
CHIR99021 differentiate due to over-activation of β-catenin signalling (Meek et al. 
2013). This increases the expression of differentiation markers, including the 
epiblast gene Brachyury (Meek et al. 2013). To confirm that CHIR99021 induces 
high levels of Brachyury gene expression in DAK31 cells, samples were harvested 
after 16 and 72 hours of induction with 2-8μM CHIR99021 and levels of Brachyury 
transcripts were measured by qRT-PCR analysis (Figure 4.5.1). The qRT-PCR data 
generated showed that increasing the concentration of CHIR99021 increased 
expression of Brachyury, with cells cultured in 8μM CHIR99021 showing the highest 
level of Brachyury transcript after 16 and 72 hours. All 3 BRACH-B1 clones were 
subjected to a CHIR99021 titration for 72 hours alongside the parental DAK31 cell 
line (Figure 4.5.2).  
 
Figure 4.5.1. qRT-PCR analysis of WT DAK31 cells after CHIR99021 titration. Cells were 
harvested after 16 and 72 hours of culture in varying concentrations of CHIR99021. All data was 
normalised to the house keeping gene β-actin (dCT) and fold change was calculated by normalising 
gene expression to cells cultured in 2i+LIF (2-DDCT).CH = CHIR99021. Data shown is the average of 
two independent experiments performed in the DAK31 cell line ± SD. 
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Figure 4.5.2. Bright field microscopy photographs of WT DAK31 and BRACH-B1 clones 
undergoing CHIR99021 titration. Photographs were taken at day 0 (when cells were cultured in 
2i+LIF conditions) and after 72 hours of culture in varying concentrations of CHIR99021. 2i+LIF 
medium contained 2μM CHIR99021. 
The parental cell line differentiated as expected in high concentrations of 
CHIR99021, showing evidence of cellular differentiation. However, BRACH-B1-1 did 
not exhibit any substantial morphological changes when cultured in medium with a 
high concentration of CHIR99021 compared to cells cultured in 2i+LIF medium.  
Both BRACH-B1-2 and BRACH-B1-3 clones produced flatter colonies when cultured 
in high concentration of CHIR99021 compared to standard 2i+LIF medium, but had 
little evidence of differentiation when compared to the parental.  
Cells treated with high concentrations of CHIR99021 were fixed and immunostained 
for the presence of BRACHYURY protein. The parental DAK31 cell line cultured in 
medium containing 8µM CHIR99021 stained positive for BRACHYURY protein 
(Figure 4.5.3). However, all three BRACH-B1 clones had no discernible 
BRACHYURY staining when treated with 8µM CHIR99021.  
Immunofluorescence staining of all three BRACH-B1 clones showed that either all 
three clones were Brachyury knock-out cell lines, or that they are less responsive to   
CHIR99021-induced differentiation. 
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Figure 4.5.3. Immunofluorescence staining of DAK31 and BRACH-B1 clones cultured with 8μM 
CHIR99021. BRACHYURY (green) protein expression was identified in the parental DAK31 cell line, 
but not in any of the BRACH-B1 clones. DAPI (blue) was performed as an immunostain control.  
The remaining culture wells were analysed by fluorescence microscopy and flow 
cytometry to identify mCherry fluorescence produced from the BLIMP1-2a-mCherry 
cassette as detailed previously. mCherry was not detected in any clones by 
fluorescence microscopy. However, flow cytometry analysis confirmed low levels of 
mCherry in all BRACH-B1 clones cultured in medium containing 8µM CHIR99021 
(Figure 4.5.4).  
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Figure 4.5.4. Flow cytometry plots of BRACH-B1 clones after CHIR99021 titration. Pools of the 3 
BRACH-B1 clones, alongside a parental control, were cultured for 72 hours with standard 2i+LIF (2µM) 
medium, or cell culture medium containing 4µM or 8µM CHIR99021 (CH). Peaks represent the level of 
mCherry expression detected from each cell pool.  
qRT-PCR analysis was performed to determine whether the expression of Blimp1, 
Ap2γ (downstream target of BLIMP1) and Nanos3 (PGC marker) were upregulated 
in BRACH-B1 clones cultured in response to high concentrations of CHIR99021.  
Blimp1 transcript levels increased substantially in all BRACH-B1 clones compared to 
the parental cell line when cultured medium containing 8μM CHIR99021 (Figure 
4.5.5). Expression of Ap2γ was elevated in the BRACH-B1-3 clone when cultured in 
medium containing 8μM CHIR99021. However, Ap2γ expression in both BRACH-
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When cultured in medium containing 8μM CHIR99021, all three BRACH-B1 clones 
had higher levels of Nanos3 transcript expression compared to the parental cells in 
the same medium conditions. However, this expression level did not surpass that in 
the ESCs cultured in 2i+LIF medium.   
 
Figure 4.5.5. qRT-PCR analysis of WT DAK31 and BRACH-B1 clones treated with CHIR99021. 
Cells from the parental (DAK31) or BRACH-B1 clones were harvested after 72 hours culture in varying 
concentrations of CHIR99021. The data presented was an average of two independent experiments. 
All data was normalised to the house keeping gene β-actin (dCT) and fold change was calculated by 
normalising gene expression to DAK31 cells cultured in 2i+LIF medium (2-DDCT)CH = CHIR99021. 
Data shown is mean ± SD. 
Overall, data generated from the CHIR99021 titration showed that the Brachyury 
promotor was able to induce the expression of the BLIMP1-2a-mCherry cassette 
within the BRACH-B1 clones. However, the low mCherry expression from the 
BRACH-B1 clones suggested that the expression from the Brachyury promotor was 
very weak during CHIR99021 induced activation of Brachyury.  
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4.5.2 Induction of the BLIMP1-2a-mCherry cassette in cells undergoing 
an Embryoid body (EB) differentiation protocol 
To determine whether the BLIMP1-2a-mCherry cassette could be activated without 
directly stimulating the Brachyury promotor using the GSK3i CHIR9901, BRACH-B1 
clones were induced to differentiate by being put through an undirected Embryoid 
body (EB) differentiation protocol (Figure 4.5.6).  
 
Figure 4.5.6. Schematic of the rat EB differentiation protocol. Rat ESCs cultured in 2i+Lif 
conditions on a MEF layer were transferred to an aggrewellTM plate at a cellular density equivalent to 
3,000 cells per microwell depression. After 2 days, these cells were transferred from the aggrewellTM 
plate to 6-well low adhesion plates with serum medium. These aggregates were retained in this 
condition for a further 4 days and then harvested at day 6.  
BRACH-B1 clones and the parental DAK31 cell line were cultured in suspension 
with 2i+LIF medium for 2 days to allow aggregation. Culturing rat ESCs in 
suspension with serum medium directly after being cultured in self-renewal 
conditions (2i+LIF on MEF layers) promoted extensive cell death, therefore, this 
2i+LIF intermediate aggregation step was introduced to increase cell survival. After 
2 days, the 2i+LIF medium was replaced with culture medium containing serum and 
the aggregates maintained in suspension for a further 4 days to drive differentiation 
of the cells. EBs were monitored for mCherry expression using fluorescent 
microscopy. mCherry fluorescence was detected from all 3 BRACH-B1 clones from 
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Figure 4.5.7. Brightfield and fluorescent microscopy photographs of the parental DAK31 and 
BRACH-B1 clones undergoing EB differentiation. Photographs were taken after cells from the 
parental or BRACH-B1 clones had been subjected to an EB differentiation protocol for 6 days.  
 
qRT-PCR analysis was performed to identify whether Blimp1 transcript expression 
had been induced within the BRACH-B1 clones after the EB differentiation protocol. 
Blimp1 transcript levels increased several-fold in all three BRACH-B1 clones 
compared to the parental cell line after the 6-day protocol (Figure 4.5.8). Expression 
of Ap2γ did increase in the BRACH-B1-1 and BRACH-B1-3 clones compared to the 
parental cell line, but was lower in the BRACH-B1-2 clone (Figure 4.5.8). Nanos3 
transcript expression was slightly increased in the BRACH-B1-1 clone when 
compared to the parental (Figure 4.5.8). However, Nanos3 expression in BRACH-
B1-2 cells was similar to the parental cell line, and was reduced in BRACH-B1-3 
cells (Figure 4.5.8). The qRT-PCR data, coupled with the fluorescence photographs 
taken after the cells had undergone the EB differentiation protocol indicated that the 
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Figure 4.5.8. qRT-PCR analysis of WT DAK31 and BRACH-B1 clones undergoing EB 
differentiation. Cells were harvested after the 6-day EB differentiation protocol. Data was normalised 
to the house keeping gene β-actin (dCT) and the fold change was calculated by normalising gene 
expression to the parental DAK31 ESCs (D0) (2-DDCT). Data is the average of two independent 
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4.5.3 Induction of the BLIMP1-2a-mCherry cassette in cells undergoing 
a PGCLC differentiation protocol 
The BRACH-B1 clones were subjected to the PGCLC differentiation protocol (Figure 
4.5.9) to observe whether the expression of Brachyury driven Blimp1 cDNA could 
enhance differentiation of rat ESCs towards a PGCLC fate.  
 
Figure 4.5.9 Schematic of the rat PGCLC differentiation protocol used for differentiation of 
BRACH-B1 clones. Rat ESCs cultured in 2i+Lif or 1i medium conditions on a MEF layer were 
transferred onto fresh MEF feeder layers and cultured in EpiLC differentiation medium for 3 days. 
These cells where then pipetted into hanging drops containing ~2,000 cells in PGCLC medium. After 2 
days, the hanging drops were collected and placed into fresh PGCLC medium in 6-well low adhesion 
plates for a further 4 days.  
BRACH-B1 clones and the parental DAK31 cell line were pre-treated for 3 days in 
2i+LIF or 1i culture medium on MEF feeder layers. After the pre-treatment, cells 
were transferred to 12-well plates coated with fresh MEFs and maintained in EpiLC 
culture medium for a further 3 days. The EpiLC medium was changed every 24 
hours to replenish active bFGF. Cells were photographed by bright field microscopy 
at the end of day 6 of the protocol to observe any morphological differences 
between the BRACH-B1 clones at this stage of the differentiation protocol (Figure 
4.5.10). After 3 days culture in EpiLC medium, there was a large amount of cellular 
debris present in wells of BRACH-B1-1 cells pre-cultured in 2i+LIF medium 
compared to cells pre-cultured in 1i medium (Figure 4.5.10). However, no obvious 
differences could be identified between BRACH-B1-2 or BRACH-B1-3 cells pre-
cultured in either 2i+LIF or 1i (Figure 4.5.10). No mCherry fluorescence was visible 
by fluorescence microscopy from any BRACH-B1 clone during the 3-day culture in 
EpiLC medium (data not shown). 
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Figure 4.5.10. Bright field microscopy of BRACH-B1 clones after a 3-day culture in EpiLC 
medium. Cells were photographed prior to pre-treatment (Day 0) and at day 6 of the differentiation 
protocol (Day 6). Pools of cells had either been pre-cultured in 2i+LIF (Pre2i+L) or 1i medium (Pre1i) 
for 3 days prior to being cultured for a further 3 days in EpiLC medium. 
Cells which had been subjected to the 3-day EpiLC differentiation protocol were 
transferred into hanging drops of PGCLC culture medium. Each hanging drop 
consisted of ~2,000 cells contained within 30µl PGCLC culture medium. Dishes 
containing the suspended hanging drops were incubated for 2 days to promote 
aggregation of the cells. After 2 days in hanging drops, the aggregates were 
transferred into 6-well low adhesion plates and retained in suspension for a further 4 
days. The aggregates were observed daily and bright field photographs taken on the 
final day of PGCLC culture (Figure 4.5.11). Fluorescence microscopy was 
performed each day to assess mCherry expression in BRACH-B1 clones. Very faint 
mCherry fluorescence was observed after day 11 of the PGCLC differentiation 
protocol (Figure 4.5.11).  
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Figure 4.5.11. Bright field and wide field fluorescence microscopy of BRACH-B1 clones at day 
12 of PGCLC differentiation. (A) Aggregates from cells pre-cultured in 2i+LIF medium. (B) 
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At day 12 of the PGCLC differentiation protocol, the aggregates were broken apart 
by gentle pipetting (trituration) and the cell suspensions stained with fluorescent 
antibodies for SSEA-1 and CD61. These surface markers were used to monitor the 
differentiation status of the cells and sort the pools into populations of cells which 
were either unstained, single stained, or double stained for both surface markers by 
FACs. The gating strategy detailed in section 2.6.7 was used. The remaining cells 
were gated to isolate populations of double negative, single stained and double 
stained populations by plotting CD61 (586/15A) versus SSEA-1 (670/14A). DAK31 
ESCs cultured in standard 2i+LIF culture conditions were used as an ESC control, 
representing the surface marker expression of rat cells prior to undergoing the 
PGCLC differentiation protocol. The gates were set against unstained DAK31 ESCs. 
The flow cytometry plots generated during the analysis of the BRACH-B1 and 
DAK31 cells are shown in Figure 4.5.12.  
All BRACH-B1 clones had a greater proportion of CD61+ve cells (Figure 4.5.12B) 
compared to the parental DAK31 cell line (Figure 4.5.12A).The BRACH-B1-1 clone 
produced two distinct populations of cells (Figure 4.5.12B). These distinct 
populations were present in cells pre-cultured in either 2i+LIF or 1i medium, 
suggesting there was a proportion of BRACH-B1-1 cells which had remained in the 
ESC state even after being subjected to the PGCLC differentiation protocol. Both 
BRACH-B1-2 and BRACH-B1-3 showed a large proportion of SSEA-1-ve/CD61+ve 
cells in both pre-cultured pools but a similar sized population of SSEA-1+ve/CD61+ve 
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Figure 4.5.12. FACs plots for B1-HDR clones undergoing PGCLC differentiation. Cells which had 
undergone the PGCLC differentiation protocol were stained for the presence of SSEA-1 and CD61. 
Each plot shows the percentage of the population which stained positively for one, both or neither of 
these antibodies. (A) Parental DAK31 ESCs and those undergoing PGCLC differentiation. (B) BRACH-
B1 clones undergoing PGCLC differentiation.  
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These stained populations were isolated by FACs and analysed for expression of 
PGC related markers via qRT-PCR. It was hypothesised that there would be an 
increased expression of PGC markers within differentiated BRACH-B1 cells 
compared to the parental line. The figures shown represent qRT-PCR data 
generated from a single experiment, with the average transcript expression being 
calculated from 3 technical replicates (Figure 4.5.13 - Figure 4.5.16). qRT-PCR data 
from the SSEA-1+ve/CD61–ve populations is absent due to the poor yield of purified 
RNA from the parental, BRACH-B1-2 and BRACH-B1-3 cell lines. 
There was a substantial increase in Blimp1 expression from the SSEA-1–ve/CD61+ve 
BRACH-B1-1 cells pre-cultured in 1i medium (Figure 4.5.13). However, all other 
populations of BRACH-B1-1 cells had similar Blimp1 expression to the parental cell 
line. BRACH-B1-2 cells pre-cultured in 2i+LIF medium had elevated Blimp1 
transcript in all sorted populations when compared to the parental line. BRACH-B1-3 
cells pre-cultured in 1i medium showed an increase in Blimp1 transcript in the 
SSEA-1–ve/CD61–ve population, but showed no substantial difference to the parental 
cell line in any other stained population. 
 
Figure 4.5.13. qRT-PCR analysis of the expression of Blimp1 transcript in SSEA1/CD61 stained 
populations of rat DAK31 and BRACH-B1 clones subjected to the PGCLC differentiation 
protocol. Cells were harvested on day 12 of the PGCLC differentiation protocol and separated into 
SSEA-1 (SS) and CD61 (CD) stained populations. All data was normalised to the house keeping gene 
β-actin (dCT) and fold change (log scale) was calculated by normalising gene expression to Day 0 
DAK31 ESCs (2-DDCT). Data shown is the mean of technical triplicates generated from one 
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Nanog transcript expression in BRACH-B1-1 and BRACH-B1-2 clones was 
considerably greater in all sorted populations pre-cultured in 1i medium compared to 
the parental cell line (Figure 4.5.14). Prior to undergoing the PGCLC differentiation 
protocol (Day 0 ESCs), the basal expression of Nanog in BRACH-B1-2 cells was 
higher than that measured in the parental cell line (Figure 4.5.14). Increased Nanog 
expression after undergoing the PGCLC differentiation protocol indicated that these 
clones were switching on Nanog expression during the differentiation protocol. 
Elevated levels of Nanog transcripts were detected in BRACH-B1-3 cells pre-
cultured in 1i medium within SSEA-1–ve/CD61–ve sorted cells, but no increased 
transcript was seen in any other sorted population of this clone compared to the 
parental (Figure 4.5.14).  
The basal expression of Oct4 in ESCs of all three BRACH-B1 clones prior to the 
PGCLC differentiation protocol (Day 0 ESCs) was substantially lower than the 
parental cell line (Figure 4.5.14). BRACH-B1-1 cells subjected to the PGCLC 
differentiation protocol had increased expression of Oct4 transcript compared to the 
parental cell line within the SSEA-1–ve/CD61–ve population (Figure 4.5.14). However, 
Oct4 transcript expression was practically undetectable in the BRACH-B1-2 and 
BRACH-B1-3 clones in all stained populations and in both CD61+ve populations of 
BRACH-B1-1 cells.  
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Figure 4.5.14. qRT-PCR analysis of the expression of pluripotency genes in SSEA1/CD61 
stained populations of rat DAK31 and BRACH-B1 clones subjected to the PGCLC differentiation 
protocol. Cells were harvested after the 12 day PGCLC differentiation protocol and separated into 
SSEA-1 (SS) and CD61 (CD) stained populations. All data was normalised to the house keeping gene 
β-actin (dCT) and fold change (log scale) was calculated by normalising gene expression to Day 0 
DAK31 ESCs (2-DDCT). Data shown is the mean of technical triplicates generated from one 
experiment ± SD. 
Nanos3 transcript expression in both CD61+ve populations of BRACH-B1-1 and 
BRACH-B1-2 cells pre-cultured in 1i medium was considerable higher than the 
levels seen in the parental cell line (Figure 4.5.15). Cells pre-cultured in 2i+LIF 
medium from BRACH-B1-1 and BRACH-B1-3 also showed a substantial rise in 
Nanos3 transcript in the SSEA-1–ve/CD61–ve population compared to the parental cell 
line (Figure 4.5.15).  
Dazl transcript expression in the SSEA-1–ve/CD61–ve and SSEA-1–ve/CD61+ve 
populations of BRACH-B1-1 cells pre-cultured in 1i medium was greater than the 
parental cell line (Figure 4.5.15). However, BRACH-B1-2 cells showed similar 
expression of Dazl to the parental cell line (Figure 4.5.15). No Dazl transcript 
expression was detected in any BRACH-B1-3 stained cell pool (Figure 4.5.15).  
Basal expression of Vasa transcript in ESCs of all three BRACH-B1 clones prior to 
the PGCLC differentiation protocol (Day 0 ESCs) was substantially lower than that in 
the parental cell line (Figure 4.5.15).  
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A rise in Vasa transcript was observed in the SSEA-1–ve/CD61–ve population of 
BRACH-B1-1 cells compared to the parental cell line (Figure 4.5.15). However, all 
other stained populations from all three BRACH-B1 clones had similar Vasa 
expression to the parental cell line (Figure 4.5.15).  
 
Figure 4.5.15. qRT-PCR analysis of the expression of PGC marker genes in SSEA1/CD61 stained 
populations of rat DAK31 and BRACH-B1 clones subjected to the PGCLC differentiation 
protocol. Cells were harvested after the 12 day PGCLC differentiation protocol and separated into 
SSEA-1 (SS) and CD61 (CD) stained populations. All data was normalised to the house keeping gene 
β-actin (dCT) and fold change (log scale) was calculated by normalising gene expression to Day 0 
DAK31 ESCs (2-DDCT).  Data shown is the mean of technical triplicates generated from one 
experiment ± SD. 
Transcript expression of markers of endoderm (Gata4, Gata6) and trophectoderm 
(Gata3) were also analysed to determine whether expression of Blimp1 cDNA or the 
loss of Brachyury expression influenced the proportion of the BRACH-B1 clones 
differentiating towards these lineages.  
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Figure 4.5.16. qRT-PCR analysis of the expression of endoderm (Gata4 and Gata6) and 
trophectoderm (Gata3) marker genes in SSEA1/CD61 stained populations of rat DAK31 and 
BRACH-B1 clones subjected to the PGCLC differentiation protocol. Cells were harvested after the 
12 day PGCLC differentiation protocol and separated into SSEA-1 (SS) and CD61 (CD) stained 
populations. All data was normalised to the house keeping gene β-actin (dCT) and fold change was 
calculated by normalising gene expression to Day 0 DAK31 ESCs (2-DDCT). Data shown is the mean 
of technical triplicates generated from one experiment ± SD. 
Both Gata4 and Gata6 transcript expression were greatly reduced in all stained 
populations of the BRACH-B1 cells compared to the parental cell line (Figure 
4.5.16). Either the disruption of the Brachyury locus via the insertion of the cassette 
or the expression of the Blimp1 cDNA was negatively impacting the differentiation of 
BRACH-B1 clones towards the endoderm lineage.  
Gata3 expression was elevated in the SSEA-1–ve/CD61–ve population of all BRACH-
B1 clones compared to the parental cell line, with the greatest expression observed 
from BRACH-B1-2 cells pre-cultured in 2i+LIF medium (Figure 4.5.16). However, all 
CD61+ve BRACH-B1 cells had reduced Gata3 expression compared to the parental 
cell line (Figure 4.5.16).  
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The qRT-PCR data presented above has been generated from a single experiment, 
so should be considered a preliminary study on the response of the BRACH-B1 
clones to a PGCLC differentiation protocol. In summary, there is evidence of 
increased early PGC marker expression from BRACH-B1 clones.  
 
4.6 Chapter 4 discussion 
The BLIMP1 transcription factor plays an essential role in directing the differentiation 
of cells within the most proximal posterior region of the epiblast away from the 
somatic cell fate and towards the germ cell fate (Ohinata et al. 2005, Bikoff et al. 
2009, John & Garrett-Sinha 2009, Schäfer et al. 2011). Rat ESCs express very low 
levels of BLIMP1 in comparison with mouse ESCs, even when cultured in identical 
in vitro cell culture conditions. The aim of this chapter was to determine whether 
increasing the expression of Blimp1 within differentiating rat ESCs could direct 
differentiation towards a PGC fate. To accomplish this, a transgene copy of the 
Blimp1 transcription factor was inserted downstream of the Brachyury promotor. 
This would allow induction of the Blimp1 transgene to occur in differentiating epiblast 
rat cells, where Brachyury expression is induced. The hypothesis was that rat ESCs 
expressing Blimp1 transgene would generate a greater proportion of PGCLCs 
compared to the parental cell line.   
 
4.6.1 A BLIMP1-2a-mCherry transgene cassette was successfully 
integrated into the rat genome downstream of Brachyury  
Insertion of the BLIMP1-2a-mCherry cassette into the Brachyury locus was highly 
efficient, with approximately 40% of transfected rat ESC clones having an 
appropriately modified Brachyury allele. Of these, 3 clones possessed a normal 
karyotype. Functionality of the inserted BLIMP1-2a-mCherry cassette was 
demonstrated by the induction of mCherry fluorescence and Brachyury transgene 
transcripts through the induction of high levels of -catenin activity using the GSK3 
inhibitor CHIR99021, a condition previously shown to induce Brachyury expression 
in rat ESCs (Meek et al. 2013). Expression of the mCherry component of the 
BLIMP1-2a-mCherry cassette was detected in all clones by fluorescence 
microscopy and flow cytometry analysis. These results showed that the 
CRISPR/Cas9 gene editing technique used was capable of efficiently knocking-in a 
transgene cassette into the rat genome, and that the transgene cassette was 
activated by inducing the endogenous gene promotor of Brachyury.  
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4.6.2 Overexpression of Blimp1 induced a small increase in the 
expression of early PGC marker genes during rat ESC 
differentiation 
As this expression cassette was designed to rely upon activation of an endogenous 
promoter without external input, the BLIMP1-2a-mCherry knock-in clones were 
subjected to two differentiation protocols that normally induce transcription of 
Brachyury. During undirected EB differentiation, increased Blimp1 transcripts and 
mCherry fluorescence were detected in clones containing the BLIMP1-2a-mCherry 
cassette compared to the parental cell line. However, there was no increased 
expression of the PGC specific marker gene Nanos3, suggesting the expression of 
the Blimp1 transgene did improve rat cell differentiation towards the germ line.   
Cell clones subjected to the PGCLC differentiation protocol had increased CD61+ve 
cells compared to the parental cell line. As CD61 was detected within the genital 
ridges of rat embryos, this increased population of CD61+ve cells might indicate a 
greater proportion of rat ESCs being directed towards the PGC fate. Increased 
expression of both Nanog and Nanos3 was detected in CD61+ve cells of two cell 
clones compared to the parental cell line. However, the expression of other 
commonly associated markers of PGCs (Vasa, DazL, Oct4) remained unchanged or 
were reduced in CD61+ve cells expressing Blimp1 transgene. Nanos3 is considered 
to be an early marker of PGC specification, while Vasa (Ddx4) and DazL are 
classified as late stage markers of PGCs (Hayashi et al. 2011, Hayashi & Saitou 
2013, Chen et al. 2014). This suggests that similar to what has been shown in the 
mouse (Ohinata et al. 2005, Bikoff et al. 2009, John & Garrett-Sinha 2009, Schäfer 
et al. 2011), BLIMP1 is required for early PGC specification, but increasing its 
expression alone is not capable of driving the expression of more mature PGC 
markers. It would be of interest to test whether the efficiency of germline 
transmission of these cell clones harbouring the BLIMP1-2a-mCherry cassette was 
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4.6.3 Knock-out of Brachyury gene expression may have had a larger 
impact on rat cell differentiation during the PGCLC differentiation 
protocol than Blimp1 transgene expression 
Although there was improvement in the expression of early PGC markers in the cell 
clones, other PGC markers were not influenced by the expression of the Blimp1 
transgene during differentiation. Additionally, there was large variability in the overall 
gene expression between the different cell clones. One reason for this may have 
been the unintended loss of Brachyury gene expression. Sanger sequencing and 
immunostaining for BRACHYURY protein revealed all clones were Brachyury knock-
outs, having either a double insertion of the transgene cassette or multiple mutations 
in the second allele resulting in the absence of BRACHYURY protein. Loss of 
functional BRACHYURY protein has been shown to reduce Blimp1, Prdm14 and 
Ap2γ expression in PGCLCs during the late streak stage of mouse embryogenesis 
(~E7.0) (Aramaki et al. 2013). Additionally, the expression of Brachyury within 
EpiLCs increases the expression of Blimp1 and Prdm14 when the cells are 
subjected to PGCLC differentiation (Aramaki et al. 2013). However, there is also 
evidence suggesting that Brachyury expression is not required for the generation of 
human PGCLCs (Kojima et al. 2017). The loss of functional Brachyury expression in 
human iPSCs was shown to have little effect on the expression of PGC markers in 
cells undergoing a PGCLC differentiation protocol compared to wildtype cells 
(Kojima et al. 2017). WNT-driven Eomes expression activated both Sox17 and 
Blimp1 gene expression, directing human iPSC differentiation towards human 
PGCLCs (Kojima et al. 2017). Therefore, the loss of Brachyury may not impact the 
ability of rat ESCs to differentiate into the germ cell lineage.  
Interestingly, the expression of endoderm and trophectoderm markers were reduced 
within the CD61+ve populations of all three cell clones compared to the parental cell 
line. Gata3 is normally upregulated in trophoblast stem cells and thought to be 
important for the development of the trophectoderm lineage during development 
(Ray et al. 2009, Home et al. 2009). The expression of Brachyury during gastrulation 
is reported to be important for the migration of ESCs out of the primitive streak to 
form the mesoendoderm (Rashbass et al. 1991, Wilson et al. 1997, Showell et al 
2004). In vivo, Brachyury-/- null cells have defects in their cellular migration, leading 
to their accumulation within the primitive streak and eventual loss due to cellular 
apoptosis (Rashbass et al. 1991, Wilson et al. 1997, Showell et al 2004).  
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A study performed in human stem cells identified that loss of the BRACHYURY 
protein resulted in reduced expression of trophoblast and mesoderm markers when 
cultured in conditions designed to promote trophoblast generation (Bernardo et al. 
2011). Therefore, the reduction of Gata3 expression and reduced levels of the 
endoderm markers Gata4 and Gata6 in all cell clones during the PGCLC 
differentiation protocol might be due to the loss of the functional Brachyury 
expression within these cells. For future investigations, transgene cassettes would 
be designed so that insertion into the gene locus would not disrupt endogenous 
gene expression. By using 2A peptide or IRES sequences, expression of the 
endogenous gene and the transgene cassette can be linked, allowing for the co-
expression of both when the endogenous promotor is activated. Alternatively, the 
use of other potential host gene targets to drive transcription factor expression 
should be considered to reduce any potential disruption to PGC specification.  
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Chapter 5 Directing differentiation via 
doxycycline-regulated expression 
of PGC transcription factors  
5.1 Introduction 
A previous study performed in mouse ESCs found that if transgene copies of the 
key PGC transcription factors (Blimp1, Prdm14 and Ap2γ) were co-expressed in 
mouse EpiLCs, a proportion of these cells would then transition into a PGCLC fate 
(Nakaki et al. 2013). The proportion of PGCLCs generated from these cells was 
increased when transgene expression was induced during the PGCLC protocol 
described by Hayashi et al (Hayashi & Saitou 2013, Nakaki et al. 2013). If PGC 
transcription factors transgenes were expressed before the cells had transitioned 
into EpiLCs, the cells reverted back to or were maintained in the naïve state; while 
expressing the factors too late during the PGCLC differentiation protocol had no 
influence on the number of cells entering the PGCLC fate (Nakaki et al. 2013). The 
results presented in chapter 3 showed that simply applying the protocol used by 
Hayashi et al did not improve the contribution of rat ESCs to the PGC lineage. 
However, could the proportion of rat cells entering the germ cell lineage be improved 
by combining ESC differentiation with overexpression of key PGC transcription 
factors?  
In this chapter, I present an experimental approach designed to manipulate the gene 
network of rat ESCs using a doxycycline-inducible Tet-On piggyBac transposon 
system. Transgene copies of the PGC transcription factors, BLIMP1, PRDM14 and 
AP2γ were placed under the regulation of a doxycycline-induced vector, and 
expressed during the differentiation of rat cells. The influence PGC transcription 
factor transgene expression had on transfected cells was monitored using 
quantitative measurement of PGC marker expression. Within this chapter, 
references to the Tet-On piggyBac transposon vectors will be shortened to “Tet-On” 
vectors.  
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5.2 Cloning PGC transcription factors into a Tet-On 
piggyBac transposon vectors 
5.2.1 Tet-On piggyBac transposon system 
The Tet-On piggyBac transposon backbone vector used during this investigation 
was provided by the Mcgrew group (Roslin Institute) (Glover et al. 2013). A 
schematic of the Tet-On vector and how the activation of gene expression is 
induced by doxycycline is shown in Figure 5.2.1.  
When transfected into a cell line, the Tet-On vector is randomly integrated into the 
genome through the action of a co-transfected transposase enzyme (HYBASE) 
(Glover et al. 2013). Once integrated, the CAG promotor drives the expression of an 
rtTA3 protein, which under standard culture conditions has no influence on the host 
cell. However, when doxycycline is added to the culture medium, the rtTA3 protein 
forms a complex with doxycycline, allowing it to interact with and activate a TRE 
promotor, inducing the expression of a downstream gene of interest.  
 
Figure 5.2.1: PB CAG rtTA3 TRE-Empty vector, as described by Glover et al. 2013. (A)  PB Tet-
On vector contains a CAG enhancer/promoter (CAG Promotor) that drives the expression of a 3rd 
generation reverse tetracycline transactivator (rtTA3). This rtTA3 element is coupled to an Internal 
Ribosome Entry Site (IRES) and puromycin resistance gene (Puro). Downstream from this is a minimal 
tetracycline response element promoter (TRE), whose activation relies on the binding of rtTA3 bound 
to doxycycline. The HpaI restriction site (HpaI) can be cut to allow insertion of gene cassette to be 
driven by the TRE promotor. Downstream of this restriction site is a Rabbit Beta-globin PolyA signal 
(Rab bGHpA). (B) During standard culture conditions, rtTA3 cannot bind to the TRE reporter (TRE). 
When introduced to the medium, doxycycline binds to rtTA3 and induces a conformational change that 
allows association of rtTA3 with the TRE promotor. Binding of rtTA3 to the TRE promotor induces 
expression of downstream gene of interest. 
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5.2.2 Generation of single PGC transcription factor expressing Tet-On 
vectors 
The objective was to clone various combinations of PGC transcription factor cDNA 
into the Tet-On vector system. A 2A peptide was inserted between each transgene 
in the gene sequence to allow re-initiation of tandem open reading frames during 
translation (Liu et al. 2017). Rat BLIMP1 cDNA was synthesised by GeneArt Gene 
Synthesis (ThermoFisher Scientific), using the gene sequence on the Ensembl 
database (ENSRNOT00000076541.1). A 2A peptide was added downstream of the 
Blimp1 sequence, followed by a mCherry cDNA sequence. The mCherry fluorescent 
marker was used for monitoring Tet-On vector activation when doxycycline was 
introduced to the culture medium. The complete BLIMP1-2A-mCherry cDNA 
sequence was PCR amplified from the GeneArt synthesis vector, with the amplifying 
primers adding homology to the Tet-On vector by primer overhangs. A kozak 
consensus sequence was also introduced by PCR primer overhangs to the 5’ region 
upstream of the Blimp1 sequence. The Tet-On vector was linearised using the 
restriction enzyme HpaI and the BLIMP1-2A-mCherry gene sequence inserted into 
the vector via Gibson cloning (Figure 5.2.2).  
 
Figure 5.2.2. Strategy for generating Dox-inducible expression of PGC transcription factors. (A) 
The empty Tet-On vector (PB CAG rtTA3 TRE-Emp) is linearised by a blunt end enzymatic digest with 
the HpaI restriction enzyme. (B) Gibson cloning is performed to incorporate a gene cassette (PGC TF 
Cassette) into the cut site. T5 exonuclease creates single-strand DNA overhangs, revealing the 
complementary sequence for the homology arms present on the cassette. This allows the DNA 
fragment to subsequently anneal to each other, generating a re-circularised vector with the gene 
cassette downstream of the Doxycycline dependant promotor (TRE promotor).  
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Sanger sequencing of the resulting expression vector confirmed the insertion of the 
BLIMP1-2A-mCherry cassette into the Tet-On vector. Once verified, reverse PCR 
amplification was used to generate a linearised Tet-On vector lacking the Blimp1 
transgene.  
This linearised vector was used to generate Tet-On vectors which would express rat 
Prdm14 or Ap2γ in the presence of doxycycline. The rat Prdm14 and Ap2γ genes 
were PCR amplified from cDNA generated from rat ESCs using oligonucleotides 
designed to the Prdm14 (ENSRNOT00000034525.5) and Ap2γ 
(ENSRNOT00000006991.5) mRNA sequences from the Ensembl database. 
Homology to the Tet-On vector and the 2A-mCherry region was introduced during 
PCR amplification by primer overhangs. Gibson cloning was used to ligate the PGC 
transcription factor transgenes into the previously linearised 2A-mCherry Tet-On 
vector (Figure 5.2.3). 
 
Figure 5.2.3. Ligation of Prdm14/Ap2y into the Tet-On vector. Inverse PCR of the previously 
generated BLIMP1-2A-mCherry vector removes the Blimp1 transgene from the sequence while 
linearising the vector. Prdm14 or Ap2γ transgenes with homology arms to the linearised vector are 
annealed together to form a re-circularised expression vector by Gibson cloning.  
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5.2.3 Generation of multiple PGC transcription factor expressing Tet-
On vectors 
Vectors containing two or all three PGC transcription factors were generated by 
Gibson cloning with multiple gene fragments. Each PGC transcription factor was 
amplified from sequence verified vectors, each gaining homology to their respective 
partner by PCR overhangs. During a “three-way” or “four-way” Gibson cloning 
reaction, each fragment would orientate themselves so that the cDNA sequence 
produced would be in the right orientation due to the homology arms. Each cDNA 
sequence was separated by a 2A peptide to ensure co-expression from a single Tet-
On vector (Figure 5.2.4).  
 
Figure 5.2.4. Schematic of how vectors containing multiple PGC transcription factors were 
generated. Displayed is a “Three-way” Gibson cloning reaction, where three individual fragments are 
joined together to form one circular vector. 
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5.2.4 List of generated Tet-On vectors generated 
A list of the PGC transcription factor vectors generated is displayed in Table 5.2.1. 
 
Table 5.2.1 Tet-On vectors constructed to express PGC transcription factors in the 
presence of doxycycline. 
 
  
Vector name Purpose Fluorescence marker 
Tet-EMPTY Empty vector to act as control None 
Tet-BLIMP1 Express rat BLIMP1  mCherry 
Tet-PRDM14 Express rat PRDM14 mCherry 
Tet-AP2γ Express rat AP2γ mCherry 
Tet-BLIMP1-PRDM14 Express rat BLIMP1 & PRDM14 mCherry 
Tet-BLIMP1-AP2γ Express rat BLIMP1 & AP2γ mCherry 
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5.3 Producing stably transfected rat ESC pools with 
Tet-inducible PGC transcription factors  
5.3.1 Transfection of rat ESC pools with the Tet-On vectors 
Three independent rat ESC lines, two dark agouti (DAK31 and E3) and one 
Sprague-Dawley (A4), were transfected with the generated Tet-On vectors using 
Lipofectamine LTX. A Tet-On vector containing no gene insert at the HpaI site (Tet-
Empty) was used as both a puromycin-resistant positive control and doxycycline 
negative control. The transposase enzyme HYBASE was co-transfected at a 1:1 
ratio with the Tet-On vectors to ensure incorporation of the vectors into the ESC 
genome. Transfections using a range of plasmid DNA concentrations were tested, 
with 500ng/ml total plasmid DNA in a 24-well having the best transfection efficiency 
whilst limiting the cell death evident at higher DNA/LTX concentrations. Therefore, 
250ng/ml of each Tet-On vector was co-transfected with 250ng/ml of HYBASE. 
Transfected cell pools were then subjected to puromycin selection (1μg/ml) to 
isolate cells with stable integration of the Tet-On vector. Cells were routinely 
passaged every 2 days into 24-well plates containing MEFs in 2i+LIF medium at a 
cell density of 1.5 x 105 cells. Pools of stably transfected cells showed similar growth 
and morphology to the parental wildtype after 2 days of culture. However, pools 
containing Tet-On vectors with multiple PGC transcription factors did show a slower 
growth rate than the parental, resulting in smaller colonies after 2 days of growth 
(Figure 5.3.1).  
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Figure 5.3.1 Stably transfected cells containing Tet-On vectors. Bright field photographs of cell 
pools of DAK31 rat ESCs containing 3 of the Tet-On vectors compared to the parental when cultured in 
standard 2i+LIF conditions for 2 days. Each pool was seeded at 1.5 x 105 cells on MEF layers. Pools 
from all rat cell lines showed reduced growth rate and colony size when stably transfected with Tet-On 
vectors containing multiple PGC transcription factors. 
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5.3.2 mCherry expression in transfected cells cultured with 
doxycycline 
Expression of PGC transcription factor/mCherry gene cassettes was induced by 
culturing the transfected cell pools in medium containing 1μg/ml doxycycline for up 
to 48 hours. Expression of the mCherry fluorescent marker in the presence or 
absence of doxycycline was monitored using both fluorescent microscopy (Figure 
5.3.2) and by flow cytometry (Figure 5.3.3). The gating strategy detailed in section 
2.6.7 was used. The remaining cells were gated to isolate populations of mCherry+ve 
cells by plotting mCherry (610/20A) versus cell counts. The gates were set against 
rat ESCs transfected with the Tet-Empty vector. 
 
Figure 5.3.2. mCherry fluorescence from Tet-BLIMP1 vector DAK31 ESC pools cultured in the 
presence of doxycycline. Photographs show Tet-BLIMP1 transfected cells cultured in 2i+LIF medium 
in the presence (+) or absence (-) of doxycycline for two days. 
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Figure 5.3.3. Flow cytometry plots showing mCherry expression from Tet-On vector cell pools. 
Histograms represent the number cells expressing mCherry in the presence (+dox) and absence (-dox) 
of doxycycline. Paler peaks represent cells cultured in –dox conditions, while darker peaks represent 
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Both detection methods showed that transfected cells cultured in the presence of 
doxycycline were positive for mCherry expression. The expression profiles and 
intensity of mCherry expression from all three rat cell lines were similar, indicating 
that efficiency of doxycycline induced Tet-On vector activation was equally effective 
in all cell lines. The flow cytometry data presented in Figure 5.3.3 showed cells 
expressing multiple PGC transcription factor transgenes had more variable intensity 
of mCherry expression when compared to the distinct peaks seen from cells 
expressing a single transgene. Additionally, the flow cytometry data showed that 
even when stably transfected pools were cultured in the presence of 1µg/ml 
puromycin for an extended period, there were cells within that population which 
were mCherry negative in the presence of doxycycline (Figure 5.3.3).  
 
5.3.3 qRT-PCR analysis of transfected cell pools cultured with 
doxycycline 
The expression of mRNA transcripts from transfected cell pools was determined by 
performing qRT-PCR analysis on RNA processed from cells cultured in the 
presence and absence of doxycycline (Figure 5.3.4). The results represent the 
average transcript expression taken from the three independent rat ESCs. All cell 
lines transfected with a Tet-On vector containing at least a single cDNA copy of a 
PGC transcription factor saw significantly increased total mRNA transcript level of 
the PGC transcription factors they were expressing compared to the Tet-On Empty 
vector (Figure 5.3.4). Increased PGC transcription factor expression in the single, 
double and triple Tet-On vectors were very similar (Figure 5.3.4), indicating that the 
complexity of the larger vectors was not affecting the activation of the transgene 
cassettes in the presence of doxycycline.  
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Figure 5.3.4. qRT-PCR analysis of Tet-On transfected ESC pools in presence and absence of 
doxycycline. Average of three independent rat cell lines (two DA lines, one SD line). All data was 
normalised to the house keeping gene β-actin (dCT) and the fold change (2-DDCT) values (Log scale) 
generated by normalising gene expression to –Dox Tet-Empty transfected cell pools. Bars represent 
mean ± SD, *P<0.05, **P<0.01. 
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5.4 Embryoid body (EB) differentiation of stably 
transfected rat ESCs 
5.4.1 Activation of PGC transcription factor transgene expression 
during an undirected EB differentiation protocol  
PGC transcription factor transgene expression was induced at different stages 
during an undirected embryoid body differentiation protocol in order to identify 
whether the PGC transcription factors could induce the expression of endogenous 
PGC markers, potentially directing a proportion of the cell population towards a 
germ cell-like fate. The three rat cell lines transfected with the Tet-On vectors were 
induced to differentiate via embryoid body (EB) differentiation for 6 days using EB 
differentiation protocol designed for rat ESCs (Figure 5.4.1).  
 
Figure 5.4.1: Schematic of the rat EB differentiation protocol. Rat ESCs cultured in 2i+Lif 
conditions on a MEF layer were transferred to an aggrewellTM plate at a cellular density equivalent to 
3,000 cells per microwell depression. After 2 days, the cell aggregates were transferred from the 
aggrewellTM plate to low adhesion plates with serum medium. These aggregates were retained in this 
condition for a further 4 days and then harvested at day 6. Doxycycline was introduced at Day 0, Day 2 
and Day 4. Once introduced, doxycycline was maintained in the medium until the cells were harvested 
(day 6).  
In summary, the protocol involved culturing cells in suspension in 2i+LIF conditions 
for 2 days to allow for cellular aggregation. Moving rat ESCs directly into serum 
medium induced widespread cellular death, therefore, it was important to perform an 
intermediate aggregation step in 2i+LIF medium. These aggregates were then 
moved into serum medium for a further 4 days to induce transition out of the naïve 
state. This transition was monitored by the loss of Rex1-EGFP expression from the 
E3 rat cell line during the EB differentiation protocol (Figure 5.4.2).  
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Figure 5.4.2. eGFP fluorescence from Tet-empty transfected cells undergoing an EB 
differentiation protocol. Photographs depict Tet-empty cells at day 0, day 2, day 4 and day 6 of the 
EB differentiation protocol. The bottom panels show the reduction of eGFP expression as the cells 
differentiate out of the naïve ESC state (day 0).  
Doxycycline was introduced into the culture medium at different time points (Day 0, 
Day 2 or Day 4) to induce expression of the transgene cassettes within the 
incorporated Tet-On vectors. Transfected cells which were not exposed to 
doxycycline were used to monitor leakiness from the Tet-On vectors and whether 
this leakiness could influence gene expression.  
Tet-On vector activation by doxycycline was determined by monitoring mCherry 
expression using fluorescent microscopy. In all cases, cells containing a mCherry 
expressing Tet-On vector cultured in the presence of doxycycline from Day 0, Day 2 
(Figure 5.4.3A) or Day 4 (Figure 5.4.3B) showed mCherry expression. No mCherry 
was visible from cells cultured in the absence of doxycycline or transfected with the 
Tet-Empty vector (Figure 5.4.3A & B). 
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Figure 5.4.3 mCherry fluorescence from Tet-BLIMP1 transfected cells undergoing an EB 
differentiation protocol. (A) Expression of mCherry in Tet-BLIMP1 transfected cells at day 0 and day 
2 of the EB differentiation protocol in the presence and absence of doxycycline. Tet-Empty cells in the 
presence of doxycycline showed no mCherry expression. Tet-BLIMP1 cells cultured in the presence of 
doxycycline from day 0 showed mCherry expression, while those in its absence did not. (B) Expression 
of mCherry in Tet-BLIMP1 transfected cells at day 6 of the EB differentiation protocol. Cells cultured in 
the absence of doxycycline remained mCherry-ve while those cultured in doxycycline were mCherry+ve. 
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To assess the effect of PGC transcription factors transgene expression on rat ESC 
differentiation, expression of pluripotency and PGC markers were analysed by qRT-
PCR. Aggregates were pelleted after the 6-day EB differentiation protocol and RNA 
processed for qRT-PCR analysis. The results represent the average transcript 
expression taken from the three independent rat cell lines.  
qRT-PCR analysis revealed that all Tet-On vector transfected cells showed a 
significant increase in transcript expression of their respective PGC transcription 
factors compared to Tet-Empty cells, regardless of which day doxycycline was 
introduced into the medium (Figure 5.4.4). Significant rises in Blimp1 expression 
was seen from all Tet-On vectors compared to Tet-Empty transfected cells (Figure 
5.4.4). Interestingly, increased expression of Blimp1 was seen at day 0 within Tet-
On transfected cells (Figure 5.4.4), when the cells were in an ESC state prior to the 
addition of doxycycline. This could be due to vector ‘leakiness’, where low level 
expression from the Tet-On vector is present even in the absence of doxycycline. 
The transcript expression of both Prdm14 and Ap2γ exhibited similar significant rises 
in the presence of doxycycline (Figure 5.4.4). The Tet-On vectors which expressed 
two PGC transcription factors showed a smaller rise in transcript expression of the 
second gene in the cassette compared to vectors expressing only a single 
transgene (Figure 5.4.4). The Tet-On vector containing cDNA copies of all three 
genes had lower expression of all PGC transcription factors compared to the single 
vectors, with Blimp1 showing the greatest reduction in total transcript level (Figure 
5.4.4). This suggests that the mRNA transcript generated from the transgene 
cassette may have had compromised stability due to its complexity, reducing the 
total transcript expression level of these genes.  
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Figure 5.4.4. qRT-PCR analysis of PGC transcription factors within Tet-On transfected cells 
after a 6-day EB differentiation protocol. Average of three independent rat cell lines (two DA lines, 
one SD line). All data was normalised to the house keeping gene β-actin (dCT) and the fold change (2-
DDCT) values (Log scale) generated by normalising gene expression to day 0 Tet-Empty transfected 
cells. (D0), (D2), (D4) represent cells which were cultured in the presence of doxycycline from day 0, 
day 2 and day 4 of EB differentiation respectively. Bars represent mean ± SD, *P<0.05, **P<0.01. 
Expression of Blimp1, Ap2γ or any combination of two PGC transcription factors 
induced a significant increase in Nanog compared to the Tet-Empty transfected cells 
(Figure 5.4.5). This difference was most noticeable when doxycycline was 
introduced at day 4 of EB differentiation onwards (Figure 5.4.5). Interestingly, the 
expression levels of cells containing a Tet-On vector with either a combination of 
two PGC transcription factors or Prdm14 alone showed a significant drop in Nanog 
expression at day 0, when cells are in an ESC state (Figure 5.4.5).  
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This may suggest that the leakiness of these Tet-On vectors was affecting the basal 
gene expression in ESCs. In all but one case, there was no significant difference in 
Oct4 expression in the presence or absence of doxycycline (Figure 5.4.5). A 
significant drop in Oct4 could be identified in cells expressing Ap2γ transgene alone 
when cultured in doxycycline at day 0 onwards, suggesting that Ap2γ may have a 
suppressive effect on Oct4 expression within these cells (Figure 5.4.5). 
The expression of Stella, both a marker of naïve ESCs and germ cells 
(Wongtrakoongate et al. 2013), was significantly increased when transgene copies 
of Blimp1 or Prdm14 or both were expressed from day 0 of the EB differentiation 
protocol (Figure 5.4.5). 
 
Figure 5.4.5. qRT-PCR analysis of pluripotency markers in Tet-On transfected cells after a 6-day 
EB differentiation protocol. Average of three independent rat cell lines (two DA lines, one SD line). 
All data was normalised to the house keeping gene β-actin (dCT) and the fold change (2-DDCT) values 
generated by normalising gene expression to day 0 Tet-Empty transfected cell. (D0), (D2), (D4) 
represent cells which were cultured in the presence of doxycycline from day 0, day 2 and day 4 of EB 
differentiation respectively. Bars represent mean ± SD, *P<0.05, **P<0.01. 
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Expression of PGC transcription factor transgenes induced a significant rise in both 
Nanos3 and Dazl expression after the 6-day EB differentiation protocol, most 
notably when the transgenes were expressed from day 4 onwards (Figure 5.4.6).  
Tet-BLIMP1-PRDM14 transfected cells had the greatest increase in Nanos3 
transcript when cultured in the presence of doxycycline (Figure 5.4.6). Tet-BLIMP1-
PRDM14 was the only vector to increase Nanos3 expression in rat cells from day 0 
of the EB differentiation protocol (Figure 5.4.6). Tet-BLIMP1, Tet-PRDM14 and Tet-
BLIMP1-AP2γ transfected cells had a significant rise in Nanos3 when cultured with 
doxycycline from day 2 (Figure 5.4.6). Cells transfected with Tet-BLIMP1-AP2γ had 
similar Nanos3 transcript expression level to cells transfected with Tet-BLIMP1-
PRDM14 when both were cultured in doxycycline from day 4 (Figure 5.4.6).  
Tet-BLIMP1 and Tet-PRDM14 both induced a significant increase in Dazl 
expression when doxycycline was introduced to the medium from day 4 onwards 
(Figure 5.4.6). However, Tet-BLIMP1-PRDM14 and TET-BLIMP1-AP2γ both 
induced a significant rise in Dazl when activated from day 0 onwards, and prompted 
the greatest changes when induced from day 4 (Figure 5.4.6).  
The transcript expression levels of Vasa showed no significant increase from any 
transfected cell line in the presence or absence of doxycycline (Figure 5.4.6). In Tet-
AP2γ, Tet-BLIMP1-PRDM14 and Tet-BLIMP1-AP2γ transfected cells, there was a 
significant decrease in Vasa expression when the exogenous PGC transcription 
factors were expressed from day 2 of the EB differentiation protocol (Figure 5.4.6). 
The cells transfected with the Tet-BLIMP1-PRDM14-AP2γ vector showed no 
significant changes in the expression of any PGC gene marker when cultured in the 
presence of doxycycline (Figure 5.4.6). This result was most likely due to the 
reduced transcript expression of the three PGC transcription factors in cells 
transfected with the Tet-BLIMP1-PRDM14-AP2γ vector.  
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Figure 5.4.6. qRT-PCR analysis of PGC gene markers in Tet-On transfected cells after a 6-day 
EB differentiation protocol. Average of three independent rat cell lines (two DA lines, one SD line). 
All data was normalised to the house keeping gene β-actin (dCT) and the fold change (2-DDCT) values 
generated by normalising gene expression to day 0 Tet-Empty transfected cells. (D0), (D2), (D4) 
represent cells which were cultured in the presence of doxycycline from day 0, day 2 and day 4 of EB 
differentiation respectively. Bars represent mean ± SD, *P<0.05, **P<0.01. 
In summary, the qRT-PCR data generated suggested that expression of PGC 
transcription factor transgenes could induce a significant rise in PGC gene markers 
during an undirected EB differentiation protocol. The greatest induction of 
endogenous PGC markers was achieved by co-expressing a combination of two 
PGC transcription factor transgenes, Blimp1 in combination with either Prdm14 or 
Ap2γ. Although the formation of functional PGC transcription factor protein has not 
been proven from transgene vectors, increased gene expression from cells 
transfected with the transgene vectors compared to the control cells suggests these 
transgene factors are the cause of increased PGC marker expression.  
 
Chapter 5         145 
5.4.2 Changes in PGC marker expression were the result of transgene 
expression, not the presence of doxycycline  
As previously shown (section 5.3.2), mCherry expression can be used as a marker 
the activation of Tet-On vectors when cultured in the presence of doxycycline. To 
examine whether the changes in PGC marker gene expression were exclusively 
inherent to the mCherry positive cells and not to non-cell autonomous effects, cells 
which had been transfected with the Tet-BLIMP1-PRDM14 and Tet-BLIMP1-AP2γ 
vectors were subjected to the EB differentiation protocol alongside Tet-Empty 
transfected cells. Expression of the transgene cassettes was induced at day 4 of the 
EB differentiation protocol by introducing doxycycline into the serum medium during 
the suspension culture phase. These conditions were chosen as they showed the 
greatest difference in expression of the PGC marker genes Nanos3 and Dazl. At 
day 6, cells were sorted into mCherry positive (mCherry+ve) and negative (mCherry-
ve) populations by fluorescence activated cell sorting (FACs) (Figure 5.4.7A). The 
gating strategy detailed in section 2.6.7 was used. The remaining cells were gated 
to isolate populations of mCherry+ve cells by plotting mCherry (610/20A) versus cell 
counts. The gates were set against rat ESCs transfected with the Tet-Empty vector. 
The sorted populations were then analysed by qRT-PCR to determine which 
population had the greatest changes in gene expression (Figure 5.4.7B).  
Flow data generated during FACs determined that only ~50% of the cells were 
mCherry+ve (Figure 5.4.7A). Since the Tet-On transposons are randomly integrated 
into the genome of ESCs, this result may have arisen through Tet-On vector 
silencing, where copies of the transposon cassette have been inserted into genomic 
regions which become inactive during cell differentiation. 
Of those cells which were mCherry+ve, there was a substantial increase in almost all 
PGC transcription factors and PGC gene markers compared to the mCherry-ve 
population and Tet-Empty transfected cells (Figure 5.4.7B). As all populations were 
cultured in the presence of doxycycline, changes in transcript expression were in 
response to PGC transcription factor transgene expression rather than a response 
to doxycycline. Therefore, it appears that expression of PGC transcription factor 
transgenes during an EB differentiation protocol does induce expression of PGC 
markers and may potentially guide a greater proportion of differentiating cells 
towards a PGC-like state.  
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Figure 5.4.7: Sorting mCherry+ve and mCherry-ve populations of Tet-On transfected cells after 
undergoing an EB differentiation protocol. (A) FACs plots of D6 EBs separating mCherry positive 
and negative populations. (B) qRT-PCR data generated from Tet-BLIMP1-PRDM14 and Tet-BLIMP1-
APy mCherry positive and negative populations. The data presented was an average of two 
experiments performed with Tet-On vector transfected DAK31 cells. All data was normalised to the 
house keeping gene β-actin (dCT) and the fold change (2-DDCT) values generated by normalising 
gene expression to day 0 Tet-Empty transfected cells. Bars represent mean ± SD. 
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5.4.3 Exogenous expression of all three PGC transcription factors from 
multiple Tet-vectors 
ESCs containing the Tet-On vector designed to express transgene copies of all 
three PGC transcription factors (Tet-BLIMP1-PRDM14-AP2γ) did show strong 
induction of the PGC transcription factor cassette in the presence of doxycycline 
(sections 5.3.2 & 5.3.3). However, during the EB differentiation protocol, the total 
transcript expression of the PGC transcription factors and the mCherry fluorescent 
marker was much lower than vectors containing one or two PGC transcription factor 
transgenes (section 5.4.1). This was seen in all three cell lines, suggesting that the 
design or construction of the Tet-BLIMP1-PRDM14-AP2γ expression vector was 
suboptimal.  
A second attempt was made to construct a vector co-expressing all three PGC 
transcription factors by introducing a transgene copy of Ap2γ downstream of the 
Blimp1-2A-Prdm14 cassette present in the Tet-BLIMP1-PRDM14 vector. This Ap2y 
transgene had a different 2A peptide attached to the 5’ end as it is reported that 
vectors comprising of multiples of the same 2A peptide are less efficient than those 
using different 2A peptides (Liu et al. 2017). The newly constructed vector however 
did not show improved transcript expression compared to the first constructed 
vector.  
As co-expression of all genes from a single expression vector was proving difficult, 
an alternative strategy was implemented to co-transfect three independent Tet-On 
vectors, each expressing a single PGC transcription factor transgene into the same 
population of cells. Addition of doxycycline to the culture medium would then drive 
each Tet-On vector separately to induce the co-expression of all three PGC 
transcription factors. Two additional Tet-On vectors were constructed, the first was a 
Blimp1 expressing Tet-On vector without a fluorescent marker, the second an Ap2γ 
expressing Tet-On vector with a blue fluorescent protein (BFP) instead of mCherry 
(Table 5.4.1). The reason for the lack of a fluorescence marker on one vector was to 
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Table 5.4.1. Newly designed vectors for expressing all three PGC transcription factors within 
the same cell population 
Vector name Purpose Fluorescence 
marker 
Tet-BLIMP1-NO Express rat BLIMP1 None 
Tet-AP2γ-BF Express rat AP2γ 




A wild-type DAK31 cell line was transfected with the Tet-On BLIMP1-NO vector and 
placed into puromycin selection to remove un-transfected cells. This resulted in a 
population of cells which would express Blimp1 transgene in the presence of 
doxycycline without fluorescence. The Tet-BLIMP1-NO cells were co-transfected 
with the Tet-On PRDM14 vector with mCherry (described previously) and the newly 
constructed Tet-AP2γ-BF vector. After two days recovery, the cells were cultured 
with doxycycline for 12 hours to induce the expression of the fluorescent markers. 
These cells were then sorted via FACs, plating cells expressing both mCherry and 
BFP into 24-well plates to recover and grow. The gating strategy detailed in section 
2.6.7 was used. However, the live cells were not gated due to the overlap of blue 
fluorescent staining with the DAPI antibody. The remaining cells were gated to 
isolate populations of double positive cells by plotting mCherry (610/20A) versus 
blue fluorescence (450/50). The gates were set against rat ESCs transfected with 
the Tet-Empty vector. Plated cells were cultured in the presence of puromycin and 
the absence of doxycycline to allow the cells to recover from sorting. To distinguish 
these cells from those transfected with the Tet-BLIMP1-PRDM14-AP2γ vector, this 
cell line was referred to as being transfected with Tet-B1-P14-Aγ. Once the cells had 
recovered from sorting, Tet-B1-P14-Aγ transfected cells were cultured in the 
presence and absence of doxycycline for two days and flow cytometry used to 
characterise the expression of both mCherry and BFP markers (Figure 5.4.8).  
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Figure 5.4.8 Flow cytometry data of DAK31 cells transfected with Tet-B1-P14-AP2γ. (A) Flow 
cytometry histograms displaying cells cultured in either the presence or absence of doxycycline for 2 
days. The pale peaks represent cells cultures in the absence of doxycycline, while darker peaks 
represent populations cultured in the presence of doxycycline. Percentages shown are the percentage 
of positive cells in the presence of doxycycline. (B)Flow cytometry plots, mCherry vs BFP. Percentages 
represent proportion of the population present within that gate.  
 
Unfortunately, even after sorting for cells positive for both mCherry and BFP, the 
resulting population was heterogeneous, comprised of distinct populations of double 
negative, mCherry only and BFP only positive cells (Figure 5.4.8B). Nevertheless, it 
was decided that these cells had been sufficiently enriched to be of use and 
analysed further. ESCs which had been cultured in the presence and absence of 
doxycycline for two days were harvested and RNA prepared for use in qRT-PCR 
analysis. This was to ensure an increase in transcript level of the three PGC 
transcription factors in the presence of doxycycline could be observed. The data 
gathered was then compared to the qRT-PCR data generated from cells expressing 
each of the PGC transcription factors separately and Tet-BLIMP1-PRDM14-AP2γ 
cells (Figure 5.4.9).  
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Figure 5.4.9. qRT-PCR analysis of Tet-B1-P14-Ay transfected ESCs. The data presented was an 
average of two experiments performed with Tet-On vector transfected DAK31 cells. All data was 
normalised to the house keeping gene β-actin (dCT) and the fold change (2-DDCT) values generated 
by normalising gene expression to –dox Tet-Empty transfected cells. Bars represent mean ± SD. 
Cells which had been co-transfected to form the Tet-B1-P14-Aγ cells showed an 
increased transcript expression of all PGC transcription factors. Additionally, the 
expression of Prdm14 and Ap2γ was elevated in Tet-B1-P14-Ay cells compared to 
the cells transfected with the previously designed Tet-BLIMP1-PRDM14-AP2γ.  
Tet-B1-P14-Aγ cells were then induced to differentiate via an undirected EB 
differentiation as discussed previously. Doxycycline was introduced at day 0, day 2, 
day 4, or not at all. Expression from the Tet-On vectors was monitored by 
fluorescent microscopy throughout the protocol.  
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Cells transfected with Tet-B1-P14-Aγ and cultured in the presence of doxycycline 
showed co-expression of both mCherry and BFP fluorescent proteins (Figure 
5.4.10B). 
 
Figure 5.4.10. Fluorescence photographs of Tet-B1-P14-Ay transfected cells. All photographs 
were taken at day 6 of the EB differentiation protocol. (A) Panels show EBs cultured in the absence of 
doxycycline. (B) Panels show EBs cultured in the presence of doxycycline from day 0 of the EB 
differentiation protocol. 
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qRT-PCR data generated for cells transfected with Tet-B1-P14-Aγ were compared 
against the data obtained with Tet-Empty cells and from Tet-BLIMP1-PRDM14-AP2γ 
cells. Transcript expression of all three PGC transcription factors from the Tet-B1-
P14-Aγ transfected cells were greater than that in Tet-BLIMP1-PRDM14-AP2γ cells 
when both were cultured in doxycycline from day 0 of EB differentiation onwards 
(Figure 5.4.11). However, when doxycycline was introduced to the cells later during 
the EB differentiation protocol, the expression of PGC transcription factors 
decreased, with cells induced from day 4 onwards having lower transcript 
expression than the Tet-BLIMP1-PRDM14-AP2γ cells. 
 
Figure 5.4.11. qRT-PCR analysis of PGC transcription factors from Tet-B1-P14-Ay transfected 
cells undergoing an EB differentiation protocol. The data presented was an average of two 
experiments performed with Tet-On vector transfected DAK31 cells. All data was normalised to the 
house keeping gene β-actin (dCT) and the fold change (2-DDCT) values generated by normalising 
gene expression to –dox Tet-Empty transfected cells. (D0), (D2), (D4) represent cells which were 
cultured in the presence of doxycycline from day 0, day 2 and day 4 of EB differentiation respectively. 
Bars represent mean ± SD. 
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Transcript expression of both Nanog and Oct4 in Tet-B1-P14-AP2γ cells was lower 
than the expression seen in the Tet-Empty and Tet-BLIMP1-PRDM14-AP2γ 
transfected cells (Figure 5.4.12). This suggested that the Tet-B1-P14-AP2γ cells 
were being driven out of the naïve cell fate more efficiently than the Tet-BLIMP1-
PRDM14-AP2γ cells. The transcript expression of Stella from both Tet-B1-P14-AP2γ 
and Tet-BLIMP1-PRDM14-AP2γ was similar in almost all conditions (Figure 5.4.12). 
There was however a lower expression of Stella in Tet-B1-P14-AP2γ transfected 
cells when cultured in the presence of doxycycline from day 4 onwards (Figure 
5.4.12). 
 
Figure 5.4.12. qRT-PCR analysis of pluripotency genes from Tet-B1-P14-Ay transfected cells 
undergoing an EB differentiation protocol. The data presented was an average of two experiments 
performed with Tet-On vector transfected DAK31 cells. All data was normalised to the house keeping 
gene β-actin (dCT) and the fold change (2-DDCT) values generated by normalising gene expression to 
–dox Tet-Empty transfected cells. (D0), (D2), (D4) represent cells which were cultured in the presence 
of doxycycline from day 0, day 2 and day 4 of EB differentiation respectively. Bars represent mean ± 
SD. 
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Expression of the PGC marker genes Nanos3, DazL and Vasa within the Tet-B1-
P14-Aγ cells were on average lower than Tet-BLIMP1-PRDM14-AP2γ cells when 
cultured in the presence of doxycycline (Figure 5.4.13).  
 
Figure 5.4.13. qRT-PCR analysis of PGC gene markers from Tet-B1-P14-Ay transfected cells 
undergoing an EB differentiation protocol. The data presented was an average of two experiments 
performed with Tet-On vector transfected DAK31 cells. All data was normalised to the house keeping 
gene β-actin (dCT) and the fold change (2-DDCT) values generated by normalising gene expression to 
–dox Tet-Empty transfected cells. (D0), (D2), (D4) represent cells which were cultured in the presence 
of doxycycline from day 0, day 2 and day 4 of EB differentiation respectively. Bars represent mean ± 
SD 
Both the three individual vector and 2A polycistronic approaches to express 
transgene copies of all three PGC transcription factors simultaneously did not 
improve PGC marker gene expression during an undirected EB differentiation 
protocol when compared to the cells expressing the combination of just two PGC 
transcription factors. This suggests that in rat ESCs, the expression of all three PGC 
transcription factors may impair differentiation of rat ESCs towards the germline 
when exposed to an undirected EB differentiation protocol. 
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5.5 Primordial germ cell-like (PGCLC) differentiation 
of stably transfected rat ESC pools 
5.5.1 Expression of PGC transcription factors during PGCLC 
differentiation 
Tet-Empty, Tet-BLIMP1, Tet-BLIMP1-PRDM14 and Tet-BLIMP1-AP2γ transfected 
cells were induced to differentiate by following the rat PGCLC differentiation protocol 
with minor modifications (Figure 4.5.9). These Tet-On transfected cells were chosen 
as they had shown induction of PGC marker genes during the undirected EB 
differentiation protocol. Therefore, it was reasonable to assume that these cells were 
more likely to be driven towards the PGC lineage during the PGCLC differentiation 
protocol. 
 
Figure 5.5.1 Schematic of the rat PGCLC differentiation protocol used for differentiation of Tet-
On transfected cells. Rat ESCs pre-cultured in 2i+Lif or 1i culture medium on a MEF layer were 
transferred onto a fresh MEF feeder layer with EpiLC differentiation medium for 3 days. These cells 
where then pipetted into hanging drops containing 2,000 cells in PGCLC culture medium supplemented 
with doxycycline (1ug/ml). After 2 days of culture, aggregates were collected and cultured fresh 
PGCLC + doxycycline culture medium in low adhesion plate for 4 days.  
Tet-Empty, Tet-BLIMP1, Tet-BLIMP1-PRDM14 and Tet-BLIMP1-AP2γ DAK31 cells 
were pre-cultured in 2i+LIF and 1i culture mediums on MEF feeder layers for 3 days. 
After pre-culture, cells were passaged onto 12-well plates coated with MEFs and 
cultured for 3 days in EpiLC culture medium. EpiLC medium was exchanged every 
24 hours to replenish active bFGF. When observed under a brightfield microscope, it 
was determined that cells which had been pre-cultured in 1i culture medium had 
less evidence of cellular debris compared to those pre-cultured in 2i+LIF, suggesting 
that 1i pre-culture had improved the survival of these cells when cultured in EpiLC 
medium (Figure 5.5.2).  
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Apart from decreased cellular debris, there appeared to be no obvious differences in 
morphology or the growth rate of cells cultured in either pre-culture medium. 
 
Figure 5.5.2. Bright field microscopy photographs of DAK31 Tet-On transfected cell pools 
during EpiLC differentiation. Photographs taken from cell pools of Tet-Empty, Tet-BLIMP1, Tet-
BLIMP1-PRDM14 and Tet-BLIMP1-AP2γ transfected cell pools. After 3 days of culture in EpiLC 
medium (day 6), increased cellular death was present in all cell pools pre-cultured in 2i+LIF medium 
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After the 3-day EpiLC medium culture, cells were collected and suspended in 
hanging drops of PGCLC medium supplemented with doxycycline (1μg/ml). 
Doxycycline was introduced at day 6 of the PGCLC differentiation protocol, 
mimicking the induction of PGC transcription factor transgenes in mouse ESCs after 
EpiLC differentiation (Nakaki et al. 2013). Each hanging drop consisted of 2,000 
EpiLCs contained within 30µl PGCLC culture medium ‘drops’. Dishes containing the 
suspended hanging drops were incubated for 2 days to allow aggregation of the 
cells. After 2 days, aggregates were transferred into 6-well low adhesion plates with 
fresh PGCLC culture medium and incubated in suspension for a further 4 days. 
mCherry fluorescent protein was detected in Tet-On cells cultured in the presence of 
doxycycline (1μg/ml) by fluorescent microscopy (Figure 5.5.3). Bright field 
microscopy revealed cell pools expressing Blimp1 cDNA alone during the PGCLC 
differentiation protocol produced fewer cellular aggregates than the other cell pools 
(Figure 5.5.3). However, the remaining Blimp1 aggregates were larger than those 
observed in other cell pools, suggesting aggregates were made up of multiple 
smaller aggregates bound together.  
 
Figure 5.5.3. Wide field fluorescence imaging of Tet-On vector transfected cell pools after 
PGCLC differentiation. D12 Aggregates shown were cultured in PGCLC medium supplemented with 
doxycycline (1μg/ml). mCherry fluorescence was detected in cells harbouring a Tet-On vector 
containing a PGC transcription factor cassette. Cells transfected with the Tet-Empty vector had no 
detectable mCherry fluorescence.   
Aggregates were broken apart by gentle pipetting (trituration) and the cell 
suspensions sorted into mCherry+ve and mCherry-ve populations by FACs (Figure 
5.5.4). By separating these populations, it could be determined whether cells with 
activate Tet-On vector transgene expression (mCherry+ve) had elevated expression 
of PGC markers compared inactive Tet-On vector transgene expression  
(mCherry-ve). 
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Figure 5.5.4. FACs plots of Tet-On vectors undergoing a PGCLC differentiation protocol. 
Percentages shown display the proportion of the population that was mCherry positive at day 12 of the 
PGCLC differentiation protocol. 
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qRT-PCR analysis showed elevated expression of Blimp1 and Prdm14 transcripts 
within mCherry+ve Tet-BLIMP1, Tet-BLIMP1-PRDM14 and Tet- BLIMP1-AP2γ cells 
compared to Tet-Empty cells (Figure 5.5.5). However, there was no substantial 
difference in Blimp1 or Prdm14 expression between the 2i+Lif or 1i pre-treated 
conditions (Figure 5.5.5). Expression of Ap2γ in all Tet-On PGC transcription factor 
cells pre-cultured in either condition was similar to that in the Tet-Empty cells (Figure 
5.5.5).  
 
Figure 5.5.5. qRT-PCR analysis of PGC transcription factors in Tet-On transfected cell pools 
undergoing a PGCLC differentiation protocol. The data presented was an average of two 
experiments performed with Tet-On vector transfected DAK31 cells. All data was normalised to the 
house keeping gene β-actin (dCT) and fold change was calculated by normalising gene expression to 
Day 0 Tet-Empty ESCs (2-DDCT). 2i = Pre-cultured in 2i +LIF medium, 1i = Pre-cultured in 1i medium. 
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Nanog expression was increased in mCherry+ve cells of all Tet-On PGC vector 
transfected cells, particularly those which had been pre-cultured in 1i medium 
(Figure 5.5.6). However, this expression level was far lower than that seen in any 
population of ESCs (Figure 5.5.6). On average, Oct4 expression in mCherry+ve cells 
expressing transgene copies of any of the PGC transcription factors was lower than 
the expression in the Tet-Empty cell pools (Figure 5.5.6). Only Tet-AP2γ 1i pre-
cultured cells had similar Oct4 expression to the Tet-Empty cells (Figure 5.5.6). Tet-
On cells pre-cultured in 2i+LIF medium had reduced Stella expression compared to 
Tet-Empty cells (Figure 5.5.6). Stella expression from the mCherry+ve cells of Tet-
BLIMP1-PRDM14 and Tet-BLIMP1-AP2γ pre-cultured in 1i medium was similar to 
that in the Tet-Empty transfected cells (Figure 5.5.6). However, there was large 
variability between the two experiments, generating large error bars for Stella 
expression in 1i mCherry positive cells.  
 
Figure 5.5.6. qRT-PCR analysis of pluripotency markers in Tet-On transfected cell pools 
undergoing a PGCLC differentiation protocol. The data presented was an average of two 
experiments performed with Tet-On vector transfected DAK31 cells.  All data was normalised to the 
house keeping gene β-actin (dCT) and fold change was calculated by normalising gene expression to 
Day 0 Tet-Empty ESCs (2-DDCT). 2i = Pre-cultured in 2i +LIF medium, 1i = Pre-cultured in 1i medium. 
Bars represent mean ± SD. 
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Expression of the PGC marker Nanos3 was increased in mCherry+ve Tet-BLIMP1-
PRDM14 and Tet-BLIMP1-AP2γ cells which had been pre-cultured in 1i medium 
(Figure 5.5.7). Interestingly, expression of Blimp1 cDNA alone did induce a small 
increase in Nanos3 transcript in 2i+LIF pre-cultured mCherry+ve cells, but not after 1i 
medium pre-culture (Figure 5.5.7). 
Due to large variations between the experimental replicates, the expression of DazL 
transcript proved difficult to interpret from the mCherry+ve cells (Figure 5.5.7). There 
may have been increased Dazl transcript expression in 1i pre-cultured mCherry+ve 
Tet-BLIMP1-PRDM14 and Tet-BLIMP1-AP2γ cells, but this could not be accurately 
determined due to the large variation between the two experiments (Figure 5.5.7).  
All mCherry+ve Tet-On cells expressing at least one PGC transcription factor had 
increased Vasa expression compared to Tet-Empty cells (Figure 5.5.7).  
 
Figure 5.5.7 qRT-PCR analysis of PGC gene markers in Tet-On transfected cell pools 
undergoing a PGCLC differentiation protocol. The data presented was an average of two 
experiments performed with Tet-On vector transfected DAK31 cells. All data was normalised to the 
house keeping gene β-actin (dCT) and fold change was calculated by normalising gene expression to 
Day 0 Tet-Empty ESCs (2-DDCT). 2i = Pre-cultured in 2i +LIF medium, 1i = Pre-cultured in 1i medium. 
Bars represent mean ± SD.  
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Transcript expression of markers of endoderm (Gata4, Gata6) and trophectoderm 
(Gata3) were also analysed to determine whether the expression of PGC 
transcription factor cDNA influenced the proportion of the Tet-On cells differentiating 
towards these lineages. Gata4 expression was reduced in mCherry+ve cells of all 
Tet-On PGC transcription factor expressing cells compared to Tet-Empty cells 
(Figure 5.5.8). Interestingly, mCherry-ve cells which had been pre-cultured in 1i 
medium also had reduced Gata4 expression compared to Tet-Empty cells (Figure 
5.5.8). However, Tet-BLIMP1-PRDM14 cells pre-cultured in 2i+LIF medium had 
similar Gata4 expression to Tet-Empty cells (Figure 5.5.8).  
Gata6 expression was considerably higher in the mCherry+ve cells of all Tet-On PGC 
transcription factor expressing cells pre-cultured in 1i medium compared to Tet-
Empty cells. In 2i+LIF pre-cultured mCherry+ve cells, Tet-BLIMP1-AP2γ cells had 
greater expression of Gata6 than either Tet-BLIMP1 or Tet-BLIMP1-PRDM14 cells. 
However, when pre-cultured in 1i medium, the mCherry+ve populations of both Tet-
BLIMP1 and Tet-BLIMP1-PRDM14 had far greater expression of Gata6 than the 
mCherry+ve population of Tet-BLIMP1-AP2γ cells.  
The mCherry+ve population of Tet-BLIMP1-PRDM14 cells pre-cultured in 2i+LIF had 
a similar Gata3 expression to the Tet-Empty cells. However, mCherry+ve Tet-
BLIMP1-PRDM14 cells pre-cultured in 1i medium, alongside both the Tet-BLIMP1 
and Tet-BLIMP1-AP2γ cells had a greatly reduced expression of Gata3 compared to 
the Tet-Empty cells. The reduction of Gata3 after 1i medium pre-culture in the 
mCherry+ve populations suggested that expression of these PGC transcription 
factors decreased the proportion of differentiating cells being driven towards 
Gata3+ve lineages such as trophectoderm. However, expression of both Blimp1 and 
Prdm14 cDNA in cells pre-cultured in 2i+LIF was able to retain the proportion of 
cells entering Gata3+ve lineages.  
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Figure 5.5.8. qRT-PCR analysis of PGC gene markers in Tet-On transfected cell pools 
undergoing a PGCLC differentiation protocol. The data presented was an average of two 
experiments performed with Tet-On vector transfected DAK31 cells.  All data was normalised to the 
house keeping gene β-actin (dCT) and fold change was calculated by normalising gene expression to 
Day 0 Tet-Empty ESCs (2-DDCT). 2i = Pre-cultured in 2i +LIF medium, 1i = Pre-cultured in 1i medium. 
Bars represent mean ± SD. 
Overall, mCherry+ve cells which had undergone the PGCLC differentiation protocol 
had a different gene expression profile to the mCherry-ve cells within the same 
culture wells, suggesting these results were due to the expression of PGC 
transcription factor transgenes rather than the presence of doxycycline. Additionally, 
co-expression of Blimp1 and either Prdm14 or Ap2γ within the mCherry+ve cells 
induced the greatest increased expression of the PGC marker Nanos3, suggesting 
that expression of these transgene factors can positively influence the differentiation 
of cells towards the germ cell lineage during a PGCLC differentiation protocol.  
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5.6 Expression of exogenous NANOG transcription 
factor using the Tet-On vector system 
5.6.1 Exogenous Nanog expression alone can induce PGCLC 
formation 
NANOG is a transcription factor that forms part of the core network maintaining ESC 
self-renewal (Chambers et al. 2003, Chambers et al. 2007, Murakami et al. 2016). 
Loss of Nanog expression can predispose ESCs to differentiation (Chambers et al. 
2007), while its overexpression can supress differentiation and promote ESC self-
renewal (Chambers et al. 2003, Murakami et al. 2016). A study performed in mouse 
ESCs determined that the expression of Nanog transgene within EpiLCs generated 
cells with a similar epigenetic pattern to in vivo early germline cells, as well as 
increased expression of PGC transcription factors and PGC markers (e.g. Nanos3) 
(Murakami et al. 2016). This was thought to be due to NANOG assisting the 
recruitment of histone modifying enzymes to the promotor regions of PGC promoting 
factors (e.g. Blimp1, Prdm14 and Ap2γ), activing their expression and thereby 
directing differentiation towards the PGC fate (Murakami et al. 2016). Could the 
proportion of rat cells entering the germ cell lineage be improved by combining ESC 
differentiation with overexpression of Nanog? 
 
5.6.2 Cloning rat Nanog into the Tet-On transposon and production of 
stably transfected cell pools  
Rat Nanog cDNA was generated by PCR amplification with oligonucleotides 
designed to bind to the NANOG mRNA sequence on the Ensembl database 
(ENSRNOT00000060937.3). Homology to the Tet-On vector and to the 2A-mCherry 
of the linearised Tet-On vector (Figure 5.2.3) were introduced to the amplified 
Nanog cDNA by a second round of PCR amplification. Ligation of the amplified 
Nanog cDNA into the linearised 2A-mCherry vector was performed by Gibson 
cloning, followed by Sanger sequencing to confirm the proper insertion of the Nanog 
ORF cDNA into the Tet-On vector. Similar to the previously generated Tet-On 
vectors, a confirmed Tet-NANOG vector was transfected into two dark agouti 
(DAK31 and E3) and one Sprague-Dawley (A4) derived rat ESC lines using 
Lipofectamine LTX and subjected to puromycin selection to remove any un-
transfected cells. Cell pools containing Tet-NANOG transfected ESC were then 
cultured in the presence and absence of 1µg/ml doxycycline for 2 days to induce the 
expression of the Nanog and mCherry fluorescent protein.  
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Expression of the mCherry marker was monitored by fluorescence microscopy 
(Figure 5.6.1A) and by flow cytometry (Figure 5.6.1B). The gating strategy detailed 
in section 2.6.7 was used. The remaining cells were gated to isolate populations of 
mCherry+ve cells by plotting mCherry (610/20A) versus cell counts. The gates were 
set against rat ESCs transfected with the Tet-Empty vector. 
 
Figure 5.6.1. mCherry fluorescence and flow cytometry data produced from DAK31 cells 
transfected with Tet-NANOG. (A) Bright field and fluorescence photographs of DAK31 cell pools 
stably transfected with the Tet-NANOG vector. 1.5x105 rat ESCs were cultured in 2i+LIF medium in the 
absence (top panels) or presence (bottom panels) of doxycycline (1μg/ml) for 2 days. (B) Flow 
cytometry histograms displaying cells cultured in either the presence (dark peak) or absence (pale 
peak) of doxycycline for 2 days. Percentages shown are the percentage of mCherry positive cells in the 
presence of doxycycline.  
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5.6.3 Functional Nanog transgene expression from the Tet-NANOG 
vector  
Rat ESCs cultured in culture medium containing high concentrations of CHIR99021 
are driven to differentiate due to the inhibition of GSK3 activity, which leads to 
stabilisation of β-catenin and therefore increases β-catenin activity (Meek et al. 
2013). A Rex1-EGFP reporter cell line was transfected with the Tet-NANOG vector 
and cultured for two days in medium containing 4 different concentrations of 
CHIR99021 (0, 1, 4, and 8μM) in the presence and absence of doxycycline (1µg/ml). 
Differentiation of the reporter cell line was monitored by observing the loss of EGFP 
expression. Cells cultured in standard 2i+LIF conditions (2μM) were used as a 
titration control. It was hypothesised that functional expression of the Nanog 
transgene from the Tet-On vector would increase the number of EGFP+ve present 
after the cells had been subjected to the CHIR99021 titration. Flow cytometry was 
performed to ascertain the effect Nanog transgene expression had on the 
expression of EGFP in the Rex1-EGFP reporter cell line (Figure 5.6.2).  
Increased EGFP expression was seen in cells cultured in medium containing 
doxycycline (red) compared to those cultured in the absence of doxycycline (green) 
(Figure 5.6.2). This showed that functional Nanog transgene was being expressed 
from the Tet-NANOG vector, reducing the number of cells differentiating in the 
presence of high concentrations of CHIR99021.  
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Figure 5.6.2 Flow cytometry of Tet-NANOG transfected Rex1-EGFP cell pools undergoing 
CHIR99021 titration. Flow cytometry histograms displaying cell pools cultured in increasing 
concentrations of CHIR99021 in the presence or absence of doxycycline for 2 days. Green peaks 
represent pools cultures in the absence of doxycycline, while red peaks represent populations cultured 
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5.6.4 Expression of Nanog cDNA during an EB differentiation protocol 
Tet-NANOG transfected cells generated from three different rat ESC lines were 
induced to differentiate for 6 days via the undirected EB differentiation protocol. This 
was to assess the effect Nanog transgene expression had on rat ESC 
differentiation, and to determine whether there was any increase in the expression 
of PGC markers during undirected differentiation of these cells.  
qRT-PCR analysis performed on cells after the 6-day protocol revealed that Nanog 
transcript levels were significantly increased when doxycycline was introduced to the 
culture medium of Tet-NANOG cells when compared to the Tet-Empty cells (Figure 
5.6.3). However, there was no significant difference in Oct4 or Stella expression in 
the presence or absence of doxycycline (Figure 5.6.3). 
 
Figure 5.6.3 qRT-PCR analysis of pluripotency markers in Tet-NANOG transfected cells. Average 
of three independent rat cell lines (two DA lines, one SD line). All data was normalised to the house 
keeping gene β-actin (dCT) and the fold change was calculated by normalising expression to the basal 
transcript level seen in ESCs harvested from Tet-Empty ESCs (D0 ESCs) (2-DDCT). (D0), (D2), (D4) 
represent cell pools which were cultured in the presence of doxycycline from day 0, day 2 and day 4 of 
EB differentiation respectively. Bars represent mean ± SD, *P<0.05, **P<0.01. 
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The expression of Nanog cDNA had no significant effect on Blimp1 or Ap2γ 
transcript expression within the Tet-NANOG cells (Figure 5.6.4). However, when 
Nanog cDNA was expressed from day 4 of the EB differentiation protocol, there was 
a significant increase in Prdm14 expression compared to the Tet-Empty cells 
(Figure 5.6.4).  
 
Figure 5.6.4 qRT-PCR analysis of PGC transcription factors in Tet-NANOG transfected cells. 
Average of three independent rat cell lines (two DA lines, one SD line). All data was normalised to the 
house keeping gene β-actin (dCT) and the fold change was calculated by normalising expression to the 
basal transcript level seen in ESCs harvested from Tet-Empty ESCs (D0 ESCs) (2-DDCT). (D0), (D2), 
(D4) represent cell pools which were cultured in the presence of doxycycline from day 0, day 2 and day 
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Expression of the PGC markers Nanos3 and Dazl were also largely unaffected by 
the expression of Nanog cDNA during the EB differentiation protocol. However, 
there was a statistically significant drop in Nanos3 transcript expression within Tet-
NANOG cells cultured in the presence of doxycycline from day 2 of the protocol, but 
not from day 4 onwards (Figure 5.6.5).  
 
Figure 5.6.5 qRT-PCR analysis of PGC marker genes in Tet-NANOG transfected cells. Average of 
three independent rat cell lines (two DA lines, one SD line). All data was normalised to the house 
keeping gene β-actin (dCT) and the fold change was calculated by normalising expression to the basal 
transcript level seen in ESCs harvested from Tet-Empty ESCs (D0 ESCs) (2-DDCT). (D0), (D2), (D4) 
represent cell pools which were cultured in the presence of doxycycline from day 0, day 2 and day 4 of 
EB differentiation respectively. Bars represent mean ± SD, *P<0.05, **P<0.01. 
Overall, these results suggested although functional expression of Nanog cDNA was 
demonstrated in the Tet-NANOG transfected cells, unlike the PGC transcription 
factors, Nanog alone could not induce expression of PGC markers in cells 
undergoing an undirected EB differentiation protocol. Interestingly, the expression of 
Nanog cDNA during EB differentiation did not appear to halt EB differentiation either 
as markers commonly associated with the pluripotent state remained low (e.g. Stella 
and Prdm14).  
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5.6.5 Expression of Nanog cDNA during a PGCLC differentiation 
protocol 
DAK31 Tet-NANOG cells were subjected to the rat PGCLC differentiation protocol 
as described previously (Section 5.5), introducing 1μg/ml doxycycline after day 6 of 
the protocol. Aggregates formed from Tet-NANOG transfected cell pools at day 12 
of the PGCLC differentiation protocol were imaged for mCherry fluorescent protein 
(Figure 5.6.6A), broken apart by gentle pipetting (trituration) and sorted into 
mCherry+ve and mCherry-ve populations by FACs (Figure 5.6.6B). By sorting Tet-
NANOG cells into these two populations, it could be determined whether the 
expression of Nanog cDNA influenced the expression of PGC gene markers.  
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Figure 5.6.6. Tet-NANOG transfected cell pools undergoing PGCLC differentiation in the 
presence of doxycycline. (A) DAK31 Tet-Nanog aggregates formed after D12 of PGCLC 
differentiation protocol. Aggregates cultured in the presence of doxycycline from Day 6 onwards. 2i+LIF 
= Pre-cultured in 2i+LIF prior to EpiLC differentiation, 1i = Pre-cultured in 1i medium prior to EpiLC 
differentiation. (B) FACs plots of D12 aggregates. Percentages represent population of mCherry+ve 
cells.  
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The separated populations were processed for RNA and used for qRT-PCR 
analysis. qRT-PCR analysis revealed there was a substantial increase in the 
expression of Nanog transcript in the mCherry+ve population of the Tet-NANOG cells 
compared to the Tet-Empty cells (Figure 5.6.7). The expression level of Nanog did 
not differ between either pre-culture conditions (Figure 5.6.7). Both Oct4 and Stella 
expression were greatly reduced in both populations of Tet-NANOG cells when 
compared to Tet-Empty cells (Figure 5.6.7).  
 
Figure 5.6.7. qRT-PCR analysis of pluripotency markers in Tet-NANOG cells undergoing a 
PGCLC differentiation protocol. The data presented was an average of two experiments performed 
with Tet-Empty and Tet-Nanog transfected DAK31 cells. All data was normalised to the house keeping 
gene β-actin (dCT) and fold change was calculated by normalising gene expression to Day 0 Tet-
Empty ESCs (2-DDCT). Bars represent mean ± SD. 
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Tet-NANOG mCherry+ve cells which had been pre-cultured in 1i medium had 
increased expression of all PGC transcription factors compared to the Tet-Empty 
cells (Figure 5.6.8). Expression of the Blimp1 was over 8-fold greater in the Tet-
NANOG mCherry+ve cells compared to the Tet-Empty, while expression of Prdm14 
transcript was nearly 10-fold greater (Figure 5.6.8). Expression of Blimp1 and 
Prdm14 were also elevated in the Tet-NANOG mCherry+ve cells which had been pre-
cultured in 2i+LIF conditions, however, these levels were far lower than those 
achieved after the 1i pre-culture condition (Figure 5.6.8).    
 
Figure 5.6.8. qRT-PCR analysis of PGC transcription factors in Tet-NANOG cells undergoing a 
PGCLC differentiation protocol. The data presented was an average of two experiments performed 
with Tet-Empty and Tet-Nanog transfected DAK31 cells.  All data was normalised to the house keeping 
gene β-actin (dCT) and fold change was calculated by normalising gene expression to Day 0 Tet-
Empty ESCs (2-DDCT). Bars represent mean ± SD. 
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Expression of the PGC gene markers Nanos3 and Dazl were slightly elevated in 
Tet-NANOG mCherry+ve cells which had been pre-cultured in 1i medium when 
compared to the Tet-Empty cells (Figure 5.6.9). However, no substantial change in 
Vasa expression could be identified in any population of Tet-NANOG cell compared 
to the Tet-Empty cells (Figure 5.6.9). 
 
Figure 5.6.9. qRT-PCR analysis of PGC gene markers in Tet-NANOG cells undergoing a PGCLC 
differentiation protocol. The data presented was an average of two experiments performed with Tet-
Empty and Tet-Nanog transfected DAK31 cells. All data was normalised to the house keeping gene β-
actin (dCT) and fold change was calculated by normalising gene expression to Day 0 Tet-Empty ESCs 
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Transcript expression of markers of endoderm (Gata4, Gata6) and trophectoderm 
(Gata3) were also analysed to determine whether the expression of Nanog cDNA 
influenced the proportion of the Tet-On cells differentiating towards these lineages. 
Gata4 expression was increased in the Tet-NANOG mCherry-ve cells when 
compared to the Tet-Empty pools (Figure 5.6.10). However, Tet-NANOG mCherry+ve 
cells had similar Gata4 expression to the Tet-Empty pools (Figure 5.6.10).  
The expression of Gata6 in Tet-NANOG cells was on average lower than the 
expression level in Tet-Empty cell pools, with only the mCherry-ve population of Tet-
NANOG cells pre-cultured in 1i medium showing a similar expression to Tet-Empty 
cells cultured in the same conditions (Figure 5.6.10). 
Gata3 expression in Tet-NANOG mCherry-ve cells which had been pre-cultured in 
2i+LIF medium was elevated compared to the Tet-NANOG mCherry+ve cells and the 
Tet-Empty cell pools pre-cultured in the same conditions (Figure 5.6.10). However, 
Tet-NANOG mCherry+ve cells pre-cultured in 1i medium had a greater Gata3 
expression compared to the Tet-NANOG mCherry-ve cells and the Tet-Empty cell 
pools pre-cultured in the same conditions (Figure 5.6.10).  
This increase in Gata3 after 1i medium pre-culture in the mCherry+ve population 
could highlight that Nanog cDNA expression increased the potential of differentiating 
cells differentiating into a Gata3+ve lineage (e.g. trophectoderm). 
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Figure 5.6.10. qRT-PCR analysis of the expression of endoderm (Gata4 and Gata6) and 
trophectoderm (Gata3) marker genes in Tet-NANOG cells undergoing a PGCLC differentiation 
protocol. The data presented was an average of two experiments performed with Tet-Empty and Tet-
Nanog transfected DAK31 cells.  All data was normalised to the house keeping gene β-actin (dCT) and 
fold change was calculated by normalising gene expression to Day 0 Tet-Empty ESCs (2-DDCT). Bars 
represent mean ± SD. 
Expression of Nanog transgene during the PGCLC differentiation protocol increased 
the expression of the PGC transcription factors Blimp1 and Prdm14, similar to that 
reported in mouse cells (Murakami et al. 2016). Slight increases in both Nanos3 and 
Dazl expression could be identified in cells expressing Nanog transgene compared 
to the Tet-Empty cells after being subjected to the PGCLC differentiation protocol. 
However, these expression levels did not surpass those detected in rat ESCs, 
suggesting Nanog alone is not strong enough to efficiently direct rat ESCs towards 
the germline.  
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5.7 Chapter 5 discussion 
Overexpression of the PGC transcription factors Blimp1, Prdm14 and Ap2γ in 
mouse EpiLCs has been shown to generate a distinct population of PGCLCs without 
the need for PGC cytokine inducers (e.g. BMP4) in the culture medium (Nakaki et al. 
2013). The efficiency of PGCLC determination was increased by inducing transgene 
expression of the PGC transcription factors in cells subjected to the PGCLC 
differentiation protocol described by Hayashi et al (Hayashi & Saitou 2013, Nakaki et 
al. 2013). Additionally, it has been reported that overexpression of pluripotency 
transcription factor Nanog in mouse cells which have transitioned irreversibly into 
the EpiLC fate directs cell differentiation towards the germ cell lineage (Murakami et 
al. 2016). The aim of this chapter was to determine whether the overexpression of 
the PGC transcription factors or Nanog via doxycycline-inducible Tet-On piggyBac 
transposon vectors could improve the proportion of rat cells directed towards the 
germ cell lineage. 
 
5.7.1 Co-expression of Blimp1 and Prdm14 or Blimp1 and Ap2γ 
transgenes increased PGC gene marker expression during rat 
ESC differentiation 
Rat cells induced to overexpress a combination of Blimp1 & Prdm14, or Blimp1 & 
Ap2γ during an undirected EB differentiation protocol had significantly increased 
expression of endogenous PGC gene markers compared to control cells. A similar 
increase in PGC marker gene expression was also obtained in cells overexpressing 
either Blimp1 and Prdm14 or Blimp1 and Ap2γ whilst undergoing the directed 
PGCLC differentiation protocol. By separating cells which were actively expressing 
the PGC transgenes (mCherry+ve) from the inactive cells (mCherry-ve), it was evident 
that increased PGC marker gene expression was only present in the mCherry+ve 
population after being induced to differentiate. This suggested that increased PGC 
gene marker expression was in response to PGC transcription factor overexpression 
and not non-cell autonomous effects (e.g. the presence of doxycycline in the culture 
medium). A similar increase in PGC gene marker expression was reported in mouse 
ESCs, where co-expression of the PGC transcription factors directed a greater 
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Interestingly, the fold change increase of PGC gene marker expression was far 
greater in cells subjected to the EB differentiation protocol than those subjected to 
the PGCLC differentiation protocol when compared to control ESCs and 
differentiated cells. This suggests that the cells generated after the EB differentiation 
protocol were more responsive to the signals directing differentiation towards the 
germline than cells cultured in the rat EpiLC differentiation conditions.  
Perhaps forming cell aggregates generated by the undirected EB differentiation 
protocol and then applying the PGCLC differentiation protocol might improve cell 
differentiation towards the germline, especially when inducing the overexpression of 
PGC transcription factors.  
Nakaki et al previously concluded that the expression of all three PGC transcription 
factors was most beneficial for directing mouse cell differentiation to PGCLCs 
(Nakaki et al. 2013). However, expression of all three PGC transcription factors in 
rat cells from either a single vector or multiple transposon vectors had a negative 
effect on PGC marker gene expression. Elevated basal levels of lineage specific 
genes are evident in rat ESCs compared with mouse ESCs, suggesting that the 
initial pluripotency state of rat ESCs might be more “primed” than their mouse 
counterparts (Blair et al. 2011, Hong et al. 2013). Therefore, the overexpression of 
all three PGC transcription factors may have directed primed rat ESCs within the 
population towards alternative lineages instead of the germline. This result may also 
suggest that not all of these three PGC transcription factors are required for rat PGC 
specification. In porcine and human cells, Sox17 and Blimp1 are required for 
generating PGCLCs, with Prdm14 and Ap2γ appearing to have little influence (Irie et 
al. 2015, Wang et al. 2016). It would be of interest to further explore the role of the 
three key PGC transcription factors, and whether Sox17 is also involved in rat PGC 
specification.  
 
5.7.2 Expression of Nanog transgene alone increased PGC 
transcription factor expression during rat ESC differentiation 
In mouse ESCs, overexpression of Nanog in EpiLCs during a PGCLC differentiation 
protocol induced the expression of all three PGC transcription factors, driving cell 
differentiation towards the germ cell lineage (Murakami et al. 2016). Overexpression 
of Nanog in rat cells subjected to an undirected EB differentiation protocol showed 
no induction of PGC specific gene markers.  
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This result suggests that unlike the co-expression of Blimp1 with either Prdm14 or 
Ap2y, Nanog alone is not able to drive the differentiation of cells undergoing the EB 
differentiation protocol towards the germline. Unlike mouse cells, where expression 
of Nanog within the first few days of cell differentiation was able to revert cells back 
into an ESC state (Murakami et al. 2016), overexpression of Nanog at any stage 
during the EB differentiation protocol did not appear to retain rat cells in an ESC 
state or revert them back into the ESC state. As rat ESC cultures have higher 
expression of lineage specific genes despite their overall pluripotent state (Blair et 
al. 2011, Hong et al. 2013), this suggests that within the heterogeneous pool, the 
more ‘primed’ rat cells cannot be directed back to a pluripotent state by the 
expression of Nanog once they are stimulated to differentiate.  
Nanog overexpressing cells pre-cultured in 1i medium and subjected to the PGCLC 
differentiation protocol had increased expression of all three PGC transcription 
factors (Blimp1, Prdm14, Ap2γ) compared to control cells, similar to what has been 
reported in mouse cells (Murakami et al. 2016). Nanog overexpressing cells also 
had increased expression of PGC specific marker genes compared to control cells. 
However, this induction did not appear to be of the magnitude determined in mouse 
ESCs (Murakami et al. 2016). NANOG is reported to bind to enhancer regions of 
Blimp1 and Prdm14 in differentiating cells, activing their expression independently of 
BMP4 and WNT signalling (Murakami et al. 2016). As Nanog transgene expression 
increased the expression of PGC transcription factors, perhaps this increase in PGC 
specific gene markers is the result of increased Blimp1, Prdm14 and/or Ap2y 
expression, rather than the direct involvement of Nanog on specific marker gene 
expression. Therefore, there could be a potential benefit in co-expressing Nanog 
with Blimp1, Prdm14 and/or Ap2γ during directed differentiation of rat cells towards 
PGCs.  
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Chapter 6 Directing differentiation away from 
the somatic lineage via the deletion 
of the OTX2 transcription factor  
6.1 Introduction 
Otx2 is a homeobox gene expressed in the epiblast compartment during 
embryogenesis (Kurokawa et al. 2004). In mouse, the OTX2 transcription factor 
targets OCT4 to alternative enhancer elements during epiblast differentiation, 
activating the expression of transcription factors which drive the cells out of the 
naïve stem cell fate (Buecker et al. 2014, Yang et al. 2014). In a recent study, it was 
shown that mouse Otx2-deficient ESCs generated a greater number of PGCLCs 
during cytokine induced PGCLC differentiation compared to their Otx2 wild-type 
counterparts (Zhang et al. 2018). Also, the overexpression of Otx2 blocked the 
expression of the PGC transcription factors Blimp1, Prdm14, and Ap2γ, preventing 
mouse ESCs entering the PGC lineage and directed the cells towards the somatic 
cell fate (Zhang et al. 2018). Otx2-/- EpiLCs cultured in PGCLC medium as described 
by Hayashi et al (2011, 2013), induced more rapid expression of all three key PGC 
transcription factors (Blimp1, Prdm14, and Ap2γ) and Nanog (Zhang et al. 2018). 
The elevated expression of these factors increased the proportion of mouse ESCs 
being driven towards the PGCLC fate (Zhang et al. 2018). The rat Otx2 locus is 
roughly half the size of the Otx2 locus found within mice, however, the coding 
sequence structure of both rat and mouse OTX2 are well conserved (Figure 6.1.1).  
 
Figure 6.1.1. Schematic of the OTX2 locus of rat and mice. Black bars indicate the translated 
exons, while white bars represent the untranslated region.  
The aim of this chapter was to determine if the loss of Otx2 expression in rat ESCs 
could increase the proportion of differentiating cells that enter the PGC lineage. A 
CRISPR/Cas9 gene editing strategy was used to create a deletion within the Otx2 
locus, disrupting OTX2 protein expression. The aim of this chapter was to generate 
rat ESC clones carrying a homozygous deletion within in the Otx2 locus, thereby 
generating Otx2-/- knock-out cells.  
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6.2 Generating rat Otx2-/- knock-out cell lines via 
CRISPR/Cas9 gene-editing  
6.2.1 CRISPR/Cas9 gene editing strategy for inducing a deletion within 
the Otx2 locus 
A CRISPR gene-editing strategy was used to generate two separate double strand 
breaks (DSBs) within the Otx2 gene. These DSBs induced the removal of a 1.4kb 
region of the Otx2 locus, spanning the first two exons of the Otx2 gene. The deletion 
removed the start codon of Otx2, resulting in a frameshift mutation and loss of 
functional OTX2 production (Figure 6.2.1).  
 
Figure 6.2.1. Strategy for generating rat Otx2-/- knock-out cell lines. Two separate gRNAs were 
designed to target Cas9 nuclease to separate sites in the OTX2 locus. DSBs would be introduced at 
these separate sites, inducing the deletion of a 1.4kb region of the Otx2 locus, including exon 1 and 
exon 2. Non-homologous end joining (NHEJ) would induce reattachment of the broken strands, forming 
a genome lacking the full Otx2 gene sequence. 
Multiple gRNA sequences were designed which would target the Cas9 nuclease to 
PAM sites upstream of exon 1 and downstream of exon 2 of the Otx2 gene. Using 
the CRISPR Design tool produced by the Zhang Lab (crispr.mit.edu), six gRNA 
oligonucleotides with PAM sites within 50 base pairs of the intended cut sites of the 
Otx2 locus were generated (Figure 6.2.2). These gRNAs were designed to target 
the rat Otx2 gene sequence presented on the ensembl database 
(ENSRNOT00000074488.2). The gRNA oligonucleotides were ligated into the 
PX458 Cas9 nuclease vector as described in Chapter 4. 
 
 





(-PAM, 20bp + G) 
PAM Direction  DSB location  
(From ATG site) 
AT1 (G)TTAGATAAGACATCATGCTA AGG 3’ to 5’ -4bp 
AT2 GACATCATGCTAAGGTTGTT TGG 3’ to 5’ -12bp 
AT3 (G)CCGGCTGGGTCCCCCCAATT TGG 5’ to 3’ -33bp 
In1 (G)tcagtataatccacgattca agg 3’ to 5’ +1262bp 
In2 ggtttcttgaccttgaatcg tgg 5’ to 3’ +1269bp 
In3 gattatactgacgacccaat agg 5’ to 3’ +1286bp 
 
Figure 6.2.2. gRNA sequences for inducing OTX2 deletion. Each gRNA would target the Cas9 
nuclease to the Otx2 gene, inducing the formation of a DSB either upstream of the ATG site or within 
intron 2/3. “5’ to 3’” gRNA would target Cas9 nuclease to the sense (5’ to 3’) strand, “3’ to 5’” gRNA 
would target Cas9 nuclease to the anti-sense (3’ to 5’) strand. 
 
6.2.2 Determining efficiency of Cas9 induced DSBs within the Otx2 
locus 
To readily assess the efficiency of CRISPR/Cas9 induced DSBs within the Otx2 
locus, rat DAK31 cells were co-transfected with varying combinations of the gRNA 
containing PX458 Cas9 nuclease vectors ( 
Figure 6.2.2). Vectors containing either AT1, AT2 or AT3 were co-transfected with 
vectors containing either In1, In2 or In3 to induce DSBs upstream of the ATG start 
codon and downstream of exon 2 within the Otx2 locus. Successful transfection was 
determined by the detection of mCherry fluorescent protein 24 hours post 
transfection. DAK31 ESCs were chosen as they contained no fluorescent marker 
which could interfere with mCherry immunofluorescence screening of the 
transfected cell pools. PCR amplification of gDNA isolated from transfected DAK31 
cells was performed with oligonucleotides spanning a region of ~1775bp of the Otx2 
locus, encompassing both exon 1 and 2 (Figure 6.2.3A). Gel electrophoresis was 
performed to confirm that Cas9-induced DSBs had occurred within the Otx2 locus 
(Figure 6.2.3B). Evidence of a deletion within the Otx2 gene would result in a band 
of ~490bp.  
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Figure 6.2.3. Validation of CRISPR cas9 induced deletion in the OTX2 locus. (A) Schematic 
showing the amplified regions of wild-type and edited Otx2 locus. ‘qRT’ indicates the building sites of 
the Otx2 qRT-PCR primers (B) Gel electrophoresis of PCR bands from DAK31 cells transfected with 
Otx2 targeting gRNA. White arrow indicates the chosen pair of gRNAs to be used to induce the knock-
out of the rat Otx2 gene.  
Every combination of AT-PX458 and IN-PX458 vector showed a faint band matching 
the size of a DSB-mediated deletion within the Otx2 gene (~490bp) and an intense 
wild-type band (~1775bp) (Figure 6.2.3B). DAK31 cells transfected with AT3-PX458 
and In2-PX458 vectors (Figure 6.2.3B - white arrow) resulted in the most intense 
deleted band of all combinations (Figure 6.2.3B). Therefore, it was decided that the 
AT3-PX458 and In2-PX458 vectors would be used to generate the Otx2-/- knock-out 
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6.2.3 Generation of rat DAK31 Otx2-/- clones 
DAK31 ESCs were co-transfected with the AT3-PX458 and In2-PX458 vectors 
(Figure 6.2.4). 48 hours after transfection, ~200 mCherry+ve transfected cells were 
single cell sorted into 96 well plates. The gating strategy detailed in section 2.6.7 
was used. The remaining cells were gated to isolate populations of mCherry+ve cells 
by plotting mCherry (610/20A) versus side scatter area (SSC-A). The gates were set 
against untransfected rat ESCs. The flow cytometry plots generated during the 
FACs of these mCherry+ve are shown in Figure 6.2.4. These single cells were 
cultured in 2i+LIF medium and allowed to recover for 7 days. Of these sorted 
mCherry+ve cells, 85 cell clones survived the single cell plating procedure and 
generated large enough colonies to propagate further. After a further 2 weeks, 30 
clones had generated colonies that could be passaged into 24-well plates. Aliquots 
of the 30 clones were frozen and screened for a deletion within the Otx2 gene by 
PCR amplification of purified gDNA. Of the 30 clones screened, 20 produced at 
least a single band which was substantially smaller than a wild-type Otx2 band. 9 
clones lacked a PCR band matching the wild-type Otx2 gene (an example is marked 
in Figure 6.2.4). Of these 9 clones, only 3 were determined to be largely 
karyotypically normal, DA15, DA16 and DA28.  
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Figure 6.2.4. Transfection of DAK31 and validation of cell clones. Transfected cells underwent 
FACs sorting, sorting single cell clones of mCherry positive cells. ~20% of the transfected cells were 
mCherry positive. Single cells were bulked up and then harvested for genomic DNA. The region to be 
edited was PCR amplified and gel electrophoresis used to determine any clones which lacked a wild-
type (WT) copy of the Otx2 gene. 
Sanger sequencing of DA15, DA16 and DA28 cell clones determined that the region 
encompassing exon 1 and 2 of the Otx2 gene had been successfully deleted (Figure 
6.2.5). Additionally, Sanger sequencing performed on another clone (DA13) was 
identified as having a wild-type copy of the Otx2 gene (Figure 6.2.5A), as well as 
multiple larger fragments which may have been the result of insertions into the locus 
via NHEJ repair of the region. Due to these larger bands, this clone was potentially a 
heterozygous Otx2+/- cell line and so would be analysed further to observe any 
potential effects caused by heterozygous expression of the Otx2 gene.  
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Figure 6.2.5. Validated Otx2-/- knock-out clones. (A) Gel electrophoresis of PCR fragments amplified 
from genomic DNA. The parental DAK31 line and cells transfected with a PX458 vector containing no 
gRNA were used as a deletion control. (B) Sanger sequencing of OTX2-/- clones compared to full Otx2 
reference sequence. (C) Sanger sequencing of OTX2-/- clones compared to an Otx2 reference 
sequence missing exon 1 and 2. Both B&C show deletions within clones DA15, DA16, and DA28 
spanning from the ATG start codon up to Intron 2 of the Otx2 gene.  
All Otx2-/- clones grew noticeably slower than the parental DAK31 cell line when 
cultured in 2i+LIF conditions (Figure 6.2.6). Colonies produced from DA13, DA16 
and DA28 clones were on average smaller and more spherical than the parental 
DAK31 cell line (Figure 6.2.6). However, this could be the result of sub-clonal 
variation due to the single cell sorting procedure.   
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Figure 6.2.6. Bright field microscopy photographs of Otx2-/- clones (DA15, DA16 and DA28) and 
the DA13 clone. Photographs were taken of the remaining clones after single cell sorting and 
screening for Otx2 knock-outs. The top panel shows the parental WT cell line (DAK31). All cells were 
seeded at 1.5 x 105 cells and cultured for 2 days in 2i+LIF culture medium. 
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6.3 Confirming loss of OTX2 protein within Otx2-/- 
clones  
6.3.1 Immunostaining clones for OTX2 protein 
Published data has shown that Otx2 gene expression increases in rat ESCs when 
cultured in a base culture medium (N2B27) containing only PD0325091 without 
CHIR99021 and LIF, referred to as 1i medium (Meek et al. 2013). To confirm that 
Otx2-/- knock-out clones did not produce OTX2 protein, cells were cultured in 1i 
medium conditions for 3 days and immunostained for OTX2 protein. 
 
Figure 6.3.1. Immunostaining Otx2-/- knock-out clones for the presence of OTX2 protein. OTX2 
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The parental DAK31 cell line cultured in 1i culture medium showed positive OTX2 
protein staining (red) (Figure 6.3.1). DA13 showed faint OTX2 fluorescent staining, 
but no OTX2 fluorescent staining was observed for DA15, DA16 or DA28 Otx2-/- 
knock-out clones (Figure 6.3.1). This meant that either the deletions induced by 
CRISPR/Cas9 gene editing had induced loss of function mutations in the Otx2 locus 
or that these Otx2-/- clones were less responsive to 1i medium culture. 
 
6.4 Differentiation potential of Otx2-/- knock-out 
clones  
6.4.1 Otx2-/- clones undergoing an Embryoid body (EB) differentiation 
protocol 
The Otx2-/- clones, alongside the parental and DA13 clone, underwent a 6-day rat 
Embryoid body (EB) differentiation protocol to observe whether the loss Otx2 
impacted the differentiation potential of these cells. Cellular aggregates produced 
after the 6-day protocol were harvested and RNA processed for qRT-PCR analysis.  
All Otx2-/- clones had reduced Blimp1 transcript expression compared to the parental 
in the ESC state (Day 0 ESCs) and after the 6-day EB differentiation protocol 
(Figure 6.4.1). However, the significance of this reduced Blimp1 is questionable due 
to the low basal expression in rat ESCs. The expression of the other PGC TFs 
(Prdm14 and Ap2γ) were elevated in Otx2-/- clones compared to the parental line 
after the 6-day protocol (Figure 6.4.1). As expected, no Otx2 transcript expression 
was detected in the Otx2-/- clones DA15, DA16 and DA28 (Figure 6.4.1). DA13 did 
show expression of Otx2, but this was lower than the Otx2 expression identified in 
the parental DAK31 cell line (Figure 6.4.1).  
Nanog transcript expression in the parental DAK31 cell line was dramatically 
decreased after cells had been subjected to the EB differentiation protocol (Figure 
6.4.1). However, Nanog expression in all Otx2-/- clones (including DA13) after the 6-
day differentiation protocol remained relatively unchanged when compared to the 
expression level in Otx2-/- ESCs (Figure 6.4.1). 
Otx2-/- clones had reduced expression of the epiblast markers Brachyury and Fgf5 
compared to the parental cell line after the 6-day differentiation protocol (Figure 
6.4.1). Additionally, DA16 and DA28 both had elevated expression of the endoderm 
marker Gata6 compared to the parental line after undergoing the EB differentiation 
protocol (Figure 6.4.1).  
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Figure 6.4.1. qRT-PCR analysis of OTX-/- clones before and after EB differentiation. Average of 
three technical replicates generated from 1 experimental repeat. Expression was normalised to the 
house keeping gene β-actin (dCT) and fold change (2-DDCT) values generated by normalising gene 
expression to day 0 DAK31 ESCs. Bars represent mean ± SD. 
Overall, the qRT-PCR data generated from cells undergoing an EB differentiation 
protocol produced a similar pattern to what had been determined in the mouse In 
vitro system (Hayashi et al. 2011, Zhang et al. 2018), loss of Otx2 expression 
prevented the inactivation of the Nanog gene and reduced the activation of Fgf5 
expression during cellular differentiation. Interestingly, the DA13 clone also showed 
a similar result to the Otx2-/- cell lines. This result could be the result of 
haploinsufficiency, that the loss of single copy of the Otx2 gene generates a similar 
phenotype to the homozygous knock-out of Otx2. However, the similar gene 
expression from DA13 could also suggest that the response seen in the the Otx2-/- 
clones are the result of sub-clonal variation rather than the loss of Otx2 expression.  
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6.4.2 Otx2-/- clones undergoing a PGCLC differentiation protocol 
The Otx2-/- clones underwent the PGCLC differentiation protocol (Figure 4.5.9) as 
described previously, to determine whether the loss of Otx2 expression helped to 
direct differentiating rat ESCs towards the PGCLC fate.  
 
Figure 6.4.2 Schematic of the rat PGCLC differentiation protocol used for differentiation of Otx2-
/- clones. Rat ESCs cultured in 2i+Lif or 1i medium conditions on a MEF layer were transferred onto a 
fresh MEF feeder layer with EpiLC differentiation medium for 3 days. These cells where then pipetted 
into hanging drops containing ~2,000 cells in PGCLC medium. After 2 days the hanging drops were 
collected and placed into fresh PGCLC medium in 6 well low adhesion plates for a further 4 days.  
6.4.2.1 EpiLC differentiation protocol 
The Otx2-/- clones (DA15, DA16 & DA28), DA13 and the parental DAK31 cell line 
were pre-cultured for 3 days in 2i+LIF and 1i culture medium on MEF feeder layers. 
After the 3-day culture, 1 x 105 of each cell line were passaged into multiple wells of 
12-well plates coated with fresh MEF layers in EpiLC medium. Cells were incubated 
for a further 3 days, with the EpiLC medium being replaced with fresh medium every 
24 hours to replenish the bFGF and activin A. Cell pools were photographed after 3 
days culture in EpiLC culture medium (Figure 6.4.3). Both 2i+LIF and 1i medium 
pre-cultured cells (Figure 6.4.3) showed a flattened morphology compared to the 
domed ESCs (Figure 6.2.6). However, Otx2-/- knock-out cell lines showed more 
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Figure 6.4.3. Bright field microscopy photographs of Otx2-/- cells undergoing EpiLC 
differentiation. Parental DAK31, DA13 and Otx2-/- clone undergoing EpiLC differentiation. 
Photographs taken at day 3 of EpiLC culture (day 6 EpiLC differentiation). Left panels are cells pre-
cultured with 2i+LIF, right panels are cells pre-cultured with 1i medium.  
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Cells which had been cultured in EpiLC medium for 3 days were harvested and 
used for qRT-PCR analysis to quantify the expression of markers commonly 
associated with EpiLC differentiation. After the 3-day culture in EpiLC medium, all 
cell lines showed a substantial reduction in Nanog transcript expression (Figure 
6.4.4). There was no substantial difference in Tcf15 expression within any Otx2-/- 
clones compared to the parental cell line after 3-day culture in EpiLC medium 
(Figure 6.4.4). Fgf5 was very weakly expressed in all three Otx2-/- clones (DA15, 
DA16 & DA28) and DA13 compared to the parental DAK31 cell line after the 3-day 
culture in EpiLC medium (Figure 6.4.4).  
 
Figure 6.4.4. qRT-PCR analysis of Otx2-/- clones after 3-day culture in EpiLC medium. Average of 
three technical replicates generated during 1 experimental repeat. Expression was normalised to the 
house keeping gene β-actin (dCT) and fold change (2-DDCT) values generated by normalising gene 
expression to day 0 DAK31 ESCs. Day 3 represents the 3rd day of cells being cultured in EpiLC 
medium, which translates to day 6 of the PGCLC differentiation protocol. Bars represent mean ± SD. 
This proposed that the loss of Otx2 expression in rat ESCs was negatively impacting 
the cells ability to enter an epiblast fate. However, as DA13 also showed a similar 
result to the Otx2-/- cells, it is still questionable whether these results are genuine 
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6.4.2.2 PGCLC differentiation protocol 
Cells subjected to the EpiLC differentiation protocol were transferred into hanging 
drops of PGCLC culture medium. Each hanging drop consisted of ~2,000 cells 
contained within 30µl PGCLC culture medium. Dishes containing the suspended 
hanging drops were incubated for 2 days to promote aggregation of the cells. After 2 
days, the aggregates were transferred into 6-well low adhesion plates and remained 
in suspension for a further 4 days. After the 12 day differentiation protocol, the 
aggregates were carefully broken apart by gentle pipetting (trituration) and the cell 
suspensions were stained with fluorescent antibodies for SSEA-1 and CD61. These 
surface markers were used to monitor the differentiation status of the cells and sort 
them into populations which were either unstained, single stained, or double stained 
for both surface markers by fluorescent activated cell-sorting (FACs). The gating 
strategy detailed in section 2.6.7 was used. The remaining cells were gated to 
isolate populations of double negative, single stained and double stained 
populations by plotting CD61 (586/15A) versus SSEA-1 (670/14A) using fluorescent 
activated cell-sorting (FACs). The gates were set against unstained DAK31 ESCs. 
Rat ESC cultures maintained in 2i+LIF on MEFs possessed both SSEA-1+ve and 
SSEA-1-ve cells (Figure 6.4.5). The parental cells which had been subjected to the 
PGCLC differentiation protocol showed a general loss of SSEA-1+ve cells within the 
whole population, but very few CD61+ve cells (Figure 6.4.5). 
After being subjected to the PGCLC differentiation protocol, the Otx2-/- clones 
(DA15, DA16 & DA28) and DA13 clone were found to have a greater proportion of 
CD61+ve cells compared to the parental DAK31 cell line (Figure 6.4.5).  
DA13, DA15 and DA16 clones pre-cultured in 2i+LIF medium retained a distinct 
population of SSEA-1+ve/CD61-ve cells, proposing that some cells from these clonal 
populations retained a stem cell characteristic despite being subjected to a PGCLC 
differentiation protocol (Figure 6.4.5). When pre-cultured in 1i medium, these same 
clones had smaller proportions of SSEA-1+ve/CD61-ve cells and a greater proportion 
of SSEA-1-ve/CD61+ve cells compared to the 2i+LIF pre-cultured cells (Figure 6.4.5). 
The 1i medium pre-culture appeared to be better suited to drive these clonal 
populations out of the stem cell fate. 
DA28 cells pre-cultured in 2i+LIF medium had a similar reduction in the number of  
SSEA-1+ve/CD61-ve cells to the parental DAK31 cell line after being subjected to the 
PGCLC differentiation protocol. 
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Pre-culturing DA28 cells in 1i medium improved the proportion of SSEA-1-ve/CD61+ve 
cells present after undergoing the PGCLC differentiation protocol, but did not 
promote a further reduction in the proportion of cells retaining the SSEA-1+ve/CD61-ve 
profile.  
 
Figure 6.4.5. Flow cytometry plots for Otx2-/- clones undergoing the PGCLC differentiation 
protocol. Each flow cytometry plot displays percentage of population which stained positively for CD61 
and SSEA-1. Rat ESCs (DAK31) = ESCs stained for SSEA-1 and CD61. Pre-2i+LIF = pre-cultured in 
2i+LIF medium for 3 days prior to EpiLC differentiation. Pre-1i = pre-cultured in 1i medium for 3 days 
prior to EpiLC differentiation. 
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These individual populations were analysed for expression of PGC related 
transcripts. It was hypothesised that there would be an increased expression of 
PGC markers within differentiated Otx2-/- clones compared to the parental line. The 
qRT-PCR data represents a single experimental replicate, with the average 
transcript expression being calculated from 3 technical replicates. Data from DA13 
cells pre-cultured in 1i medium was omitted due to an operator fault during the 
sorting of this clone.  
Blimp1 expression from the SSEA-1-ve/CD61-ve population was elevated in DA15 and 
DA16 cells which had been pre-cultured in 1i medium (Figure 6.4.6). However, 
SSEA-1+ve/CD61-ve and SSEA-1-ve/CD61+ve cells from all cell lines either showed 
similar or reduced Blimp1 expression compared to the parental DAK31 cell line 
(Figure 6.4.6). Prdm14 transcript expression was elevated in the SSEA-1-ve/CD61-ve 
and SSEA-1+ve/CD61-ve populations of DA15 and DA16 cells previously pre-cultured 
in 1i medium, as well as DA13 cells which had been pre-cultured in 2i+LIF medium 
(Figure 6.4.6). Both DA15 and DA16 cells had elevated Ap2γ expression in the 
SSEA-1-ve/CD61-ve and CD61+ve populations compared to the parental DAK31 cell 
line (Figure 6.4.6). However, DA28 cells had raised Ap2γ expression in all stained 
populations when compared to the parental cell line (Figure 6.4.6).  
The expression of all three PGC transcription factors Blimp1, Prdm14 and Ap2γ 
were elevated in the SSEA-1+ve/CD61+ve population of DA15, DA16, and DA28 
clones pre-cultured in 1i medium when compared to the parental DAK31 cell line 
(Figure 6.4.6).  
The qRT-PCR data showed that the loss of Otx2 in the Otx2-/- clones DA15 and 
DA16 had a positive influence on the expression of all PGC transcription factors 
expression during the PGCLC differentiation protocol, but there was considerable 
variability in PGC transcription factor expression between the different Otx2-/- clones.  
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Figure 6.4.6 qRT-PCR analysis of the expression of PGC transcription factors in SSEA1/CD61 
stained populations of Otx2-/- clones subjected to a PGCLC differentiation protocol. Cells were 
harvested after 12 days of PGCLC differentiation and separated into SSEA-1 (S) and CD61 (C) stained 
populations. (+) = Positive for stain, (-) = Negative for stain. Expression was normalised to the house 
keeping gene β-actin (dCT) and fold change (2-DDCT) values generated by normalising gene 
expression to day 0 DAK31 ESCs. Data shown is the mean of technical triplicates generated from one 
experiment ± SD. 
Nanog and Stella gene expression were substantially increased in SSEA-1+ve/CD61-
ve and SSEA-1+ve/CD61+ve cells of both DA15 and DA16 clones compared to the 
parental cell line (Figure 6.4.7). Oct4 expression in the SSEA-1+ve/CD61-ve and the 
SSEA-1+ve/CD61+ve populations of DA15 and DA16 was similar to that of the 
parental (Figure 6.4.7). However, Oct4 expression in the SSEA-1-ve/CD61-ve and 
SSEA-1-ve/CD61+ve cells of Otx2-/- clones was reduced compared to the parental 
(Figure 6.4.7). Pluripotency gene expression of DA28 cells was far lower than that in 
the parental DAK31 cell line (Figure 6.4.7). 
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Figure 6.4.7. qRT-PCR analysis of the expression of pluripotency genes in SSEA1/CD61 stained 
populations of Otx2-/- clones subjected to a PGCLC differentiation protocol. Cells were harvested 
after 12 days of PGCLC differentiation and separated into SSEA-1 (S) and CD61 (C) stained 
populations. (+) = Positive for stain, (-) = Negative for stain. Expression was normalised to the house 
keeping gene β-actin (dCT) and fold change (log scale) (2-DDCT-Log(y)) values generated by 
normalising gene expression to day 0 DAK31 ESCs. Data shown is the mean of technical triplicates 
generated from one experiment ± SD. 
DA15 was the only Otx2-/- clone to have a substantial increase in PGC marker 
expression within CD61+ve cells compared to the parental DAK31 cell line (Figure 
6.4.8). qRT-PCR analysis determined that Nanos3 and Dazl expression were both 
elevated in SSEA-1+ve/CD61-ve and SSEA-1+ve/CD61+ve DA15 cells pre-cultured in 
2i+LIF medium, whereas increased Vasa was detected in CD61+ve DA15 cells pre-
cultured in 1i medium (Figure 6.4.8).  
Increased Nanos3 expression was also present in SSEA-1-ve/CD61-ve DA16 and 
DA28 cells pre-cultured in 1i medium, as well as in SSEA-1+ve/CD61-ve DA13 and 
DA16 cells pre-cultured in 2i+LIF medium (Figure 6.4.8).  
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All other Otx2-/- clones had similar or reduced expression of Dazl or Vasa compared 
to the parental after undergoing the PGCLC differentiation protocol (Figure 6.4.8).  
 
Figure 6.4.8. qRT-PCR analysis of the expression of PGC marker genes in SSEA1/CD61 stained 
populations of Otx2-/- clones subjected to a PGCLC differentiation protocol. Cells were harvested 
after 12 days of PGCLC differentiation and separated into SSEA-1 (S) and CD61 (C) stained 
populations. (+) = Positive for stain, (-) = Negative for stain. Expression was normalised to the house 
keeping gene β-actin (dCT) and fold change (2-DDCT) values generated by normalising gene 
expression to day 0 DAK31 ESCs. Data shown is the mean of technical triplicates generated from one 
experiment ± SD. 
Transcript expression of markers of endoderm (Gata4, Gata6) and trophectoderm 
(Gata3) were also analysed to determine whether the loss of Otx2 expression 
influenced the proportion of the cells differentiating into these lineages during the 
PGCLC differentiation protocol. DA13, DA15, DA16 and (almost all) DA28 
populations had reduced Gata4 and Gata6 expression compared to the parental cell 
line (Figure 6.4.9). However, the SSEA-1+ve/CD61-ve DA28 cells did have similar 
Gata4 expression to the parental when pre-cultured in 1i medium (Figure 6.4.9). 
Gata3 expression was higher in SSEA-1-ve/CD61-ve and SSEA-1-ve / CD61+ve cells of 
all Otx2-/- knock-out cell lines when compared to the parental cell line (Figure 6.4.9). 
However, only DA28 showed increased Gata3 expression in SSEA-1+ve/CD61-ve and 
SSEA-1+ve / CD61+ve cells when compared to the parental (Figure 6.4.9).  
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Figure 6.4.9. qRT-PCR analysis of the expression of Endoderm (Gata4, Gata6) and 
Trophectoderm (Gata3) genes in SSEA1/CD61 stained populations of Otx2-/- clones subjected to 
a PGCLC differentiation protocol. Cells were harvested after 12 days of PGCLC differentiation and 
separated into SSEA-1 (S) and CD61 (C) stained populations. (+) = Positive for stain, (-) = Negative for 
stain. Expression was normalised to the house keeping gene β-actin (dCT) and fold change (2-DDCT) 
values generated by normalising gene expression to day 0 DAK31 ESCs. Data shown is the mean of 
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6.5 Chapter 6 discussion 
OTX2 assists the transition of mouse ESCs out of naïve pluripotency, and is 
involved in the stabilisation of the primed epiblast-like state (Yang et al. 2014, 
Buecker et al. 2014). This is accomplished by redirecting transcription factors such 
as OCT4 to alternative enhancer elements, driving the expression of genes involved 
in Epiblast fate determination (Yang et al. 2014, Buecker et al. 2014). Loss of Otx2 
expression in Nanog expressing mouse ESCs reduces the proportion of cells within 
an FGF-induced early primed state, suggesting that Otx2-/- ESCs are more resistant 
to differentiation into the Epiblast fate (Acampora et al. 2017). However, it has also 
been shown that mouse Otx2-/- knock-out cell lines generate a greater proportion of 
PGCLCs compared to wild-type cells when induced to differentiate via a PGCLC 
differentiation protocol (Zhang et al. 2018). It has been proposed that the loss of 
Otx2 extends the time that mouse cells are in a competent state to enter the PGCLC 
lineage, before the cells become committed to differentiate into other cell fates 
(Zhang et al. 2018). During the course of this project, it has been shown that 
although basal expression of Otx2 in rat ESCs is lower than mouse ESCs, Otx2 is 
induced in rat cells cultured in EpiLC medium. Based on the work in mouse ESCs, it 
was hypothesised that loss of Otx2 expression in rat ESCs would improve the 
proportion of cells being directed towards the germ cell lineage during a PGCLC 
differentiation protocol.  
 
6.5.1 Otx2 expression is not required for maintaining rat ESCs in vitro  
A CRISPR/Cas9 gene-editing strategy was used to generate rat ESCs clones 
lacking a functional copy of the Otx2 gene. Approximately 70% of rat ESC clones 
post cell-sorting had the intended deletion within one or both alleles of the Otx2 
gene. Of these edited clones, 45% had evidence of a deletion within both alleles of 
Otx2 gene. Due to the generally high efficiency of CRISPR/Cas9 induced edits in 
rodent cell lines (Jin & Li 2016), it was anticipated that the majority of the clones 
would have indels introduced at either or both CRISPR cut sites if all clones had 
been analysed. Three Otx2-deficient rat ESC clones were selected based on their 
normal karyotype, and were shown to lack detectable OTX2 protein by 
immunostaining. These results demonstrate that OTX2 is not required for the self-
renewal of rat ESCs.  
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6.5.2 Otx2 knock-out impairs the differentiation of rat cells into an 
epiblast state  
Rat Otx2-/- clones were subjected to two independent differentiation protocols to 
determine whether the loss of Otx2 affected the differentiation of rat ESCs into an 
Epiblast-like state. When induced to differentiate during the undirected EB 
differentiation protocol, rat Otx2-/- clones had reduced expression of the epiblast 
markers Fgf5 and Brachyury compared to the parental cell lines. Additionally, rat 
Otx2-/- clones retained similar Nanog expression to clones in the ESC state, while 
Nanog expression was lost in the rat ESC parental cell line. OTX2 and NANOG are 
reported to have antagonistic functions in mouse ESCs, Nanog+ve/Otx2-ve cells are 
considered to be naïve stem cells while Nanog-ve/Otx2+ve cells have primed stem cell 
characteristics (Acampora et al. 2017). In the mouse, OTX2 helps stabilise the more 
primed epiblast-like state by targeting OCT4 to alternative enhancer elements of 
genes associated with epiblast differentiation (Yang et al. 2014, Buecker et al. 
2014). Therefore, as hypothesised, the loss of functional OTX2 protein expression 
within rat ESCs may have reduced the capacity of these cells to differentiate out of 
the naïve state and into the epiblast fate. Finally, Otx2-/- clones had increased 
expression of the PGC transcription factors Prdm14 and Ap2γ. In mice, NANOG can 
induce the expression of Prdm14 independently of the BMP4 signalling pathway 
within EpiLCs (Murakami et al. 2016). This may suggest that the increased Prdm14 
expression observed in Otx2 null rat ESCs could be related to the sustained 
expression of Nanog within the Otx2-/- cells. Ap2γ expression has been detected in 
the trophectoderm lineage during embryogenesis (Chazaud et al. 1996, Auman et 
al. 2002), suggesting that some ESCs may have been directed towards the 
trophectoderm lineage in the absence of OTX2 rather than the epiblast.  
Rat Otx2-/- clones subjected to the more directed EpiLC differentiation protocol had 
reduced Fgf5 expression compared to the parental cell line. This result was similar 
to that generated by mouse Otx2-/- knock-out cell lines (Zhang et al. 2018), 
supporting the suggestion that loss of OTX2 protein impairs the ability of rat cells to 
differentiate efficiently into the epiblast fate. However, unlike the cells which had 
been subjected to the EB differentiation protocol, Nanog expression was almost 
undetectable in Otx2-/- cells cultured in EpiLC medium. A small decrease in Nanog 
expression has been shown in mouse Otx2-/- cells during EpiLC differentiation 
(Zhang et al. 2018), but is not as dramatic as that seen in the rat Otx2-/- cells.  
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This suggests that the EpiLC differentiation conditions used were still capable of 
driving Otx2-/- rat ESC differentiation out of naïve state. Activin A (a key component 
of the EpiLC medium) can be used to direct the differentiation of mouse (Tada et al. 
2005, Yasunaga et al. 2005) and human (D’Amour et al. 2005) ESCs to produce 
endoderm. Rat ESCs have been previously reported to have a pre-disposition for 
differentiating into the endoderm lineage (Nichols et al. 1998). Therefore, when 
epiblast differentiation via the loss of Otx2 expression is suppressed, perhaps 
Activin A drives a greater proportion of rat ESCs towards the endoderm lineage. The 
concentrations of cytokines within the EpiLC medium used to induce mouse EpiLC 
differentiation are perhaps more suited for driving rat ESCs towards the endoderm 
lineage rather than the epiblast. Future investigations should determine whether 
accurate titration of factors such as Activin A can identify a suitable concentration of 
cytokines that effectively stimulates rat EpiLC differentiation. In summary, loss of 
Otx2 expression impaired the ability of rat ESCs to transition into the Epiblast fate, 
but did not prevent cellular differentiation into other lineages.  
 
6.5.3 Otx2 knock-out does not reliably improve rat PGCLC 
determination when cells are subjected to the PGCLC 
differentiation 
Rat Otx2-/- clones subjected to the PGCLC differentiation protocol had an increased 
proportion of CD61+ve cells (14% - 32.5%) compared to the parental cell line (3% - 
4%), especially after pre-treatment in 1i medium. This is similar to what has been 
shown in the mouse ESC, where a greater proportion of CD61+ve cells are present 
from Otx2-/- cells (~80%) compared to the control (~10%) after PGCLC 
differentiation (Zhang et al. 2018). Otx2-/- mouse cells are also reported to have 
increased PGC transcription factor and Nanog expression within the PGCLC 
population compared to control cells (Zhang et al. 2018). Two Otx2-/- clones had 
increased expression of PGC transcription factors and pluripotency genes within the 
CD61+ve population. However, only one of these two clones had increased 
expression of PGC specific marker genes. This suggests that the loss of Otx2 in rat 
cells may not have the same effect on PGCLC determination as it does in the 
mouse. However, as there appeared to be some increase in PGC transcription 
factor expression, there could be a benefit in combining Otx2 knock-out with 
overexpression of the PGC transcription factors. Using a CRISPR/Cas9 strategy 
similar to that used in Chapter 4, PGC transcription factor transgene cassettes could 
be inserted downstream of the Otx2 promotor.  
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The loss of Otx2 expression coupled with increased PGC transcription factor 
expression might increase the efficiency of directing rat ESC differentiation towards 
the PGC lineage.  
 
6.5.4 Otx2 knockout reduces the expression of endoderm markers and 
increases Gata3 expression when cells are subjected to the 
PGCLC differentiation protocol 
All Otx2-/- CD61+ve rat cells had reduced expression of endoderm markers Gata4 and 
Gata6 when compared to the parental cell line. The loss of Otx2-/- expression in 
mouse embryos leads to defects in the endoderm of the developing mouse embryo 
(Rinn et al. 1998, Acampora et al. 1998, 2009), regions which are positive for Gata4 
and Gata6 expression (Cai et al. 2008). In zebrafish both Gata4 and Gata6 are 
noted to be reduced in the absence of Otx2 expression during endoderm 
specification in early development (Tseng et al. 2011). Therefore, Otx2-/- rat cells 
may require stronger differentiation cues to direct cellular differentiation towards the 
endoderm lineage, e.g. the presence of Activin A within the medium (Tada et al. 
2005, Yasunaga et al. 2005, D’Amour et al. 2005).  
Sub-populations of Otx2-/- cells also had increased Gata3 expression when 
compared to the parental cell line. In mouse ESCs, loss of Nanog and Otx2 
expression induced an increase in trophectoderm markers such as Gata3 
(Acampora et al. 2017). Increased Gata3 expression in the rat Otx2-/- cells was also 
detected in populations with low expression of Nanog. Therefore, the combined loss 
of Otx2 expression and Nanog in differentiating rat cells may also direct 
differentiation towards the Gata3+ve cell lineages (e.g. trophectoderm) rather than 
the PGC lineage. In conclusion, knockout of the Otx2 gene could potentially allow 
cells to differentiate into other cellular lineages such as the trophectoderm, even 
when put through a directed differentiation protocol.  
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Chapter 7 Concluding remarks 
7.1 Rat ESCs & PGCLC differentiation 
During mammalian embryogenesis, a small proportion of cells within the proximal 
posterior region of the post-implantation epiblast adopt a germ cell fate (Ohinata et 
al. 2005, Dudley et al. 2007, Rao et al. 2010, Welling & Geijsen 2013, Günesdogan 
et al. 2014, Irie et al. 2014). This differentiation event is initiated by BMP4 and 
WNT3 signals generated by the adjacent extraembryonic ectoderm and visceral 
endoderm (Ohinata et al. 2005, Dudley et al. 2007, Rao et al. 2010, Welling & 
Geijsen 2013, Günesdogan et al. 2014). It is thought that the appropriate 
concentration of these signalling molecules, their location and the developmental 
timing of their actions (~E5.5 - E6.5 in mice) are crucial to ensure successful 
establishment of the germline (Tam & Zhou 1996, Ohinata et al. 2009). 
Transplantation experiments have shown that uncommitted “developmentally 
competent” post-implantation epiblast cells can be directed into the PGC fate if 
introduced into this “germ cell” inductive environment (Tam & Zhou 1996, Ohinata et 
al. 2009).  
ESCs derived from rats will successfully colonise the somatic tissue of chimaeric 
animals (Buehr et al. 2008, Li et al. 2008), however, the efficiency of germline 
contribution of rat ESCs has been noted in our laboratory as being more variable 
than that observed from mouse ESCs (data not shown). This variability in germline 
transmission is likely to be influenced by two factors, the genetic integrity or the 
developmental competence of the ESCs. Cultured cell lines, including ESCs, are 
prone to aneuploidy (Liu et al. 1997, Sugawara et al. 2006) and genetic 
mutations/variations (Kim et al. 2017) during extended culture and passaging. ESCs 
carrying such genetic abnormalities are normally prevented from contributing to the 
germline and developing into functional gametes (Liu et al. 1997, Longo et al. 1997). 
Genetic damage can also impair differentiation potential, disrupting appropriate 
regulation of key developmental genes involved in pluripotency, self-renewal and/or 
fate determination (Mikkola et al. 2006, Imreh et al. 2006). Accumulation of these 
genetic abnormalities during the culture of rat ESCs may restrict their differentiation 
potential, reducing the efficiency of rat ESC transmission into the germline. 
However, this issue can be minimised by using rat ESCs with a lower passage 
number, reducing the impact of genetic damage to the variability in germline 
transmission (Li et al. 2017).  
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Reduced germline transmission could also be the result of rat ESCs in 2i+LIF 
culture being in state that has less potential than the authentic in vivo rat epiblast. 
Rat ESCs display increased expression of lineage specific genes compared to 
mouse ESCs (Blair et al. 2011, Hong et al. 2013), suggesting that established rat 
ESCs might exist in a primed, peri-naïve state compared to the naïve mouse ESCs.  
This state could be a key feature of rat ESCs in culture or be a by-product of 
maintaining rat ESCs in 2i+LIF culture conditions. Indeed, in common with mouse 
and human epiblast stem cells, rat ESCs are sensitive to the level of WNT/β-catenin 
signalling, where too little or too much β-catenin signalling in rat ESCs can induce 
differentiation (Buehr et al. 2008, Ying et al. 2008, Meek et al. 2013). This peri-naive 
state of rat ESCs may compromise their response to the pro-germline differentiation 
signals within the PGC-niche environment of the developing embryo, thereby 
effectively reducing the efficiency of the germline transmission of rat ESCs 
compared to the mouse. To mimic the naïve state of in vitro mouse ESCs, human 
pluripotent stem cells have been cultured in medium containing histone deacetylase 
(HDAC) inhibitors (Guo et al. 2017). HDAC-treated human cells expressed 
pluripotency markers which were only present in unprimed pluripotent cells but could 
not be efficiently differentiated into certain lineages such as definitive endoderm and 
neuroectoderm without first being pre-primed for differentiation (Guo et al. 2017). As 
the expression of epiblast markers in rat cells was improved when cells were pre-
cultured in medium lacking CHIR99021 and LIF, perhaps a similar issue is present 
in our rat ESCs; efficient directed differentiation requires rat cells to be primed prior 
to exit out of the naïve state, ensuring the cells are susceptible to the differentiation 
cues in the directed differentiation medium. 
The poor response of rat ESCs to the directed “Hayashi” PGCLC differentiation 
protocol, indicated that reduced PGC specification might directly contribute to the 
limited germline transmission of rat ESCs in vivo. Low level expression of PGC 
genes in the differentiated rat ESC cultures could indicate that either very few cells 
adopt a PGCLC fate or that the cells are unresponsive to the PGC inductive signals. 
Efficient induction of mouse ESCs into PGCLCs is thought to require transition 
through an EpiLC phase, where cells will respond to the PGCLC induction signals 
(Hayashi et al. 2011, 2013). However, differentiating rat cells had low expression 
levels of markers associated with EpiLC differentiation, indicating a failure to 
generate a suitable population of responsive cells.  
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Pre-treating rat cells in conditions that reduced β-catenin signalling increased the 
expression of epiblast markers including Fgf5, but this did not translate to increased 
expression of PGC-specific marker genes when the PGCLC differentiation protocol 
was applied. Inefficient activation of the PGCLC programme suggested that the 
differentiation of rat ESCs might be compromised by both reduced formation of the 
EpiLC state and by sub-optimal PGCLC differentiation signals in the ESC culture 
medium.  
   
7.2 Manipulation of the epiblast network to improve 
germ cell fate 
Two directed differentiation approaches were applied to improve the efficiency of rat 
PGCLC differentiation in vitro. These experimental approaches both involved the 
manipulation of the epiblast transcriptional network, either through the 
overexpression of PGC regulatory factors or the removal of a potentially antagonistic 
somatic differentiation factor. As well as the difference in sensitivity to β-catenin 
signalling (Buehr et al. 2008, Ying et al. 2008, Meek et al. 2013) and elevated 
expression of differentiation markers (Blair et al. 2011, Hong et al. 2013), a striking 
difference between rat and mouse ESCs is the negligible levels of Blimp1 
expression in rat ESCs. Downregulation of Blimp1 expression reduces the efficiency 
of PGC specification in mice, due to the cells being unable to downregulate pro-
somatic differentiation genes and reactivate the pluripotency gene network required 
for PGCs (Bikoff et al. 2009, John & Garrett-Sinha 2009, Schäfer et al. 2011). Rat 
cells expressing Blimp1 transgene had increased expression of Nanog and the early 
PGC-specific marker Nanos3 compared to parental controls when subjected to the 
“Hayashi” PGCLC differentiation protocol. However, expression of other commonly 
associated PGC markers such as the late stage PGC-specific markers Vasa and 
DazL or the Oct4 transcription factor remained relatively unchanged or were 
reduced. Therefore elevated expression of Blimp1 in rat ESCs might help to 
suppress unscheduled ESC differentiation or sporadic expression of somatic 
markers but requires increased expression of other PGC regulators to activate the 
full complement of PGC markers. 
Overexpression of multiple PGC related factors did increase the expression of PGC-
markers in differentiating rat ESCs. However, in contrast to mouse ESCs (Nakaki et 
al. 2013), the most effective combination was not the expression of all three factors 
but was BLIMP1 combined with either PRDM14 or AP2γ.  
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Over-expression of all three factors in rat ESCs was less effective, reducing the 
induction of PGC markers, even when the three factors were expressed from 
independent expression vectors. This indicated that expression levels of the PGC 
regulators was probably not a limiting factor. It also indicated that high level 
expression of PRDM14 and AP2γ together during rat ESC differentiation was 
potentially counterproductive in rat cells. In the mouse, PRDM14 and AP2γ have 
been noted to associate at similar enhancer regions (Günesdogan et al. 2014), 
resulting in the net upregulation of germ cell and pluripotency markers while also 
downregulating FGF signalling and somatic differentiation (Auman et al. 2002, 
Yamaji et al. 2013, Nakaki & Saitou 2014). At this time, there does not seem to be 
any reported evidence of Prdm14 and Ap2y working as direct antagonists to one 
another in the literature.  
However, reduced germ cell marker expression in cells co-expressing both factors 
alongside Blimp1 may be related to the timing of gene expression. Interestingly, it is 
known that expression of BLIMP1, PRDM14 and AP2γ occurs in temporal order 
during in vivo PGC specification in the mouse. Blimp1 expression is first detected in 
PGC precursor cells at ~E6.25 dpc, closely followed by Prdm14 expression at 
~E6.75 dpc and finally Ap2γ at ~E7.25 dpc (Ohinata et al. 2005, 2009, Schäfer et al. 
2011). Presumably the successive and overlapping actions of these factors ensure 
that the development of the epiblast cells advances appropriately to promote 
differentiation toward a germ cell fate (Ohinata et al. 2005, 2009, Schäfer et al. 
2011). Overexpression of Ap2γ in mouse ESCs can promote their differentiation into 
a trophoblast stem cell (TSC) fate, increasing the expression of the pro-TSC 
transcription factor Elf5 (Kuckenberg et al. 2010). Preliminary data generated from 
rat ESCs showed that cells overexpressing Ap2γ alone had increased expression of 
Elf5 and other markers associated with trophoblast such as Gata3. However, large 
variation in trophoblast marker expression between the different rat ESC lines made 
it difficult to definitively consolidate the data. Simultaneous expression of Ap2γ and 
Prdm14 (a known FGF signalling inhibitor (Yamaji et al. 2013, Nakaki & Saitou 
2014)) in peri-naïve rat ESCs may interfere with PGC differentiation, diverting cell 
differentiation into other cell lineages such as trophoblast. It would be of interest to 
observe whether inducing the overexpression of the PGC transcription factor 
transgenes at comparative time points to the in vivo system would improve the 
efficiency of rat germ cell fate determination.  
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Given that expression of PGC regulators appears to be temporally controlled during 
the early phase of PGC differentiation (Ohinata et al. 2005, 2009, Schäfer et al. 
2011), experimental systems where these transcription factors can be expressed at 
an appropriate time might provide a way to avoid potential conflict between 
differentiation signals and boost PGC differentiation. The insertion of Blimp1 
downstream of the Brachyury promoter was an attempt to target expression of 
Blimp1 transgene to the post-implantation epiblast, thereby shifting differentiation 
away from the formation of the somatic lineages and enhance formation of PGCLCs. 
Key aspects of this approach were that the knock-in transgene did not require any 
external intervention, would only be expressed in differentiating ESCs, and could be 
executed in vivo when ESCs are injected into blastocysts. However, the results of 
the in vitro experiments suggest that although this approach could be achieved 
technically, cell clones had low level expression of early PGC markers, making this 
technique less efficient than the doxycycline-induced expression of PGC regulator 
cassettes.  
In view of the results obtained with the doxycycline-inducible vectors, a more 
effective construct would combine BLIMP1 with either AP2γ or PRDM14.  
An issue with this approach is that it relies on sufficient cells differentiating into a 
suitably receptive EpiLC/Epiblast state. Therefore, it would be necessary to ensure 
these rat cells are capable of entering this cell fate, either by modification of the 
differentiation protocol or the pre-treatment of cells prior to differentiation.  
Another approach to controlling rat ESC differentiation was through overexpression 
of the pluripotency regulator Nanog. Overexpression of the NANOG transcription 
factor in mouse EpiLCs directs their differentiation towards the germ cell fate 
(Murakami et al. 2016). Expression of a Nanog transgene during rat cell 
differentiation increased the expression of Blimp1, Prdm14 and Ap2γ, which was 
consistent with what was reported for mouse EpiLC differentiation (Murakami et al. 
2016). Although this suggests that Nanog is involved in the activation of PGC 
transcription factor expression in rats, the increase in PGC-specific marker gene 
expression in Nanog overexpressing cells was not as substantial as that seen in rat 
cells expressing Blimp1 in combination with Prdm14 or Ap2γ. Perhaps co-
expression of Nanog transgene with the PGC transcription factors during directed 
differentiation would further enhance the efficiency of rat cell differentiation into the 
germ cell fate?  
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It has been observed in mice that entry into the EpiLC state is accompanied by 
downregulation of the pluripotency related genes, including Nanog (Hayashi et al. 
2011). This implies that loss of Nanog function might be critical for allowing ESCs to 
exit pluripotency, creating a developmental window when epiblast cells can respond 
to differentiation signals. It would be interesting to see if this pattern of expression 
could be simulated in the rat ESCs carrying the doxycycline-inducible Nanog 
transgene. Over-expression of Nanog in the undifferentiated rat ESCs prior to 
differentiation could reinforce and promote the naïve phenotype (reducing non-
scheduled differentiation). This would be followed by downregulation of Nanog by 
withdrawal of doxycycline when the cells are exposed to EpiLC conditions, inducing 
a germ cell fate receptive state. Finally, re-expression of the Nanog transgene could 
be induced when cells are cultured in PGCLC conditions, potentially assisting PGC 
differentiation. 
An important assumption that underpinned the experimental approaches in this 
project was that the functions of the key PGC regulators, Blimp1, Prdm14 and Ap2γ 
were conserved between rat and mouse. Although, rat and mouse are genetically 
similar and share many common features in early embryonic development, such as 
formation of the epiblast into an epithelial cup prior to gastrulation (Huber 1915, 
Nichols & Smith 2009, Nichols & Smith 2011, Bedzhov et al. 2014, Irie et al. 2014), it 
remains possible that the rat and mouse differ in the key PGC regulators. In porcine 
and human cells, BMP and WNT signalling induce the expression of Sox17 and 
Blimp1 (Irie et al. 2015, Wang et al. 2016, Kobayashi et al. 2017). Elevated levels of 
Sox17 were identified by single-cell RNA sequencing in both embryonic hPGCs and 
in vitro derived PGCLCs, while the knockdown of Sox17 in human IPSCs 
undergoing the PGCLC differentiation protocol reduced the number of TNAP 
positive cells and the expression of key PGC markers (e.g. Blimp1) (Irie et al. 2015). 
Elevated Sox17 expression has also been detected in porcine derived PGCLCs 
compared to the pig IPSCs (Wang et al. 2016), potentially emphasising a role for 
SOX17 in the formation of pig PGCs. Although Sox17 may play a crucial role in the 
generation of PGCs in species which produce bilaminar discs during embryogenesis 
(Irie et al. 2015, Wang et al. 2016, Kobayashi et al. 2017), it is difficult to say 
whether it would play a similar role in rodents who produce epithelium cups instead 
(Huber 1915, Nichols & Smith 2009, Nichols & Smith 2011, Bedzhov et al. 2014, Irie 
et al. 2014) without further investigation.  
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The second strategy taken to improve the differentiation of rat ESCs toward a germ 
cell fate was to restrict differentiation into the somatic cell lineages. By uncoupling 
somatic cell differentiation, it was hoped that the rat cells would become more 
available to the PGC inductive signals in the differentiation medium by losing a 
potential differentiation route, thus improving the efficiency of germ cell fate 
determination. Loss of the OTX2 transcription factor in mouse ESCs decreases the 
proportion of cells able to differentiate into the somatic cell lineages and increases 
the efficiency of germ cell determination both in vitro and in vivo (Zhang et al. 2018). 
Knocking out Otx2 expression in rat cells decreased the expression of somatic cell 
differentiation gene markers when cells were induced to differentiate. However, 
increased expression of both PGC transcription factors and PGC-specific marker 
genes were present in only a single Otx2 knock-out clone when subjected to the 
“Hayashi” PGCLC differentiation protocol. Although these results match what has 
been reported for Otx2 knock-out cell lines generated from other model organisms 
(Acampora et al. 1998, Rhinn et al. 1998, Tseng et al. 2011, Zhang et al. 2018), it is 
not enough to conclude that the loss of Otx2 expression is beneficial for rat germline 
determination. The results however do support future investigations into the 
potential antagonistic role of Otx2 in rat PGCLC fate determination and the benefits 
of its removal during PGC differentiation.  
Combining PGC transcription factor overexpression while preventing somatic cell 
differentiation may improve the efficiency of rat ESC differentiation into the germline. 
Overall, manipulation of the epiblast gene network of rat ESCs showed an 
improvement in the efficiency of differentiating rat cells into the germ cell fate. Cells 
subjected to an undirected embryoid body differentiation protocol showed the 
greatest induction in PGC-specific markers during transgene expression compared 
to those subjected to the “Hayashi” PGCLC differentiation protocol. This suggests 
that the protocol developed in mouse is sub-optimal for rat ESC differentiation into 
the germline. Additionally, this highlights one of the crucial issues with in vitro 
experimental research, despite the in vitro culture conditions being designed to 
mimic the niche in vivo environment of the embryo, these conditions are not identical 
to those the cells would experience within a developing rat embryo. To fully 
interrogate whether the implemented strategies do improve rat germ cell fate 
determination, it would be necessary to inject these manipulated cells into rat 
embryos to form chimaeric animals.  
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Improved rat ESC engraftment into the germline of the donor embryo would confirm 
the experimental approach used was beneficial for increasing the efficiency of rat 
ESC differentiation into the germline.  
 
7.3 Future work 
During this investigation, it was determined that directed differentiation of rat ESCs 
towards the epiblast and germ cell fate in vitro cannot be accomplished following the 
same protocol as mouse ESCs. Efficient induction of mouse ESCs into PGCLCs is 
thought to require transition through an EpiLC phase, where cells become 
responsive to the PGCLC induction signals (Hayashi et al. 2011, 2013). The 
difficulties in activating the PGCLC programme in in vitro cultured rat cells may have 
been related to the inefficient differentiation of rat ESCs into the EpiLC cell fate, 
reducing the number of cells which enter a PGC inductive state and therefore 
limiting the number of cells which can be successfully directed into the germ cell fate 
(Figure 7.3.1). Future investigations should compare the states of in vitro and in vivo 
rat cells to identify any distinct differences between the two, opening potential 
avenues of research for improving the efficiency of differentiating rat ESCs into 
PGCLCs. 
 
Figure 7.3.1: Models of the rodent ESC-PGCLC differentiation. A) Differentiation of mouse ESCs 
(mESCs) into PGCLCs in culture based on development of “Hayashi” PGCLC differentiation protocol. 
B) Hypothesised model of rat ESC differentiation when subjected to the “Hayashi” PGCLC 
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Gene expression profiling such as single-cell RNA sequencing would prove useful in 
better understanding how the pluripotent state of the rat ESCs compares to the in 
vivo rat ICM. Additionally, the epigenetic status of our rat ESCs could be explored 
further using gold standard techniques such as bisulfite sequencing or ChIP-Seq. 
Analysing the epigenetic status of rat ESCs would help identify whether the 
presence or absence of repressive and active epigenetic markers on gene 
promotor/enhancer elements of pro-epiblast or germ cell regulators is different to 
those of the rat epiblast or mouse ESCs, reducing the efficiency of generating rat 
PGCLCs. With a better understanding of the state of the rat ESCs, it would be 
possible to tailor the culture conditions of our rat ESCs to direct them into a state 
which better mimics the pre-implantation epiblast prior to PGC specification, 
potentially making the cells more responsive to differentiation cues and thereby 
improve the efficiency of differentiation out of the naïve state and towards the 
epiblast and/or germline. HDAC inhibitors have been used to induce a naïve state in 
human pluripotent stem cells that is closer to the ground state pluripotency observed 
from strains of mouse ESCs (Guo et al. 2017). Significantly, HDAC-treated cells did 
not efficiently differentiate into certain lineages such as definitive endoderm (Guo et 
al. 2017).  
Introducing HDAC inhibitors into the culture medium of rat ESCs might be useful for 
directing the differentiation towards the germline by not only ensuring the rat ESC 
genome is in a more epigenetically accessible state prior to differentiation, but also 
by potentially restricting rat ESC differentiation into unwanted cell lineages such as 
definitive endoderm, increasing the proportion of rat cells which adopt a germ cell 
fate. Resetting rat ESCs into a more naïve state might also make it easier to prime 
cells for differentiation into the epiblast/PGC cell fates due to the less repressive 
epigenetic state of the cells.  
An important assumption in this project was that the key PGC regulators would be 
conserved between mouse and rat. Expression of the PGC transcription factors 
required for mouse PGC determination were detected in the genital ridges of rat 
embryos, and so it seemed reasonable to explore their potential role in rat PGC 
specification by inducing their overexpression. Future investigations could explore 
their role in rat germline determination further by generating knock-out rat ESC lines 
lacking the expression of Blimp1, Prdm14 and/or Ap2γ.  
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If these factors shared a similar importance to PGC specification as described in the 
mouse, then it would be expected that germline transmission of the rat ESCs would 
be comprised when the cells are injected into an embryo to form chimaeric animals. 
Additionally, single-cell RNA sequencing of rat in vivo PGCs during development 
should be performed and compared to similar data generated from other species 
such as mice and humans. This multispecies comparison could assist in identifying 
the network of factors present during rat PGC specification and highlight factors 
which could be manipulated to improve the efficiency of directing differentiation into 
the germ cell fate. Comparing this data to that generated from the in vitro rat cells 
subjected to the “Hayashi” differentiation protocol would also assist in determining 
whether rat ESCs were being successfully directed towards a PGC cell fate, and 
what stage of PGC development the in vitro generated cells more closely resemble.  
Many of the experimental approaches used in this project did increase the 
expression of germ cell-specific markers in differentiating rat ESCs, suggesting that 
with refinement, these strategies could provide the basis for improving the efficiency 
of generating rat PGCLCs. The efficiency of PGC-specific marker induction was 
greatest in rat cell lines inducing the expression of either Blimp1 and Prdm14 or 
Blimp1 and Ap2γ from incorporated Tet-On piggyBac transposon vectors.  
One of the key advantages of this in vitro system is the ability to induce transgene 
expression at any time by introducing doxycycline into the culture medium.  
This system can be used to identify at what stage during in vitro rat PGCLC 
differentiation does overexpression of PGC regulators improve the efficiency rat 
PGC differentiation. This can be accomplished by inducing transgene expression at 
different stages throughout the PGCLC differentiation protocol and then identify the 
order and/or time point of expression which best induces germ cell fate 
determination. However, this system is more difficult to translate into the in vivo 
system, due to its reliance on external intervention to function.  
Therefore, manipulation of the epiblast gene network of rat ESCs using a HDR-
approach would be a more favourable strategy to implement in the future when 
transitioning into the in vivo system. An unintended outcome of incorporating a 
transgene cassette downstream of the Brachyury promotor was inducing the 
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It is reported that generation of CRISPR/Cas9 induced knock-out cell lines is more 
efficient than CRISPR HDR knock-ins (Kimura et al. 2015, Jin & Li 2016), signifying 
there is a high probability that any isolated rat cell clone harbouring an incorporated 
transgene cassette also will have an NHEJ-induced mutation of the other Brachyury 
allele. BRACHYURY null mice are embryonic lethal at ~E10.5 due to reduced 
posterior mesoderm formation and impaired notochord and allantois development 
(Aramaki et al. 2013). However, prior to this, loss of functional BRACHYURY protein 
also reduces the sustained expression of the key PGC transcription factors during 
the late streak stages (~E7.0), considerably reducing the survival of developing 
PGCs (Aramaki et al. 2013). On this basis, it has been suggested that Brachyury 
expression is critical for the sustained expression of the PGC regulators during PGC 
specification. An alternative ‘rewiring’ strategy to the one presented could be to 
target the 3’ end of the Brachyury gene instead of the transcriptional start site. A 
gene cassette would be designed with a 2A peptide at its 5’ end, ensuring 
polycistronic expression of the endogenous Brachyury gene as well as the 
transgenes contained in the cassette. The CRISPR/Cas9 cut site could be within the 
terminal exon of the Brachyury gene, with any missing nucleotides from the 
Brachyury sequence being replaced within the template vector. This strategy would 
reduce the chance of unintended indel formation within the gene disrupting 
endogenous gene expression and ensure full translation of the Brachyury transcript 
whilst also making sure termination does not occur before the introduced transgenes 
have also been translated.  
The reduced effectiveness of this method compared to the doxycycline-induced 
vectors may also have been related to the use of the relatively late epiblast marker 
Brachyury to drive transgene expression (Rivera-Pérez & Magnuson 2005).  
The Brachyury gene was chosen as a suitable target for inducing Blimp1 transgene 
expression due to it being linked with both the differentiation of epiblast cells 
(Rivera-Pérez & Magnuson 2005) and PGC specification (Aramaki et al. 2013), 
ensuring transgene expression occurred when rat cells were most likely to be 
susceptible to PGC differentiation cues. However, other gene targets could be 
considered such as FGF5 and OTX2. As Otx2 is expressed during the EpiLC 
transitionary phase (Yang et al. 2014, Buecker et al. 2014, Murakami et al. 2016), 
and knock-out of the Otx2 gene had a positive influence on PGC transcription factor 
expression in mouse (Zhang et al. 2018), this would be an appropriate alternative for 
driving transgene expression during differentiation out of the naïve ESC state.  
218  Chapter 7 
Using a similar strategy as that for HDR template insertion into the Brachyury locus, 
PGC transcription factor transgene cassettes could be inserted downstream of the 
Otx2 promotor, reducing the number of cells entering the somatic fate whilst driving 
differentiation towards the PGC lineage.  
An alternative approach could be the use of bacterial (BAC) or yeast (YAC) artificial 
chromosome DNA constructs. BACs and YACs have been used to introduce large 
gene cassettes into the genome of pre-implantation embryos including the 
regulatory elements necessary to drive gene expression, ensuring that transgene 
expression closely matches endogenous gene expression (Schedl et al. 1996, 
Headon & Overbeek 1999, Rostovskaya et al. 2012, Jung et al. 2016). These 
constructs can be transmitted through the germ line (Schedl et al. 1996, Headon & 
Overbeek 1999, Jung et al. 2016), and in the case of BACs, have been successfully 
incorporated into the rat genome previously using CRISPR/Cas9 gene editing and 
piggyBac transposition (Jung et al. 2016). Phenotypic changes during mouse 
embryo development have been shown to be induced by transgene expression from 
a YAC vector (Schedl et al. 1996, Headon & Overbeek 1999), showcasing the 
potential of these constructs to drive cellular differentiation of edited cells. A 
BAC/YAC vector could be incorporated into the genome of rat ESCs, inducing the 
expression of Blimp1 in combination with either Prdm14 or Ap2γ using the 
regulatory elements of an epiblast gene such as Brachyury or Otx2. When induced 
to differentiate, the edited cells would drive the expression of the PGC regulators 
when endogenous epiblast gene expression occurs, potentially assisting the 
directed differentiation of the cells towards the germ cell fate.  
A major technical issue encountered during this investigation was the sensitivity of 
rat ESCs to single cell sorting. The survival of rat ESCs post FACs was poor, with a 
high proportion of the surviving clones being karyotypically abnormal (outside the 
normal range). Rat ESCs can be cultured after colony dissociation (Buehr et al. 
2008, Ying et al. 2008), but ESCs carrying genetic abnormalities are normally 
prevented from contributing to the germline (Liu et al. 1997, Longo et al. 1997), 
potentially reducing the efficiency of ESC transmission into the germline. Human 
stem cells are reported to be sensitive to manipulation in vitro, reducing the cell 
recovery and survival of cells after FACs (Hoffman & Carpenter 2005). Human cells 
cultured in the presence of Y-27632 (ROCK inhibitor) for 24 hours post FACs have 
been shown to have a greater survival rate, recover faster and generate fewer 
karyotypically abnormal clones (Emre et al. 2010).  
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Rat ESCs cultured in DMEM/F12 medium supplemented with Y-27632 have been 
shown to have improved colony forming efficiency and reduced spontaneous 
differentiation during standard culture compared to 2i+LIF conditions (Yaoyao et al. 
2017). It would therefore be interesting to determine whether the addition of Y-
27632 or any other cell survival factor could prove beneficially for isolating a greater 
number of healthy rat ESCs harbouring the desired genome edit post FACs.  
As there is limited published literature on the markers of rat PGCs, it would also be 
beneficial to identify a greater selection of potential markers to purify PGCLCs 
generated from rat ESCs. Although the isolation of PGCLCs has been accomplished 
by staining pools for the presence of C-KIT (Yamaji et al. 2010) and Tissue Non-
specific Alkaline Phosphatase (TNAP) (Hayashi et al 2011), sequencing techniques 
such as microarrays performed on mouse PGCs have identified a greater number of 
germ-cell related genes which have proven useful for identification of mouse PGCs 
(Davood et al. 2011). Screening rat PGCs for germ cell-specific surface markers 
could improve the purification of rat PGCLCs from a differentiated pool of cells by 
providing alternative targets for antibody selection and FACs sorting. Another 
solution to using cell surface markers to identify PGCLCs could be the use of 
reporter cell lines. Cells harbouring a Nanos3-fluroscent protein reporter have been 
used to monitor differentiation of mammalian cells into the PGC lineage both in vitro 
and in vivo (Yamaji et al. 2010, Irie et al 2015, Kobayashi et al. 2017). Attempts 
were made to generate a rat ESC Nanos3-mCherry reporter cell line during this 
investigation, however, failure to identify gRNAs able to induce DSBs in the Nanos3 
locus meant this this was not accomplished. 
Modelling germ cell fate determination in vitro is a powerful tool to generate insights 
into the molecular mechanisms which drive and regulate differentiation into the 
germline. This knowledge would be invaluable to translate this into potential future 
cell therapies and fertility treatments in humans. Additionally, cell banking of in vitro 
pluripotent cell-derived gametes will be an invaluable contribution to the 
conservation of endangered species, as well as potentially reduce lengthy breeding 
programmes and increase the efficiency of generating livestock animals with 
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Figure A 1. Tet-EMPTY vector map 
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Figure A 2. Tet-BLIMP1 vector map 
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Figure A 3. Tet-PRDM14 vector map 
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Figure A 4. Tet-AP2γ vector map 
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Figure A 5. Tet-BLIMP1-PRDM14 vector map 
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Figure A 6. Tet-BLIMP1-AP2γ vector map 
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Figure A 7. Tet-BLIMP1-PRDM14-AP2γ vector map 
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Figure A 8. Tet-BLIMP1-NO vector map 
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Figure A 9. Tet-AP2γ-BF vector map 
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Figure A 10. Tet-NANOG vector map 
 
 
